Effect of Photoilluminated Riboflavin in Combination with some Anti Cancer Compounds on Macromolecules & R. B. C. by Husain, Eram
EFFECT OF PHOTOILLUMINATED RIBOFLAVIN IN COMBINATION 
WITH SOME ANTl CANCER COMPOUNDS ON 
MACROMOLECULES & R. B. C. 
THESIS 
SUBMITTED FOR THE AWARD OF THE DEGREE OF 
Boctor of ^l)ilQfl;opt)p 
IN 
BIOCHEMISTRY 
w 
BY ^ 
ERAM HUSAIN 
DEPARTMENT OF BIOCHEMISTRY 
FACULTY OF LIFE SCIENCES 
ALIGARH MUSLIM UNIVERSITY 
ALIGARH (INDIA) 
2008 
,n ^""' I't.. 
A natural daylight absorbing pigment of particular interest is vitamin B2 or 
riboflavin which is present in all aerobic cells. The photodynanuc action of 
riboflavin is known to involve the generation of reactive oxygen species. Studies 
in this laboratory have formerly shown the damaging effect of this sensitizer on 
several biological molecules. Hitherto the effect of certain biologically relevant 
endogenous/externally added compounds can inhibit/promote photodamage in 
living system. In this context an important class of biologically active and 
commercially valuable compounds which could potentially interact with 
riboflavin in humans may be the externally administered drugs. Since the vitamin 
and drug can occupy common locations in a biological system, light mediated 
interactions between them can initiate desirable/undesirable consequences. With 
reference to this framework of sensitizer-drug interactions, a recent report from 
this lab examined the combination of riboflavin and aminophyUine. AminophyUine 
is a routinely used medicine for various respiratory disorders especially asthma. 
AminophyUine in combination with riboflavin was found to augment degradative 
capacities of the sensitizer with aminophyUine getting oxidized in the process. 
Chemotherapeutic drugs are an essential category of compounds that need to be 
probed in this milieu. 
The aims of photogenotoxicity studies are to evaluate the 'genetic health' 
of surviving cells. During the past several years, phototoxicity has been studied 
at the molecular level. Phototoxic effects span from the cytotoxic-apoptotic effect 
to the induction of primary DNA damage and a variety of stress acting on the 
cell. Ultimately, it can lead to the induction of hereditary DNA modification. The 
development of new drugs has highlighted the necessity to develop the 
assessment of phototoxicity in the safety evaluation of compounds. The study is 
proposed to specifically address all the consequences of riboflavin-induced 
toxicity, the in vitro methods that can be proposed and used to screen for toxicity 
of sensitizer riboflavin and the photosensitization process resulting from the 
activation of drugs by light. Biological systems and endpoints of interest in that 
1 
particular objective are listed. The clinical relevance of interaction mediated 
consequences of drug and sensitizer is represented in patients undergoing 
radiation and chemotherapy cumulatively, wherein the potential interactions 
need to be carefully considered. 
Energy in the visible and UVA (315-400 nm) region can be absorbed by 
endogenous flavins and transferred to biomolectdes where it causes damage. 
Photosensitized damage to biomacromolecules such as DNA and proteins, 
participates in phototoxicity, photogenotoxicity and solar UV-carcinogenesis. 
Chemoprevention of photosensitized damage is an important method to curtail 
the phototoxic effects of endogenous sensitizers. The aforementioned are a few 
phototoxic effects exhibited by riboflavin, the sensitizer. It is rational to postulate 
scientifically that an agent rendering protection to the above would be entitled as 
'photochemoprotective' and the analysis 'photochemoprevention'. 
In the present analysis the impact of photoactivated riboflavin has been 
elucidated in the presence of chemotherapeutic drugs cisplatin and 5-fluorouracil. 
Perhaps, the potential properties of both drugs in the presence of riboflavin as a 
sensitizer and the ongoing impact of interactions on biological molecules have 
not been investigated. In this study a conscious and planned effort was designed 
to explore not only the degree of these interactions and imderstanding the photo 
mechanism alone but also the concurrent influence on biologically relevant 
molecules. The thesis is in continuation with our previous drug based study and 
aims to extend our effort into the sensitizer-drug array of interactions. 
In view of this, first chapter of the thesis specifically addresses cisplatin 
mediated inhibition on photoinduced oxidative damage by the sensitizer, 
riboflavin. The chapter has been bifurcated to deal with proteins and DNA 
individually. Binding of the sensitizer to the target biomolecules enhanced with 
photoactivation. Significantly, the observed binding correlates with firstly, the 
formation of free radicals and secondly, the degradative efficiency of riboflavin. 
A prominent decline effect by cisplatin on riboflavin induced structural 
alterations, impairment of enzymatic activity and damage to proteins was 
indicative of curbed photodecomposition. This corresponds to reduced 
photoexcitation of the sensitizer in presence of this particular platinum drug. The 
second unit to the first chapter reaffirms the occurrence of an analogous series of 
inhibition reaction. DNA degradation in cells such as lymphocytes implies 
genotoxicity by riboflavin. Using a cellular system of lymphocytes isolated from 
human peripheral blood and alkaline single cell gel electrophoresis, it was 
confirmed that cisplatin is indeed capable of rendering protection to DNA 
breakage in cells also. An interesting finding in the provisos of cisplatin was 
reduced generation of reactive oxygen species in cells. Nevertheless, a principal 
reason contributive to cytotoxicity of cisplatin is free radical production in 
normal cells. The concentration of drug utilized in our study is pharmacologically 
relevant and is used clinically for patients undergoing therapy. Furthermore 
cisplatin is equally efficient in causing DNA damage in this system. The complex 
riboflavin-cisplatin reduced the degradation catalyzed by each of them 
individually. The drug forms a complex with native entity of riboflavin. This 
complexation plausibly inhibits the photoexcitation phenomenon and reduces the 
damaging potential consequently. 
In the second chapter of the thesis, drug 5-fluorouracil different in class 
and mechanism of action has been prudently chosen to illustrate the oxidative 
potential of sensitizer in its presence. The drug behaves in a biphasic manner in 
case of both proteins and DNA with lower concentrations of the drug inhibiting 
the photosensitization phenomenon. Intermolecular interaction is ascertained to 
be the plausible reason for the anomalous pattern displayed by this particular 
drug at higher concentrations. The inhibition trend was similar with both the 
target biomolecules. The third and final chapter of the thesis addresses the 
spectial properties of native and excited riboflavin in the presence and absence of 
both drugs and vice versa. Cisplatin inhibited the excitation of riboflavin and 
retained it in its native condition strengthening the behavior to be postulated as 
'photochemoprotective'. In addition, 5-fluorouracil is shown to behave in an 
atypical biphasic manner. 
Based on our research on the role of riboflavin as photooxidative stress, 
we describe here the identification of the platinum drug cis-diamminedichloro-
platinum(ll) as a chemopreventive agent for photoprotection. The causative role 
of photoexcited state in photodamage suggests that direct molecular antagonism 
of photosensitization reactions could be by physical quenchers. This leads to 
screening of the damaging facet offering a novel chemopreventive opportxmity 
for photoprotection. Akin to studies conducted earlier where compounds have 
been identified as pronotmced quenchers of photoexcited states activity (QPES). 
QPES compounds antagonize the harmful excited state cherrustry of endogenous 
sensitizers by physical quenching, facilitating the harmless return of the 
sensitizer excited state to the electronic ground state by energy dissipation. In 
our investigational consequence cisplatin displayed screening efficacy in 
riboflavin-sensitized photodamage by complex formation. It is believed that 
cisplatin is atypical quencher that binds with the sensitizer offering protection at 
the protein and DNA reaction scheme. Furthermore, photoprotection of human 
peripheral lymphocytes exposed to photoillimiinated riboflavin has been 
demonstrated. Favorably, undesirable aspect of cisplatin is suppressed substantially 
by this interaction. This preventive mechanism may be used for the novel 
chemoprevention of phototoxicity, photo-genotoxicity and solar-UV carcinogenesis. 
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^^ Summary" 
A natural daylight absorbing pigment of particular interest is vitamin B2 or 
riboflavin which is present in all aerobic cells. The photodynamic action of 
riboflavin is known to involve the generation of reactive oxygen species. Studies 
in this laboratory have formerly shown the damaging effect of this sensitizer on 
several biological molecules. Hitherto the effect of certain biologically relevant 
endogenous/externally added compoimds can inhibit/promote photodamage in 
living system. In this context an important class of biologically active and 
commercially valuable compounds which could potentially interact with 
riboflavin in humans may be the externally administered drugs. Since the vitamin 
and drug can occupy common locations in a biological system, light mediated 
interactions between them can initiate desirable/tmdesirable consequences. With 
reference to this framework of sensitizer-drug interactions, a recent report from 
this lab exaxnined the combination of riboflavin and aminophylline. Aminophylline 
is a routinely used medicine for various respiratory disorders especially asthma. 
Aminophylline in combination with riboflavin was found to augment degradative 
capacities of the sensitizer with aminophylline getting oxidized in the process. 
Chemotherapeutic drugs are an essential category of compounds that need to be 
probed in this milieu. 
The aims of photogenotoxicity studies are to evaluate the 'genetic health' 
of surviving ceUs. During the past several years, phototoxicity has been studied 
at the molecular level. Phototoxic effects span from the cytotoxic-apoptotic effect 
to the induction of primary DNA damage and a variety of sfress acting on the 
ceU. Ultimately, it can lead to the induction of hereditary DNA modification. The 
development of new drugs has highlighted the necessity to develop the 
assessment of phototoxicity in the safety evaluation of compoimds. The study is 
proposed to specifically address all the consequences of riboflavin-induced 
toxicity, the in vitro methods that can be proposed and used to screen for toxicity 
of sensitizer riboflavin and the photosensitization process resulting from the 
activation of drugs by light. Biological systems and endpoints of interest in that 
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particular objective are listed. The clinical relevance of interaction mediated 
consequences of drug and sensitizer is represented in patients undergoing 
radiation and chemotherapy cumulatively, wherein the potential interactions 
need to be carefully considered. 
Energy in the visible and UVA (315-400 nm) region can be absorbed by 
endogenous flavins and transferred to biomolecules where it causes damage. 
Photosensitized damage to biomacromolecules such as DNA and proteins, 
participates in phototoxicity, photogenotoxicity and solar UV-carcinogenesis. 
Chemoprevention of photosensitized damage is an important method to curtail 
the phototoxic effects of endogenous sensitizers. The aforementioned are a few 
phototoxic effects exhibited by riboflavin, the sensitizer. It is rational to postulate 
scientifically that an agent rendering protection to the above would be entitled as 
'photochemoprotective' and the analysis 'photochemoprevention'. 
In the present analysis the impact of photoactivated riboflavin has been 
elucidated in the presence of chemotherapeutic drugs cisplatin and 5-fluorouracil. 
Perhaps, the potential properties of both drugs in the presence of riboflavin as a 
sensitizer and the ongoing impact of interactions on biological molecules have 
not been investigated. In this study a conscious and planned effort was designed 
to explore not only the degree of these interactions and understanding the photo 
mechanism alone but also the concurrent influence on biologically relevant 
molecules. The thesis is in continuation with our previous drug based study and 
aims to extend our effort into the sensitizer-drug array of interactions. 
In view of this, first chapter of the thesis specifically addresses cisplatin 
mediated inhibition on photoinduced oxidative damage by the sensitizer, 
riboflavin. The chapter has been bifurcated to deal with proteins and DNA 
individually. Binding of the sensitizer to the target biomolecules enhanced with 
photoactivation. Significantly, the observed binding correlates with firstiy, the 
formation of free radicals and secondly, the degradative efficiency of riboflavin. 
A prominent decline effect by cisplatin on riboflavin induced structural 
alterations, impairment of enzymatic activity and damage to proteins was 
indicative of curbed photodecomposition. This corresponds to reduced 
photoexcitation of the sensitizer in presence of this particular platinum drug. The 
second unit to the first chapter reaffirms the occurrence of an analogous series of 
inhibition reaction. DNA degradation in cells such as lymphocytes implies 
genotoxicity by riboflavin. Using a cellular system of lymphocytes isolated from 
human peripheral blood and alkaline single cell gel electrophoresis, it was 
confirmed that cisplatin is indeed capable of rendering protection to DNA 
breakage in cells alsOv An interesting finding in the provisos of cisplatin was 
reduced generation of reactive oxygen species in cells. Nevertheless, a principal 
reason contributive to cytotoxicity of cisplatin is free radical production in 
normal cells. The concentration of drug utilized in our study is pharmacologically 
relevant and is used clinically for patients imdergoing therapy. Furthermore 
cisplatin is equally efficient in causing DNA damage in this system. The complex 
riboflavin-cisplatin reduced the degradation catalyzed by each of them 
individually. The drug forms a complex with native entity of riboflavin. This 
complexation plausibly inhibits the photoexcitation phenomenon and reduces the 
damaging potential consequently. 
In the second chapter of the thesis, drug 5-fluorouracil different in class 
and mechaiiism of action has been prudently chosen to illustrate the oxidative 
potential of sensitizer in its presence. The drug behaves in a biphasic manner in 
case of both proteins and DNA with lower concentrations of the drug inhibiting 
the photosensitization phenomenon. Intermolecular interaction is ascertained to 
be the plausible reason for the anomalous pattern displayed by this particular 
drug at higher concentrations. The inhibition trend was similar with both the 
target biomolecules. The tiiird and final chapter of the thesis addresses the 
spectral properties of native and excited riboflavin in the presence and absence of 
both drugs and vice versa. Cisplatin inhibited the excitation of riboflavin and 
retciined it in its imtive condition strengthening the behavior to be postulated as 
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'photochemoprotective'. In addition/ 5-fluorouracil is shown to behave in an 
atypical biphasic manner. 
Based on our research on the role of riboflavin as photooxidative stress, 
we describe here the identification of the platinum drug cis-diamminedichloro-
platinum(n) as a chemopreventive agent for photoprotection. The causative role 
of photoexcited state in photodamage suggests that direct molecular antagonism 
of photoserwitization reactioixs could be by physical quenchers. This leads to 
screening of the damaging facet offering a novel chemopreventive opportunity 
for photoprotection. Akin to studies conducted earlier where compounds have 
been identified as pronoimced quenchers of photoexcited states activity (QPES). 
QPES compounds antagonize the harmful excited state chemistry of endogenous 
sensitizers by physical quenching, facilitating the harmless retvim of the 
sensitizer excited state to the electronic groimd state by energy dissipation. In 
our investigational consequence cisplatin displayed screening efficacy in 
riboflavin-sensitized photodamage by complex formation. It is believed that 
cisplatin is atypical quencher that binds with the sei^itizer offering protection at 
the protein and DNA reaction scheme. Furthermore, photoprotection of human 
peripheral lymphocytes exposed to photoilluminated riboflavin has been 
demonstrated. Favorably, undesirable aspect of cisplatin is suppressed substantially 
by this interaction. This preventive mechanism may be used for the novel 
chemoprevention of phototoxicity, photo-genotoxicity and solar-UV carcinogenesis. 
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''FREE RADICALS'' 
Free radicals are species that contain unpaired electrons. The oxygen 
radicals, such as superoxide radical, hydroxyl radical and non free radical 
species, such as hydrogen peroxide and singlet oxygen, are various forms of 
activated oxygen (Gtdcin et al., 2002; Yildirim et al., 2000), generated in many 
redox processes. These radicals are generated during cellular metabolism, as a 
result of energy production from mitochondria or as part of an antimicrobial 
(Weiss & LoBuglio, 1982) or antiviral (Griot et al., 1989) response, as well as 
during detoxification reactions carried out by cytochrome P-450 system (Scholz 
et al., 1990). Ulfraviolet light, ionizing radiation, redox cl;iemicals and cigarette 
smoke are a few environmental agents that also generate reactive species readily. 
The antioxidant defense system in cells consists of two components, the 
antioxidant enzyme component that traps and destroys radicals. It includes 
enzymes like superoxide dismutase, catalase and glutathione peroxidase; and the 
other is low molecular weight antioxidant component that includes vitamins (A, 
C, E), glutattiione and thioredoxin. These substances are the body's natural defense 
against endogenously generated reactive spedes and other free radicals. Over-
production of free radicals, together with A, C and E avitaminosis and a reduced 
level of the antioxidant enzymes, is considered to be the main reason leading to 
oxidative stress. 
Oxidative stress, induced by oxygen radicals, is believed to be a primary 
factor for the damage of biomolecules such as carbohydrates, proteins, lipids and 
DNA (Kellogg & Fridovich, 1975; Lai & Piette, 1977; Wiseman & HaUiweU, 1996) 
thus accelerating aging, cancer, cardiovascular diseases, neurodegenerative diseases 
and inflammation (Ames, 1983; Stadtman, 1992; Suii, 1990). The primary source 
of free radicals in most oxygenated biological system is superoxide anion, which 
is an oxygen centered radical and exists in equilibriimi with its protonated form, 
the hydroperoxide radical (Dean et al, 1997). This toxic species is produced by a 
number of enzyme systems in autooxidation reactions and by non-enzymatic 
electron transfers that tmivalently reduce molecular oxygen, for instance 
photochemical reactions. The major sources of these free radicals are modest 
leakage from the electron transport chain of mitochondria, chloroplasts and 
endoplasmic reticulxun. They are also produced deliberately by activated 
macrophages and some other immvme system cells as a cytotoxic weapon (Babior, 
1978). Although superoxide radical is relatively non-reactive in comparison with 
many other free radicals (Dean et al., 1997), it itself is a precursor to other active 
free radicals (Halliwell & Gutteridge, 1985) that have the ability to react with 
biological macromolecules and thereby induces tissue damage (Halliwell & 
Gutteridge, 1984). It has also been implicated in several pathophysiological 
processes due to its transformation into more reactive species such as hydroxyl 
radical that initiate peroxidation of membrane lipids, leading to accumulation of 
lipid peroxides. Among various reactive oxygen species, hydroxyl radical is most 
reactive and induces severe damage to the adjacent biomolecules (Gutteridge, 
1984). Superoxide anion has also been observed to directly initiate lipid 
peroxidation (Wickens, 2001). 
A detailed study of radicals illustrates that all reactive oxygen species are 
reactive to varying degrees in the biological system. It is now accepted that free 
radicals, especially oxygen-centered radicals such as superoxide radical, singlet 
oxygen, hydroxyl radical, alkoxyl and peroxyl radical which are highly 
heterogeneous attack lipids, proteins and DNA to induce membrane damage, 
protein modification, enzyme inactivation, strand break and base modification of 
DNA, eventually leading to a variety of pathological events such as cancer, aging 
(Sies, 1991), artherosclerosis, diabetes mellitus, inflammation (Abella et al., 1996), 
Itmg diseases (Iwamae et al., 1998), AIDS (Pace & Leaf, 1995; Edeas et al., 1995) 
and cardiovascular pathologies (Hogg & Kalyanaraman, 1998). Hence the physiological 
roles of free radicals have become a prominent area of interest in antioxidant-
prooxidants research (Minghetti & Levi, 1998; Mohanakumar et al., 1998). 
"OXIDATIVE STRESS AND HUMAN DISEASES'' 
There is curreniiy much interest in the role of free radicals in human 
diseases (Sies, 1985). Oxygen radicals and other activated oxygen species are 
known to participate in numerous physiological and pathological processes. 
Situations which augment oxidant exposure or compromise antioxidant capacity are 
commonly referred to as oxidative stress. It can result from exogenous sources 
i.e. redox active xenobiotics (Marcillat et al., 1989) or from increased endogenous 
oxidative metabolism i.e. mitochondrial electron transport (Davies et al., 1982). 
Regardless of its source, oxidative stress has been foxmd to affect the behavior of 
several different cell types. 
Oxidative stress is believed to contribute to the general decline of 
functions that are associated with many human diseases including Alzheimer 
disease (Bozner et al., 1997), amyotrophic lateral sclerosis (ALS) (Jackson & 
Bryan, 1998), Parkinson disease (Mukherjee & Adams, 1997), atherosclerosis 
(Fiorillo et al., 1998), ischemia/reperfusion neuronal injuries, degenerative 
diseases of the human temporomandibular-joint, cataract formation (Varma et 
al, 1995), macxilar degeneration (Nicolas et al., 1996), degenerative retinal 
damage (Andersson et al., 1998), rheumatoid arthritis (Miyata et al., 1998), 
multiple sclerosis, muscular dystrophy (Rando et al., 1998), human cancers 
(Meyer et al., 1998) as well as the aging (Beckman & Ames, 1998) process itself. 
Increased cellular level of ROS due to oxidative stress can result in an increased 
steady state level of oxidative DNA damage. Normal cellular metabolism is 
associated with the production of reactive oxygen species by mitochondria which 
may consequently damage DNA and proteins (Croteau & Bohr, 1997; Berlett & 
Stadtman, 1997) that xmder certain conditions induces apoptosis and necrosis. 
ROS mediated cell damage has been linked to both necrosis and apoptosis 
(Matstishima et al., 1998). Excessive formation of ROS as well as depletion of 
cellular antioxidants results in apoptosis (Shimizu et al., 1996). Increasing 
evidences have proved that ROS play a role in death receptor-mediated 
apoptotic pathways by modulating the expression of Fas or Fas ligand 
(Hockenbery et al., 1993) which is suggestive of ROS induced cell death. 
// ''RIBOFLAVIN 
The term "Flavin" refers to the yellow chromophoric and redox active 
projsthetic group of a class of respiratory proteins and enzymes occurring widely 
in animals and plants, namely the flavoproteins. They are tiie most likely 
candidates for the photoreceptor pigment in the ubiqxiitous 'blue light' 
photoreceptive processes observed in a wide range of animals and plants. Such 
effects include the photoaccumulation (phototaxis) of imicellular algae and the 
photoresponse of fungal sporangiophores. Flavin is also thought to be the light 
emitting chromophore in many bioltuninescent bacteria. Their observed role in 
the photochemical oxidation of dairy products (Kim et al., 2003) £md the 
photodegradation of environmental pollutants (Hussein & Alkhateeb, 2007) 
makes flavin photochemistry an interesting and developing area of study. It has 
been the subject of intense research over the past forty years (Sikorska et al., 2005). 
Riboflavin also known as vitamin B2 is a water soluble vitamin, belonging 
to the huge family of flavins. Riboflavin is chemically 6,7-dimethyl-9-D-l ribityl-
isoalloxazine. It has a recommended daily requirement of 2-3 mg and is widely 
distributed in human tissues and fluids in free and conjugated forms (Heelis, 
1982). It is essential for normal cellular functions, growth and development. In its 
coenzyme forms of flavin adenine dinudeotide (FAD) and flavin mononucleotide 
(FMN), riboflavin performs key metabolic functions as an intermediary in the 
transfer of electrons in biological oxidation-reduction reactions. Eukaryotes 
convert riboflavin to FAD which in turn serves as a coenzyme for glutathione 
reductase and other enz)anes. Gluthathione reductase mediates the regeneration 
of glutathione, which plays an important role in scavenging free radicals and 
reactive oxygen species, preventing oxidative damage to proteins, DNA and 
other compoxinds (Giustarini et al., 2004). Accumulation of oxidative damage in 
proteins and DNA may trigger stress responses such as nuclear translocation of 
nuclear factor kB, cell cycle arrest and apoptosis (Rahman et al., 2004). Recently, 
it was suggested by Manthey et al. (2006) that riboflavin deficient cells are arrested 
in Gl phase of the cell cycle. Their study further confirmed that riboflavin 
deficiency in HepG2 cells increases the incidence of DNA strand breaks as 
judged by comet assay and is associated with increased expression of cluster of 
genes that play a role in cell stress and apoptosis. The cluster of apoptosis related 
genes activated by riboflavin deficiency included pleiomorphic adenoma gene-like 1 
and perjbrin-1. Effects of riboflavin deficiency on protein carbonylation, DNA 
strand breaks and cell cycle progression are biologically important. Riboflavin 
deficiency impairs the oxidative folding of proteins and genomic stability in 
human lymphocytes, causes anemia in him\ans. Apart from its enzymatic 
activity it is a vital component of healfliy diet (Friedrich, 1988). During periods of 
dietary deprivation or physiological and pathological stress himians are vulnerable 
to riboflavin deficiency. Ariboflavinosis primarily leads to degenerative changes in 
the nervous system and variety of clinical abnormalities including growth 
retardation, anemia and skin lesions. Riboflavin has become the thrust area of 
many researchers recentiy, after it was shown to protect vital tissues from 
ischemia-induced oxidative injury resulting from heart attack or stroke (Betz et aL, 1994). 
Exposure of certain chemicals to light can lead to the generation of 
reactive oxygen species (Vuillaume, 1987) which in turn can induce mutagenic 
interactions (Hassan & Moody, 1984; Joenje, 1989). Photochemistry of riboflavin 
has been a well studied subject over the years with nmnerous publications dealing 
remarkably with it. The study of riboflavin sensitized photomodification of 
biomolecules has special relevance because these type of reactions could occur in 
different systems exposed to visible light as parenteral infusions, cell culture 
media, foods, and they can also play a role in vivo, in tissues exposed to visible 
light, as skin and the ocular lens (Edwards & Silva, 2001). As a matter of fact, 
skin is the largest organ in the body exposed to sunlight (Mukhtar, 1992). 
Adverse responses to sunlight include both acute responses such as bums and 
inflammatory disorders and chronic responses such as skin aging and skin 
cancer (Ahmad & Mukhtar, 2004; Mukhtar, 1992). Riboflavin is also considered a 
potential chromophore for inducing genetic damage from multivitamin 
formulations exposed to phototherapy illuminations (Ennever et al., 1983). 
Riboflavin is ubiquitous in human tissues. When exposed to visible hght 
or UV radiation of sunlight it exerts its toxic effect that causes injuries leading to 
cell death and induces photodamage to the skin (Minami et al., 1999). In certain 
cases, human skin receives less oxygen from arterial blood than other tissues. 
Physical conditions requiring oxygen such as hard jogging under strong sunlight 
is a relative example when more photoinduced damage occurs in the skin 
(Minami et al., 1999). It has been suggested that the production of superoxide 
radical by energy transfer from photoexcited riboflavin to molecular oxygen 
largely attributes to its phototoxic effect (Korycka-Dahl & Richardson, 1980). In 
view of the relevance of riboflavin in physiological processes and its ability to 
produce ROS upon photoexcitation, it is considered to be a suitable model to 
investigate the possible mechanism of photooxidation of biological entities (Tsai 
etal.,1985). 
Despite of convincing toxicological literature postulating deleterious 
potential of this vitcunin its application as a photosei^itizing drug in phototherapy 
for the treatment of neonatal hyperbilirubinemia, to reduce bilirubin levels has 
been known for quite some time (Behrman et al., 1974). Corbin (2002) suggested 
that riboflavin, which has an extremely good safety profile, can inactivate high 
levels of a broad range of viruses and bacteria in platelet concentrates, fresh 
frozen plasma and in red blood cells. Recentiy, Eubanks et aL (2005) utilized 
riboflavin in the inactivation of botulinum neurotoxin A which has undoubtedly 
explored the beneficial aspect of riboflavin's photochemistry. Natural occurrence of 
this vitamin in human cells (Edwards et al, 1999) and its non-toxic nature in 
native state because of relatively low concentrations has commanded favor from 
researchers in photochemistry recently. Its normal concentration in tissues is too 
low for an appreciable photochemical activity (Edwards et aL, 1999). Yet the 
generation of phototoxic ROS in tissues repeatedly exposed to light can not be denied. 
// RIBOFLAVIN AND FREE RADICALS'' 
Riboflavin is an excellent photosensitizer that can act via radical species 
(Type 1 mechanism) or via the generation of singlet oxygen (Type II mechanism). 
The normal form of riboflavin in neutral aqueous solution in the ground-state is 
the flavoquinone species, RFI H (oxidized form) dominant in the pH range of 
0.4-9.75 (Min & Boff, 2002). Riboflavin reacts via its singlet and triplet excited 
states with molecular oxygen and generates reactive oxygen species such as short 
lived superoxide anion and riboflavin radical (Kumari et al., 1996; Kim et al., 
1993). A substantial amoimt of hydrogen peroxide is also produced (Sato et al., 
1995). Hydrogen peroxide in the presence of transition metal ions imdergoes 
modified Haber-Weiss reaction to produce a more deleterious specie, hydroxyl 
radical (Henle & Lirm, 1997; McCormick et al., 1998) which is a well known 
oxidant (McCormick et al., 1998). These species exert a collective damaging effect 
on several biological molecules (Naseem et al., 1993; Jazzar & Naseem, 1994), 
cause K* leakage and in the presence of Cu(II) induce hemolysis of red blood 
cells (Ali et al., 2000) and damage lens (Andley & Clark, 1988). 
Among all, singlet oxygen is known to be a highly reactive species and 
has the capability to directly react with electron-rich double bond systems, 
including lipids, vitcunins, aminoacids, peptides and proteins. Thus, these species 
have been implicated in the etiology of various pathological conditions. Singlet 
oxygen has been foimd to induce strand breaks in plasmid DNA in a second 
order reaction (Di Mascio et al., 1989) by the secondary oxidation of 8-oxodG 
which is very reactive towards singlet oxygen (Sheu & Foote, 1995). Mechanistic 
studies of singlet oxygen chemistry have shown that singlet oxygen attack, upon 
an unsaturated compound is electrophilic (Gollnick, 1968). This suggests that the 
greater the electron donor ability of the molecule, the better the chances that 
singlet oxygen will react with a specific molecule (Rosenthal & Pitts, 1971). It 
thus appears that the xmderlying mechaiucs of free radical attack, whether by a 
type I or II, are electrophilic and indicates titat the best electron donor becomes 
the best substrate for both hydrogen abstraction and singlet oxygen reactions 
(Seah & Burgoyne, 2001). More precisely riboflavin undergoes simultaneous 
photoadditon and photoreduction reactions giving rise to cyclodehydroriboflavin 
(CDRF), formylmethylflavin (FMF) and lumichrome (LC), lumiflavin (LF), respectively. 
These photodegradation products are photoreactive (Joshi, 1989). 
''RIBOFLAVIN AND PROTEINS'' 
Proteins constitute approximately 68% of the dry weight of cells and 
tissues and are therefore potential targets for photooxidation and damage. Due 
to their high concentration both inside and outside the cell, catalytic nature and 
high rates of reaction with radicals (Davies, 2004); modifications by free radicals 
have an amplified effect on their activity i.e. susceptibility to proteolysis, 
inactivation and degradation. Protein damage may also have an effect in the long 
term as they primarily regulate gene expression. The relevance of protein 
damage in extreme cases is possibly in cell lysis. Free radical fluxes can lyse cells. 
'Professional phagocytes' generate such a flux at the cell surface in killing 
bacteria and parasites (Wolff et al., 1986). Oxidative modification of total proteins 
is described under many pathological conditions (Kwon et aL, 1998). It is suggested 
with respect to enzymes that inactivation precedes proteolysis (Hemmings, 1980; 
Holzer & Heinrich, 1980). The degradation of proteins may occur by a two step 
mechanism in which the protein is initially modified such that it becomes more 
susceptible to proteolytic attack (Weiner et al., 1994). In the second step, a protease 
specific for the modified enzyme finally catalyses the actual proteolytic degradation. 
The modification of amino acid residues by hydroxyl and singlet oxygen 
and subsequent changes in en2yme activity have been used to identify residues 
crucial for protein function such as methionine, tryptophan, histidine and 
sulphydryl groups (Garrison, 1968; Davies, 2003; Agon et al., 2006). Protein 
fragmentation by hydroxyl is a selective process where fragments of defined 
rather than random length are generated (Wolff & Dean, 1987). The number of 
fragments produced varies from protein to protein. Among the manifold effects 
of fragmentation, increase in the mmiber of amino groups is prominent (Wolff & 
Dean, 1987), suggesting that cleavage involves peptide-bond hydrolysis. There is 
evidence that fragmentation occurred by oxidation and subsequent spontaneous 
hydrolysis of proline residues (Wolff et al., 1986). In general, the consequence of 
radical modification is inactivation of enzymes. In the absence of molecular 
oxygen though, OH induces crosslinks in proteins which are often resistant to 
reduction, such as dityrosine (Halliwell & Gutteridge, 1984). Some crosslinking 
may also occur in the presence of oxygen but fragmentation is the paramount 
effect. Using BSA and Chinese hamster ovary cell soluble proteins, Wolff and 
Dean (1986) have exemplified the sensitivity of proteins to oxygen free radicals 
derived from gamma irradiation, metal ions and H2O2. Oxygen free radicals 
derived horn ascorbate and Cu(II) (Marx & Chevion, 1986) as well as glucose in 
presence of oxygen and Cu(II) also caused similar effects (Himt et al., 1988). The 
latter reaction is important as it appears to exalt Hie glycation of proteins in 
addition to Amadori rearrangement, during diabetes and aging (Hunt et al., 1988), 
Dean et al. (1989) have proposed that protein cleavage is initiated at proline and 
histidine which may be the major sites of damage during radical attack on 
proteins. They are transformed to glutamate and aspartate respectively. A survey 
of the literature reveals that, in many cases, exposure of proteins to oxygen 
radicals, both in vivo and in vitro which leads to aggregation and the resultant 
susceptibility to proteolysis is due to increased exposure of hydrophobic surfaces 
to these radicals (Stadtman, 1992; Starke-Reed & Oliver, 1989). 
Davies (1987) has reported that proteins which have been exposed to 
certain oxygen radicals also exhibit altered primary, secondary and tertiary 
structure. Conformational changes may also be involved in the process. It was 
foimd that about two radical events per molecule of BSA suffice to cause 
conformational changes detectable in fluorescence spectra (Wolff et al., 1986). 
These studies were affirmations to previous findings where oxygen radicals and 
other activated oxygen species such as H2O2 were shown to increase protein 
degradation in intact cells and intracellular organelles, as well as in vitro systems. 
All the chemical reactions of organic biomolecules in cells are catalyzed by 
eiuzymes. Thousands of different enzymes, each capable of catalyzing a different 
kind of chemical reaction, have been discovered in different organisms (Nelson 
& Cox, 2000). A limited number of enzymes require visible light for their 
catalytic activity as is the case of those participating in photosynthesis (Nelson & 
Cox, 2000) or DNA repair, the DNA-photolyases (Sancar, 2000). Enzymes that are 
constituted exclusively by amino acids and no other chemical groups are not 
affected by visible light irradiation either in their catalytic activity or their 
structure (Silva, 1987). Nevertheless, it is possible that this type of radiation 
could modify conjugated enzymes, whose prosthetic groups absorb visible light 
(Edwards & Silva, 2001). Proteins are employed as photochemical targets indicating 
that protein-sensitizer interaction and the local enviroiunent aroimd the 
sensitizer plays an important role. The 20 amino acids from which all the 
proteins of organisms are built do not absorb UVA or visible radiation. Only 
tryptophan (Trp) and tyrosine (Tyr) and to a lesser extent phenylalanine (Phe) 
absorb UVB light, these being responsible for the characteristic Hght absorbance 
by proteins at wavelengths between 270 and 280 nm (Edwards & Silva, 2001). 
It is noteworthy to consider that visible light induces photooxidation of 
amino acids and vitamins in parenteral nutrition infusates. The infusates contain 
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multivitamin mixtures that usually include riboflavin or FMN, compoimds that 
are efficient photosensitizers. Studies on infusates containing amino acids indicated 
photooxidation of only Trp, His and methionine by the action of visible light. 
These results are in accordance with the selectivity of riboflavin induced 
photochemical damage in lysozyme, where out of 20 amino acids present in the 
enzyme structure only Trp, Tyr and His were modified. There is considerable 
evidence suggesting the photoconversion of aromatic amino acids Trp and Tyr 
when irradiated with monochromatic visible light (450 nm) in the presence of 
riboflavin. In the case of Tyr, it has been reported that the main photoproduct is 
dityrosine whereas, for Trp a complex mixture of indolic, flavinic and indolic-
flavin type aggregates is obtained. In the light of the above, visible light needs 
the presence of a suitable photosensitizer to induce modification on the enzymes 
imder study. At the same time, riboflavin and FMN are photosensitizers i.e., they 
can induce the photomodification of compounds that do not directiy absorb or 
are not direcfly modified by visible light (Silva, 1987). 
Riboflavin has complex photochemistry both in the presence and absence 
of other substrates (Kim et al., 1993). As an endogenous photosensitizer, riboflavin 
can induce photooxidative damage of cell-matrix compoimds in skin and eyes, 
which could cause inflammation, accelerate aging and induce mutations (Diaz et 
al., 1996). The effects of photosensitized riboflavin on DNA and bases have been 
studied extensively (Kumar et al., 2004). Energy in the UVA region (315-400nm) 
is absorbed by flavins and transferred to DNA where it causes damage (Peak & 
Peak, 1995). However, proteins and enzymatic interactions are not yet well 
researched. The reason lies basically on the complexity of structures and the 
types of proteins. It has been reported that protein boxmd chromophores are 
capable of inducing protein oxidation (Viteri et al., 2003). Riboflavin modifies 
collagen photochemically and leads to formation of crosslinking molecules (Kato 
et al., 1994). Silva et al. (1994) have also demonstrated that irradiation of lysozyme 
with visible light in the presence of riboflavin and molecular oxygen results in 
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binding of the sensitizer to tryptophan residues and photooxidation of few 
amino acid residues of the enzyme. Flavin mononucleotide photosensitized 
crosslinking using N-acetyltyrosine containing six carbon side chains as a protein 
model has been studied (Shen et al, 2000). Experimental evidence suggests that 
non-radiative energy tremsfer occur between riboflavin and albumins. The optical 
spectroscopy investigations show that the potential binding point of riboflavin to 
either HSA or BSA is only one, whereas at high riboflavin concentrations 
(RF/albumin higher than 1.6/1), the interaction becomes more complex. 
''RIBOFLAVIN AND UNA" 
Nearly 100 different free radical damages have been identified 
(Dizdaroglu, 1992). Free radical damage to DNA constitutes a significant threat 
for aerobic organisms. The load of oxidative damage from endogenous process is 
evidently significant. As a measure of this load, specific oxidative damages may 
accumulate with time in the DNA of animal cells (Ames et al., 1993) although the 
precise numbers are subject to debate (Lindahl, 1993). Whilst free radical attack 
produces a multitude of DNA damage, the ability of some repair activities to 
recognize a range of substrates allows relatively few enzymes to repair the bulk 
of base and sugar lesions. General repair mechanisms act as secondary repair 
pathways and can handle more complex lesions (Demple & Harrison, 1994). 
Numerous inverse correlations have been made between the metabolic rate of 
various mammalian species and their maximum life span. It is being used along 
with other observatior\s to argue that oxidative damage is a cause of various 
pathological conditions (Sies, 1991). Concomitantly, there has also been an 
increasing interest in oxygen radicals and lipid peroxidation as sources of DNA 
damage and therefore as promoters of cancer (Harman, 1981; Gensler & 
Bernstein, 1981). This interest derived in large part from the realization that the 
use of oxygen by aerobic organisms is accompanied by the formation of reactive 
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by-products; free radical forms of oxygen that can damage most cellular 
component. Repair enzymes that mediate the removal of oxidative damages 
from DNA help coimteract the potential cytotoxic, mutagenic and carcinogenic 
effects of these damages (Demple & Harrison, 1994). In order to tmderstand 
carcinogenesis at the molecular level it is essential to determine the conformational 
changes in the target biomolecules and relate these findings to possible 
aberrations in the functioning of modified macromolecules. Many of the chemical 
agents that induce cell killing by apoptosis also stimulate the intracellular 
generation of reactive species (Burkitt et al., 1996). Oxygen radicals have been 
suggested to be involved in the action of a number of DNA damaging drugs 
(Lown et al., 1982). Several lines of evidence clearly emphasize that the 
generation of free radicals is intimately associated with the photodynamic effect 
of various drugs involved in cancer therapy (Hoebeke et al., 1997). 
Spectrum of DNA damage due to oxidative stress is elucidated well with 
literature relating free radicals to diseases. Oxidative damage to DNA is a result 
of interaction of DNA with reactive oxygen species, in particular the hydroxyl 
radical. Hydroxyl radical produces a multiplicity of modifications in DNA 
(Gutteridge, 1984). Oxidative attack by hydroxyl radical on deoxyribose moiety 
will lead to the release of free bases from DNA generating simple abasic (AP) 
sites and strand breaks with various sugar modifications (Brawn & Fridovich, 
1981). In fact, one of the major types of damage generated by reactive oxygen 
species is AP site where a DNA base is lost. AP sites are also formed at an 
appreciable rate from spontaneous depurination. It is estimated that at least 
10,000 depurination events occur per cell per day imder physiological conditions, 
A similar amoimt of AP site is thought to be generated by normal aerobic 
respiration. In addition to AP site, a wide spectrum of oxidative base modifications 
occurs with reactive oxygen species. The C4-C5 double bond of pyrimidine is 
•particularly sensitive to attack by hydroxyl radical generating a spectrum of 
oxidative pyrimidine damage including thymine glycol, uracil glycol, urea 
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residue, 5-hydroxyuracil, 5-hydroxy-cytosine and others. Similarly, interaction of 
hydroxyl radical with purines generates 8-hydroxyguanine (oh^Gua), 2-
hydroxyadenine, formamidopyrimidines and other less characterized purine 
oxidative products. It has been estimated that endogenous reactive oxygen 
species can result in about 200,000 base lesions per cell per day. The biological 
consequences of many of the oxidative products are known. For instance, 
unrepaired thymine glycol is a block to DNA replication and is thus potentially 
lethal to cells. On the contrary, 8-oxoG an abundant oxidative damage to dG, is 
readily bypassed by the DNA polymerase and is highly mutagenic. Unrepaired 
8-oxoG will mispair with dA, leading to an increase in G to T transition mutations. 
When activated by light, photosensitizers can damage cells and organisms 
by their effects on critical biomolecules. The interactions of photosensitizers like 
riboflavin and their secondary products (singlet oxygen) with DNA have been 
well investigated and their damage pathways well defined or atleast amply 
postulated. Photosensitization experiments carried out by other researchers have 
indicated that imder cell free conditions, photosensitizers like methylene blue, 
riboflavin, acridine orange and hemato- porphyrin induced similar types of DNA 
damage characterized by a high number of base modifications sensitive to the 
repair endonuclease Fpg protein and DNA strand breaks and AP sites to a lesser 
degree. 
The binding of riboflavin to DNA is a condition favorable to the formation 
of free radicals. Purines and pyrimidines eire knov^m to form charge-transfer 
complexes with riboflavin as the constant electron acceptor (Hush & Cheung, 
1975). These complexes are formed by a partial transfer of an electron from the 
highest filled molecular orbital of the donor (nucleobase) to the lowest empty 
molecular orbital of the acceptor (photosensitizer or its reactive products) and it 
is well known that these two energies are related to the ionization potential of 
the donor and the electron affinity of the acceptor. Photodynamic attack on DNA 
whether by a type I or type II reaction are essentially charge transfer reactions 
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which implies that analogue molecules of purines and pyrimidines with a greater 
electron donor ability than the nucleic acid bases will be more reactive or will be 
able to assume the target of preference in charge transfer reactions or in singlet 
oxygen attacks. 
Among the nucleic acid bases, guanine is most sensitive towards singlet 
oxygen/photodynamic mediated oxidation (Rosenthal & Rtts, 1971). The guanine 
radical cation is the initial product of DNA oxidation and can lead to the 
formation of 8-hydroxyguanine by hydration followed by one-electron oxidation 
(Kasai et al., 1992). Cadet et al. (1994) have reported the generation of 2-amino-
imidazolone (Iz) and 2,2-diaminooxazolone (Z) as the oxidation products of 
deoxyguanosine. 2-aminoimidazolone (Iz) is able to form a stable base pair with 
guanine but is unstable under oxidative conditions (Kino et al., 1998). Riboflavin 
mediated photosensitization has been known to efficiently photo-induce oh^Gua 
in calf thymus DNA as well as in cellular DNA in manunalian cells (Kasai et al., 
1992). 8-hydroxyguanine has been reported to mispair with adenine, being a 
causative base lesion of G:C to T:A transverse mutations (Cheng et al., 1992). In a 
similar report by Bessho et al. (1993) mutation was induced in cultured mouse 
cells by photoirradiation in the presence of riboflavin; oh^Gua was possibly 
involved in the process. Further investigations regarding molecular nature of 
oh^Gua in the riboflavin-photosensitization mutation induction in vivo found that 
G:C to T:A transversions were the major type of base change mutations in the 
supF gene in wild type and mutM mutator mutant Escherichia coli strain (Tano et 
a l , 1998). G:C to C:G changes occurred in the delayed transfection of DNA after 
riboflavin mediated photosensitization of supF gene in E.coli mutY mutator strain. 
In an earlier report from this laboratory it was suggested that binding of 
riboflavin to DNA may occur even in the absence of visible light (Alvi et al., 1984). 
Some support for the intercalation model is provided by the finding that the 
formation of singlet oxygen radical is considerably faster in the presence of DNA 
than RNA (Naseem et al., 1988). It has been shown that riboflavin can also cleave 
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RNA molecules with specificity at G:U base pairs via a photoinduced mechanism. 
The photoreaction results in the removal of one nucleoside downstream of the 
uracil residue. The effect requires bivalent metal ions (Burgstaller et al., 1997). 
'THOTODYNAMIC THERAPY'' 
Photodynamic therapy involved the treatment of diseased tissues and 
cells using a photosensitizer and visible light. Such photomedical treatment have 
been used since the ancient Egyptian times but it was only in 1993 that this 
therapeutic modality was made available to modem medicine with the approval 
of photofrin for the treatment of bladder cancer in Canada (Dolphin, 1994). 
Photod5mamic tiierapy is based on the attractive basic concept of combining two 
therapeutic agents, harmless by themselves, to obtain selective tvunor destruction 
(Hoebeke et al., 1997). Evidences reflect that generation of ROS is conciu'rently 
associated with the photod5niamic effect of sensitizers involved in this therapy. A 
highly activated sensitizer can transfer energy from its triplet state by two 
processes, directiy to molecular oxygen with the generation of superoxide radical 
or by interaction with solvent or substrate by electron or photon transfer witih the 
production of radicals (Hoebeke et al, 1997), 
Certain low molecular weight organic compoimds, designated as 
photosensitizers can damage biomolecules upon irradiation with light 
(Burgstaller et al., 1997). Endogenous products of photosensitizer may lead to 
misreplication, mutations and cancer (Shibutani et al, 1991). Natural and 
synthetic photosensitizers have attracted considerable interest because of their 
utilization in photochemotherapy, the treatment of disease with photosensitizing 
drug plus light (Diwu & Lown, 1994). 
Recently, riboflavin has been suggested to be a useful drug to kill tumor 
tissues in the process of photodynamic therapy (Edwards et al., 1994; lonita et al., 
2003). The phototoxic activity of riboflavin is enriched with Tyr and becomes 
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higher when Trp is added to the medium. The addition of photoproducts 
obtained by irradiation of a culture medium enriched with riboflavin and Trp to 
non-irradiated cells induces morphological changes similar to those of apoptotic 
cells (Edwards et al., 1994). Inactivation of neurotoxin A by photoilluminated 
riboflavin was demonstrated recently (Eubanks et al., 2005). The field of 
pharmacology and medicine has been developing with the fastest pace. The 
eminent feature responsible for this is the ability of science to harness the 
utilizable properties, curbing the toxicities by modem approaches. Though a 
large amount of work has been done on tumor destruction in photodynamic 
therapy, the mechanism underlying this technique/aversion of deleterious 
effects of omnipresent biomolecules especially regarding photochemical damage 
has not been well studied (Zhao et al., 2006). Photosensitized damage 
participates in solar-UV carcinogenesis, photogenotoxicity, phototoxicity. 
Chemoprevention of photosensitized damage is one of the most important 
methods for reducing the above phototoxic effects (Hirakawa et al., 2005). 
''RIBOFLAVIN AND DRUGS'' 
Light promoted degradation is being increasingly investigated in 
substrates of relevance in biology and medicine (Quintero & Miranda, 2000; 
Posadaz et al., 2000; Edwards & Silva, 2001; Cosa, 2004). Drugs belong to this 
class of biologically active and commercially valuable substrates. Though 
decomposition of drugs due to direct environmental irradiation can not be 
disregarded the presence of photosensitizing substances in their vicinity can 
aggravate the damage caused to them (Massad et al., 2005). Nevertheless, during 
elaboration, storage, or in vivo, after medicinal administration of drugs, in the 
presence of photochemically active molecule they might be able to absorb visible 
light and generate potentially aggressive species. These species can be transient 
entities consisting of the electronically excited states of a photosensitizer or 
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deleterioxis reactive oxygen species, generated from these excited states (Massad 
etal.,2005). 
A particixlar daylight absorber sensitizer is Vitamin B2 or riboflavin, which 
is a natural compound present in living organisms (Heelis, 1982). The ubiquitous 
presence of this vitamin, its photosensitizing characteristics and the damaging 
potential in its excited state are imdoubtedly a few factors that make it an 
interesting and advantageous area of study. The usual mechanism of action of 
this sensitizer is rather complex, with tiie concurrent involvement of oxidative 
species, singlet molecular oxygen and superoxide radical anion which are 
produced with quantmn yields of 0.49 and 0.009 respectively (Krishna et al., 
1991). It has been shown that 79% of the excited triplet of riboflavin is used to 
produce ^Oa (Chacon et al., 1988). Abstraction of an electron from a substrate AH, 
by excited riboflavin was shown to result in the formation of a cation radical 
AH*; and riboflavin semiquinone anion radical (Heelis, 1982). The riboflavin 
semiquinone anion radical could give the electron to AH*, undergo dismutation 
to oxidized AH and to fully reduced riboflavin, or give the electron to dissolved 
dioxygen that will then become a superoxide anion radical (Silva & Godoy, 1994). 
The reactions leading from the superoxide anion radical to hydrogen peroxide 
and to hydroxyl radicals are well established. It is known that light excited 
riboflavin which has a reduction potential of 1.89 V can oxidize a large variety of 
compotmds. In fact, in the absence of another oxidizable substrate, light excited 
riboflavin could even oxidize another riboflavin molecule (in the groimd state) 
and convert it to lumichrome (Moore et al., 1963). 
The toxic potential of riboflavin is thoroughly known. However, the 
photoexcitation phenomena exhibited by riboflavin has not been exploited 
completely in photodynamic therapies. Riboflavin sensitized photooxidation 
mediated by superoxide radical aiuon has been postulated to account for the 
disappearance of a series of compounds belonging to biologically and 
environmentally relevant families (Heelis, 1982; Silva et al., 1999). In the presence 
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of interacting species such as drug, the association could be a dark complexation 
between the drug and the excited vitamin which has been repeatedly reported 
for riboflavin with different tj^es of substrates (Posadaz et al., 2000; Massad et al., 
2004). Besides, the transient species singlet and triplet excited states of riboflavin 
can also interact with drug. The interaction of oxygen active species with 
pharmaceutical products is particularly important since, as a result of the 
photodamage, the drug can degrade, either decreasing its original therapeutic 
activity or even worse, modifying its specific effects and/or eventually 
generating toxic products. Nevertheless, a positive effect that can arise from the 
interaction of the drug with some photogenerated oxidative species is the 
eventual scavenging of the oxygenated species. In this context, the prevalence of 
an association process is a desirable possibility since the final result is the 
elimination of the oxidative species without considerable loss of the scavenger 
(Massad et al., 2005). In terms of the efficacy of the drug, the interaction can lead 
to reduced curative potential. An extension to photodynamic potential of the 
sensitizer would be, perhaps the minuscule possibilities of the photosensitizer 
suppressing the tmdesirable side-effects associated with the drug or vice versa. 
This myriad of possibilities could be relative to the properties of drug as well as 
the sensitizer as individual entities, concentration of the drug and sensitizer, type 
of sensitizer, the reaction media, presence of possible inhibitors and the 
irradiation source (Tsao & Eto, 1994). 
'TLATINUMS'' 
The metal derivatives are the loci of interest due to their curative potential 
for a plethora of cancers. These agents work by crosslinking DNA subunits. The 
resultant crosslinks acts to inhibit DNA synthesis, transcription and other functions. 
The platinum compoimds can act in any stage of the cell cycle. Cisplatin was the 
first platinum agent to be used in clinics in the early 1970's and was proved very 
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effective in the treatment of several types of cancer (Sweetman, 2002). In spite of 
its beneficial antitumor action, dose related toxicity limited its application in 
clinical oncology (Zicca et al., 2002). Therefore, in an attempt to overcome these 
issues, new platimmi analogues have been synthesized and tested over the years. 
From tihese, the second generation carboplatin and the third generation 
oxaliplatin have been the most successful and are oirrently vised not only in clinical 
trials but also as a standard therapy for certain tumor types (Almeida et al., 2006). 
''CIS-DIAMMINEDICHLOROPLATINUMdD/CISPLATIN'' 
The interest in platinum based antitumor drugs dates back to the 1960s 
with the serendipitous discovery by Rosenberg et al. (1965) showing the 
inhibition of cell division by Pt complexes. This group of researchers, while 
studying the effect of electrical field on bacterial growth observed that the 
current delivered between platinum electrodes iiUiibited replication of E.coli. 
With subsequent experiments it was established that growth inhibition was not 
due to the electrical current but because of certain salts of platinum that were 
liberated during this process. Platinum compoimds foxmd to be responsible for this 
phenomenon were identified as cis-diamminedichloroplatinum(II) (cis-ptCh (NH3)2]) 
and cis-diamminetetrachloroplatinxrai(IV) (cis-[PtCl4(NH3)2]) (Rosenberg, 1971). 
Rosenberg & Van Camp (1970) evaluated cis-diamminedichloroplatinum to be 
the most active after performing experiments with several animal tumor systems 
such as Sarcoma 180 and Leukemia L1210 bearing mice. 
In 1971, cis-diamminedichloroplatintmi entered the phase I clinical trials 
(Higby et al., 1974). Approval for the treatment of testicular and ovarian cancer 
was given in 1978. Today cis-diamminedichloroplatinum or cisplatin as it is 
commonly known, is one of the three most widely utilized antitumor drugs in 
the world and has aimual sales approximately reaching to $500 million (U.S) 
(Weiss & Christian, 1993). It has been successfully used for the treatment of 
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testicular and ovarian cancers, oropharyngeal carcinoma, bronchogenic carcinoma, 
cervical carcinoma, lymphoma, osteosarcoma, melanoma, bladder carcinoma and 
neuroblastoma (Weiss & Christian, 1993). Cisplatin has been used effectively in 
the chemotherapy of recurrent brain tumours and intracranial germ cell tumours 
(Spence et al., 1992). The cure rate for testicular cancer is now greater than 90% 
when tumors are promptly diagnosed (Bosl & Motzer, 1997). The optimal 
manner of administering the drug is not established, although investigators have 
used various schedules such as bolus injection (Hayes et al., 1977), prolonged 
infusion (Loo et al., 1978), and fractional daily usage (Einhorn & Donohue, 1977). 
The typical doses are 100 mg/day for upto five consecutive days (Reedijk, 1996) 
or a series of intravenous injections as sterile saline solution administered every 
3-4 weeks at a dose of 50-120 mg/m^. Once cisplatin is in the blood stieam, it 
remains intact due to the relatively high concentration of chloride ions (»100 mM). 
Cisplatin is a neutral, water-soluble, coplanar complex. The drug enters 
the cell by either passive diffusion or active uptake and is converted to its active 
form through sequential thermal ligand exchange in an aquation reaction 
replacing its chloride ions with water or hydroxyl groups (Singh & Turro, 2004). 
Hydrolysis occurs inside the cell due to a much lower concentration of chloride 
ion (»3-20 mM) and therefore a higher concentration of water. Lippard (1987) 
reported that when cisplatin is dissolved in aqueous solution, chloride ions are 
displaced to allow the formation of cisplatin hydrolysis products 
([Pt(NH3)2(H20)2]+2^ Pt(NH3)2(OH)(H20)++H+), which are \he reactive forms of 
the compound that react witii DNA. The active metabolite ds-[Pt(NH3)2(OH2)2]2+ 
is monoaquated (Singh & Turro, 2004). Inside the cell, cisplatin has a number of 
possible targets: DNA, RNA, sulphur<ontaining en2ymes such as metallothionein 
and glutathione. Although cisplatin can coordinate to RNA, this interaction is not 
believed to play an important role in the drug's mechanism of action in the body 
for two reasons. First, a single damaged RNA molecule can be replaced by newly 
synthesized material; studies have revealed that cisplatin does not affect RNA 
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synthesis. Second, when cisplatin was administered in vitro at its lethal dose to a 
strain of cancer cells, only small fractions (1% to 10%) of RNA molecules were 
damaged (Pil & Lippard, 1997). 
Cisplatin primarily induces DNA damage or modification resulting in 
programmed cell death or apoptosis when uiuepaired (Fukutomi et al., 2006). It 
binds with N7 of purine bases forming monoadducts as these nitrogen atoms do 
not form hydrogen bonds with any other DNA bases. Because cisplatin is a 
bifunctional agent its monoadducts are transformed into inter- and intrastrand 
crosslinks by reaction of the second reactive site of the drug with the second 
nucleobase. The most important of these appear to be the ones in which the two 
chlorine ligands of cisplatin are replaced by purine nitrogen atoms on adjacent 
bases on tfie same strand of DNA; and are referred as 1,2-intrastrand crosslinks 
as mentioned previously. The purine bases most conunonly involved in these 
adducts are guanines; however, adducts involving one guanine and one adenine 
are also fotmd. Finally, cisplatin forms l,2-d(GpG) (60-65% of the total) and 1,2-
d(ApG) (22-30% of the total) intrastrand crosslinks and to a lesser degree 1,3-
d(GpXpG) intrastrand crosslinks and interstrand crosslinks (Fichtinger-Schepman 
et al., 1985). The l,2-d(GpG) and l,2-d(ApG) intrastrand crosslinks, which 
comprise about 90% of tiie cisplatin-DNA adducts causes the purines to become 
destacked and the DNA helix to become kinked, precisely bending it by 34° 
towards its major groove and unwinding it by 13° (Bellon et al., 1991). Cisplatin-
DNA adducts can inhibit fundamental cellular processes, including replication 
(Suo et al., 1999), transcription (Vichi et al., 1997), translation (Heminger et al., 
1997) and DNA repair (Szymkowski et al., 1992). As it turns out, however, 
formation of any platinated coordination complex with DNA or adduct 
formation is not sufficient for cytotoxic or cell killing activity. The corresponding 
trans isomer of cisplatin, namely trans-DDP also forms a coordination complex 
with DNA but unlike cisplatin, trans-DDP is not effective chemotherapeutic 
agent. Due to the difference in geometry between cis- emd trans- isomers, the 
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types of interactions by the two compounds with DNA are not the same. Trans-
DDP cannot form 1,2-intrastrand crosslinks with DNA. Since, trans-DDP is 
inactive in killing cancer cells, it is beheved that the 1,2-intrastrand adducts 
formed between cisplatin and DNA are important for the anticancer activity of 
cisplatin (Pil & Lippard, 1997). It appears that these differences are critically 
important in determining the efficacy of a particular compotmd for the treatment 
of cancer. For this reason, a great deal of effort has been placed on discovering 
the specific cellular proteins that recognize cisplatin-DNA complexes and then 
examining the interactions of these proteins with the complexes and the 
subsequent events leading to cancer cell death (Pil & Lippard, 1997). Cisplatin 
has been used both as a single agent and in combination for cancer 
chemotherapy. These treatments have been reported to diminish complexities 
such as the elevation in lipid peroxidation and the depletion in protective 
enzyme activities in the kidney that are induced by cisplatin (Wozniak et al., 2004). 
Treatment of ttunor cells with cisplatin provokes several responses 
including membrane peroxidation (Sugiyama et al., 1989), dysfunction of 
mitochondria (Brady et al., 1990), inhibition of protein s)nithesis and DNA 
damage (Kharbanda et al., 1995). Along with its usage several inconvenient side 
effects are included that need to be dealt with carefully in order to maximize 
antitmnor activity and minimize toxicity. Intrinsic or acquired resistance, its 
toxicity towards healthy cells (Zhang & Lippard, 2003), reduction of antioxidant 
plasma level and generation of free radicals in normal cells (Weijl et al., 1998; 
Yoshida et al., 2003) limit the organotropic profile of the drug. The disadvantages 
include severe toxicity such as nephrotoxicity, neurotoxicity and emetogenesis 
symptomised by nausea, vomiting, renal damage and VIII nerve damage. 
Nephrotoxicity being the major adverse effect accompaiued by its usage 
develops primarily in the S3 segment of the proximal tubule (Blachley & Hill, 
1981). High doses of cisplatin produce hepatotoxicity, but the impairment of 
kidney function is recognized as the main side effect and the most important 
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dose limiting factor (Kersten et al., 1998). Cisplatin induced nephrotoxicity is 
closely associated with an increase in lipid peroxidation in the kidney tissues 
(Greggi Antunes et al., 2000) and decrease in the activity of enzymes that prevent 
oxidative stress or protect the kidney from such stress (Weijl et al., 1998). 
A mechanism by which cisplatin exerts its cytotoxicity is through the 
generation of ROS (Auersperg et al, 1998). The drug is able to generate reactive 
oxygen species, such as superoxide anion and hydroxyl radical. Masuda et al. 
(1994) found cisplatin-induced generation of active oxygen radicals in a cell-free 
system. They have shown that cisplatin generated superoxide anion and 
hydroxyl radical, as measured by chemiluminescence using a Cypridina luciferin 
analog, upon interaction with calf thymus DNA in phosphate-buffered saline at 
pH 7.6. They concluded that a single electron released by tiie cisplatin-DNA 
interaction and O2 dissolved in PBS is involved in the production of Oj and OH" 
radical. Furthermore, ESR analysis by Yoshida et al. (2003) revealed that the ROS 
produced by cisplatin was OH, and that OH formation was caused directly by 
cisplatin without DNA at physiological pH. It has been proven indirectly that 
ROS production is involved in tiie renal damage caused by cisplatin (Von Hoff et al., 
1979), This may lead to failure of the andoxidative defense mechanism against 
free radical mediated organ damage and genoto/icity of cisplatin (Wozniak et al., 
2004). 
To help alleviate nephrotoxicity, intravenous hydration and diiu-esis have 
been employed (Weiss & Christian, 1993) but in many cases they do not provide 
clinically effective protection. The use of serotonin receptor antagonists have 
helped reduce nausea and vomiting in a few cases. A number of rescue agents 
such as mesna, WR-2721, diethyldithiocarbamate and thiosulfate, selenium and 
bismuth subnitrate have also been used to control cisplatin toxicity; however, the 
exact role of these agents is not well understood, and they are yet not routinely 
being used in Pt chemotherapy (Reedijk, 1999). 
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"ANTIMETABOLITES" 
In 1948, Dr. Sidney Farber showed that a fohc add analog could induce 
remission in childhood leukemia. Approximately 10 out of 16 patients treated 
demonstrated evidence of hematologic improvement. This experiment provided 
the foundation for scientists to synthesize a number of other agents that either 
target naturally occurring compovmds or inhibit key enzymatic reactions in their 
biochemical pathways. In general, all antimetabolites interfere with normal 
metabolic pathways, including those necessary for synthesizing new DNA. The 
most widely used antifolate in cancer therapy with activity against leukemia, 
lymphoma, breast cancer, head and neck cancer, sarcomas, colon cancer and 
bladder cancer is methotrexate. Methotrexate inhibits a crucial enzyme required 
for DNA synthesis and consequently, exerts its effect on the S phase of the cell 
cycle. Another widely used antimetabolite that thwarts DNA synthesis by 
interfering with the nucleotide (DNA components) production is 5-fluorouracil. 
It too has a wide range of activity including colon cancer, breast cancer, head and 
neck cancer, pancreatic cancer, gastric cancer, esophageal cancer and hepatomas. 
A unique and interesting aspect of this drug is its toxicity profile. 5-Fluorouracil 
is metabolized by a naturally occuring enzyme called dihydropyrimidine 
dehydrogenase, DPD. There is a small population of people who may be 
deficient of this particular enzyme. Lacking DPD does not interfere with normal 
body biochemistry and thus, the phenotype is silent. However, when these 
patients are challenged with this chemotherapy drug, they are unable to 
metabolize it and as a result, get acute and severe toxicity. The most often 
observed toxicities include bone marrow suppression, severe GI toxicities and 
neurotoxocities which may include seizures and even coma. Early diagnosis and 
providing the patient with an antidote like thymidine is a respite. Other 
antimetabolites that inhibit DNA synthesis and DNA repair include; cytarabine, 
gemcitabine, 6-mercaptopurine, 6-thioguanine, fludarabine and cladribine. 
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''5-FLUOROURACIU' 
5-Fluorouracil a pyrimidine analog is an important anticancer drug used 
widely in the treatment of a variety of solid tumors such as colorectal, breast, 
stomach and liver carcinomas (Tobias, 1992). It is assumed that the cytotoxic 
action of the fluorinated pyrimidine is mediated primarily via inhibition of 
thymidylate synthetase (Santi et al., 1974), the key enzyme that promotes the de 
novo synthesis of thymidylic acid which leads to the formation of dTTP, a 
substrate of DNA polymerase. Following transport into the cell, a significant 
portion of 5-fluorouracU is converted to FdUMP by sequential action of pyrimidine 
phosphoribosyl tranferase, nucleoside monophosphate kinase and ribonucleotide 
reductase. FdUMP forms a ternary complex with the enzyme thymidylate 
synthetase and its cofactor 5,10-methylene tetraydrofolate. This complex cannot 
break down further into separate entities, and as a result the enzyme is rendered 
Inactive. The de novo synthesis of dTTP is blocked, which results in inhibition of 
DNA synthesis, a process called "thymineless death". Thymidylate synthetase is 
overproduced in many 5-fluorouracil resistant cell lines, implying that this 
enzyme is indeed the target of its metabolite, FdUMP (Zhang et al., 1992). 
FdUMP is converted to FdUTP by the enzyme nucleoside monophosphate 
kinase. Studies have shown that FdUTP can be used as a substrate by 
mammalian DNA, causing misincorporation of FdUMP into DNA (Weckbecker, 
1991). Although the misincorporated nucleotide can be removed by the cellular 
DNA repair system, 5-fluorouracil substituted DNA does not appear to be an 
ideal substrate for uracil DNA glycosidase (Caradonna & Cheng, 1980). 
Incorporation of 5-fluorouracil into DNA produces many deleterious effects, 
such as inhibition of further DNA synthesis (Schuetz et al., 1984), DNA 
fragmentations due to single and double strand breaks (Lorm et al., 1989) and 
mutations induced by 5-fluorouracil base pairing with guanine instead of 
adenine (Herrington & Takahashi, 1973). It is apparent that 5-fluorouracil 
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metabolites not only inhibit DNA synthesis but also cause other undesirable 
effects due to misincorporation of FdUTP into DNA. 
Although this potent drug has been used in cancer chemotherapy for 
nearly four decades, its major mechanism of action is still being debated. 
Although competitive inhibition of thymidylate synthetase by 5-fluorouracil is a 
major mode of action of this fluoropyrimidine, this effect alone cannot explain its 
cytotoxicity or the antitumor action (Ghoshal & Jacob, 1997). 
Elucidation of the primary mode of action of this drug was crucial for 
further development of more potent drugs with significantly reduced adverse 
reactions that are characteristic of most antineoplastic agents. Research in this 
area has casted doubt on the reduced synthesis of thymidylic acid as the only 
mechanism for the 5-fluorouracil induced inhibition of cellular proliferation 
(Ghoshal & Jacob, 1997). A few possibilities include alterations in mRNA 
expression (Will & Doliuck, 1987), iiJubition of mRNA splicing (Patton, 1994), 
and interference with tRNA modifications (Tseng et al., 1978). However, because 
of the relatively low response rate and the short duration of the response period, 
various attempts have been made to potentiate the antitumor activity of 5-
fluorouracil and prolong the survival time of cancer patients (Araki et al., 2000). 
Although some 5-fluorouracil dosing schedules, such as continuous 
infusion, have been demorvstrated to increase the response rate compared to 
bolus injection (Lokich et al, 1989), attention is still being focused on biochemical 
modulation of 5-fluoroiu'acil by combination with cytotoxic or non-cytotoxic 
agents to enhance 5-fluorouracil's activity. To date, the most effective regimens 
have been combinations of 5-fluorouracil and leucovorin or cisplatin. The 
combination of 5-fluorouracil and cisplatin, in particular, has been reported to 
result in high response rates in patients with head and neck cancer (Fonseca et 
al., 1997) and colorectal cancer (LoRusso et al., 1989). 
Scanlon et al. (1986) and Shirasaka et al. (1993) showed that the high 
response rates attained witii 5-fluorouracil plus cisplatin are based on increased 
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inhibition of thymidylate synthase by FdUMP, induced by elevated levels of 5, 
lO-methylenetetrahydrofolate (CH2FH4) and tetrahydrofolate (FH4). This occiured 
because cisplatin inhibits the transport cf L-methionine (Met) and indirectly 
causes elevation of intracellular (CH2FH4) and FH4 levels in tumor cells in vitro 
and in vivo. 5-Fluorouracil plus cisplatin is the most beneficial chemotherapy 
regimen available for the treatment of patients with gastric cancer and head and 
neck cancer. 
According to recent trials, the combination of consecutive lower dose 
(below 10 mg/m2) cisplatin and continuous infusion 5-fluorouracil appears to be 
effective treatment for cancer patients, the same as the combination of a single 
conventional dose of cisplatin and 5-fluorouracil (Tsuji et al., 1999). In fact. 
Weaver et al. (1984) have reported superior response rates in head and neck 
cancer patients by combining continuous infusion 5-fluorouracil (1000 mg/m^) 
with bolus cisplatin (100 mg/m^), whereas the response rates of head and neck 
cancer to each drug individually were low. Kamano et al. (1997) have also 
reported enhanced antitumor activity of continuous infusion of 5-fluorouracil 
plus consecutive lower dose cisplatin in tumor bearing mice. 
Recent studies have reported inactivation of enzyme trypsin by 
photoexcited riboflavin (Husain et al., 2006) and also that the drug 
aminophylline in combination with riboflavin was found to augment 
degradative capacities of the sensitizer (Ali & Naseem, 2002), with aminophylline 
getting oxidized in the process (Hasan et al., 2006). These studies clearly 
indicated interactive consequences affecting native abiUties. However, 
interaction of this particular endogenous sensitizer in the perspective of chemo-
and photo- therapy with specific relevance to cellular macromolecules is poorly 
imderstood. 
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/ / Materials & Methods'' 
''MATERIALS'' 
Acetic acid 
Acrylamide 
Agarose 
Ammonium per sulphate 
Beta-mercaptoethanol 
Bis-acrylamide 
Bovine serimi albumin (BSA) 
Calf thymus DNA (CT-DNA) 
Cis-diamminedichloroplatinum (CDDP) 
Coomassie brilliant blue 
Dinitrophenylhydrazine (DNPH) 
Diphenylamine 
Ethidium bromide (EB) 
Ethylenediaminetetraacetic acid (EDTA) 
5-Fluorouracil (5-FU) 
Folin's phenol 
Glycine 
Low melting point agarose (LMPA) 
Methanol 
Nitro blue tetrazolium (NBT) 
Phosphate buffered saline (PBS) 
Riboflavin (RF) 
RPMI1640 media 
Sodium carbonate 
Sodiimi dodecylsulphate (SDS) 
Sodium hydroxide (NaOH) 
Supercoiled plasmid pUC 18 
Qualigens Fine Chemicals, India 
SRL, India 
Sigma Chemical Co., USA 
SRL, India 
E. Merck, India 
SRL, India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
BDH, India 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
BDH, India 
SRL, India 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
SRI, India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
BDH, India 
Sigma Chemical Co., USA 
BDH, India 
Sigma Chemical Co., USA 
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Thiobarbituric acid (TBA) Sigma Chemical Co., USA 
Trichloroacetic add (TCA) Glaxo, India 
Trinitrobenzenesulphoruc acid (TNBS) SRL, India 
Triton X-100 BDH, India 
• All other chemicals were commercial products of analytical grade. 
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''METHODS'' 
'Irradiation procedure' 
Each sample according to the experiment being followed was placed 
directly imder fluorescent light at a distance of 10 cm. At this point fluence rate 
was 38.6 w/m^ as measured by a laser power meter (model: Lasermate, 
Coherent, USA). There was no measurable change in temperature of the 
solutions at the end of irradiation. Additives', including photosensitizer of 
required concentration was added just prior to irradiation. 
'^fragmentation of proteins by riboflavin in the presence of drug' 
The reaction mixture (1.0 ml) contained 10 mM potassium phosphate 
buffer pH 7.5, bovine serum albumin (2 mg/ml) and varying concentrations of 
riboflavin/drug/both. After incubation in a white light transilliuninator for 
specified time intervals, the reactions were stopped by adding 1 mM EDTA and 
were precipitated with 5% TCA. The tubes were immediately transferred to ice 
for 1 hour before centrifugation at 2000 rpm for 10 minutes at room temperature 
to remove the unfragmented protein. The generation of material soluble in TCA 
was assessed by estimating free amino groups using trinitrobenzenesulphonic 
acid (TNBS) (Snyder & Sobocinski, 1975). 25 i^l of 30 mM aqueous TNBS and 1.0 
ml of disodiumtetrahydroborate buffer (pH 9.5) was added to 100 nl of sample, 
vortexed to ensure complete mixing and allowed to stand at room temperature 
for 30 minutes. The absorbance was read at 420 nm against a blank consisting of 
25 ]i\ of 30 mM TNBS and 1.1 ml of borate buffer (pH 9.5). The reaction was 
calibrated with glycine. The principle of this assay is based on the formation of 
highly absorbing chromophore of picrylsulphonamide formed by condensation 
of the reagent with free amino groups. 
32 
^Trypsin Assay' 
Trypsin was assayed by the method of Kxinitz (1974) using casein as the 
substrate. The reaction mixture in a final volume of 2 ml contained 10 mg casein, 
10 mM phosphate buffer (pH 7.4), trypsin (15 ng) with riboflavin/cisplatin/both/none 
was incubated imder fluorescent light for 60 minutes prior to assay to determine 
their effect. After incubating at 37 °C for 30 minutes, the reaction was terminated 
by the addition of 1 ml of 10% TCA. The sample was then centrifuged at 2500 
rpm for 10 minutes to remove the undigested protein as precipitate, and the 
supernatant was used for determining the acid soluble peptides using the 
method of Lowry et al. (1951). 
^Assay for protein carbonyls' 
Protein carbonyls were measured bylhe method of Levine et al. (1994). 1 
ml sample was mixed with 400 |il of ice cold 40% TCA and centrifuged at 4 °C for 
10 minutes at 12,000 g. Protein pellet was dissolved in 200 nl of 100 mM PBS pH 
7.4. To this solution 200 ^ 1 distilled water and 400 nl of 20 mM DNPH in 4 N HCl 
was added. This solution was incubated for 90 minutes at 37 °C with shaking. 
Following incubation protein was precipitated with 350 \d of 40% TCA at 12,000 
g. Protein pellet was washed thrice with 1 ml mixture of ethanol and ethylacetate 
(1:1; v/v). Finally, protein pellet was dissolved in 6 M guanidine hydrochloride 
and absorbance was measured at 360 and 280 nm. Protein carbonyl formation 
was expressed as ratio of absorbance at 360-280 nm. 
'SDS-Polyacrylamide Gel Electrophoresis' 
SDS-PAGE was performed essentially, according to the method of 
Laemmli (1970). Stock solutions of 30% acrylamide containing 0.8% bis-
acrylamide, 1 M Tris-HCl, pH 8.8 and 10% SDS were prepared to make 10% and 
33 
15% gel for BSA and trypsin respectively. They were mixed in appropriate order 
and proportions and poured with the help of perista pump into the mould 
formed by two glass plates (8.5 x 10 cm) separated by 1.5 mm thick spacers. 
Bubbles and leaks were avoided. A comb providing a template for 7 sample 
wells was inserted into the stacking gel solution before polymerization began. 
When the polymerization was complete in about 1 hour, the comb was removed 
and wells were overlaid with running buffer. Protein samples were prepared to 
give a final concentration of 1% (w/v) SDS, 0.5% (v/v) p-mercaptoethanol, 
0:0625 M Tris-HCl pH 6.8 and 10% (v/v) glycerol. A trace of bromophenol blue 
was added as a tracking dye. Samples were then heated in a boiling water bath 
for about 3 minutes and applied to the wells. The electrode buffer containing 
0.025 M Tris-HCl, 0.2 M glycine and 0.2% SDS was used. Electrophoresis was 
performed initially at 50 V for 15 minutes and then at 100 V till the tracking dye 
reached die bottom of the gel. After the electrophoresis was complete BSA bands 
were detected by staining the gels by 0.1% Coomassie brilliant blue R-250 in 40% 
methanol and 10% acetic acid. Destaining was carried out with 10% glacial acetic 
add. Trypsin gels were stained by silver nitrate method (Merril et al., 1981). 
'Silver staining^ 
After electrophoresis, gels were immersed in a mixture of 30 ml of 50% 
acetone, 0.75 ml of 50% TCA and 12.5 nl of 37% formaldehyde for 10 minutes 
with constant shaking for fixation. They were then washed thrice with distilled 
water. Gels were again soaked in 30 ml of 50% acetone for 10 minutes. After this, 
they were treated with a solution containing 30 ml of distilled water and 50 \il of 
10% NaiSaOj. Next they were washed with distilled water. They were then 
soaked in a solution containing 0.4 ml 20% silver nitrate, 0.3 ml of 37% 
formaldehyde and 30 ml of distilled water for 8 minutes. After washing with 
distilled water, the gels were transferred to a solution contaiiung 0.02 g/ml of 
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sodium carbonate, 12.5 nl of 37% formaldehyde and 12.5 nl of 10% Na2S203 to 
make them alkaline. After 10-20 seconds they were suspended in 1% glacial 
acetic acid for 1 minute to stop the reaction. Then they were finally washed with 
distilled water since the bands were visible by now. 
'Absorption studies' 
The absorption spectra were obtained by using Beckman DU-40 
spectrophotometer (USA) equipped with a plotter. The absorption spectrum of 
riboflavin (50 nM) was recorded in the range 300-500 nm. The UV measurements 
of BSA/calf thymus DNA in the presence and absence of riboflavin/drug/both 
were made in the range of 250-300 and 200-300 nm respectively. 
'Spectrophototnetric study for drug-riboflavin interaction' 
The effects of increasing concentrations of drug on absorption spectra of 
riboflavin were observed. The reaction mixture (3.0 ml) contained 50 i^M riboflavin 
and increasing concentrations of drug. The spectra were recorded before and 
after incubation for 60 minutes in white light. 
'Fluorescence studies' 
The fluorescence studies were performed on a Shimadzu spectrofluoro-
photometer RF-5000 (Japan) equipped with a plotter and a calculator. Riboflavin 
was excited at its absorption maxima (\max) of 330 nm. Emission spectra was 
recorded in the range of 480-540 nm. The emission spectrum of BSA was recorded 
with excitation at 280 nm, in the range of 300-400 run. 
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^CD measurements' 
CD measurements were carried out with a Jasco spectropolarimeter, 
model J-720 equipped with a microcomputer. The iiistrument was calibrated 
with D -10-camphorsulforiic acid. All the CD measurements were made at 25 °C 
with a thermostatically controlled cell holder attached to Neslab's RTE-110 water 
bath with an accuracy of ± 0.1 °C. Spectra were collected with a scan speed of 20 
nm/min and a response time of 1 s. Each spectrum was the average of four 
scans. Far UV CD spectra were taken at protein concentration of 2 jiM with a 1 
mm path length cell. The results were expressed as MRE (Mean Residue Ellipticity) 
in deg cm^ mol-^  which is defined as MRE=6obs/(10xnx/xCp) where 9obs is the CD 
in milli-degree, n is the number of amino acid residues (583), / is the path length 
of the cell and Cp is the mole fraction. Helical content was calculated from the 
MRE values at 222 nm using the following equation as described by Chen et al. 
(1972). 
% a-helix=(MRE222 nm - 2340/30300) x 100 
Treatment of supercoiled plasmid pUC 18 DNA with different 
compounds in the presence of riboflavin' 
Reaction mixtures (30 nl) contained 10 mM Tris-HCl (pH 7.5), 0.5 ^g plasmid 
pUC 18 DNA and other components as indicated in the legends. Incubations 
were performed in a white light transilluminator for time periods specified in the 
legends. After incubation, 10 ^1 of a solution containing 40 mM EDTA, 0.05% 
bromophenol blue tracking dye and 50% (v/v) glycerol was added and the 
solution was subjected to electrophoresis in submarine 1% agarose gels. The gels 
were stained with ethidium bromide (0.5 ng/ml), viewed and photographed on a 
transilluminator. 
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'Determination of oxidative DNA damage' 
Calf thymus DNA damage was determined by using the ethidium 
bromide binding assay (Stoewe & Prutz, 1987). A total 3 ml of PBS (pH 7.4) 
containing calf thymus DNA (ZS^M) with different concentrations of 
riboflavin/drug/both were incubated in white light for 60 minutes. After 
incubation, 50 i^l of 0.75 mg/ml EB was added and the fluorescence was 
measured using a Shimadzu RF-5000 (Japan) spectrofluorimeter with excitation 
at 340 run and emission at 500-600 nm. A solution containing all reagents and 
DNA except riboflavin/drug was used as the control for 100% fluorescence, and 
zero fluorescence was assessed in a solution identical to the control except DNA. 
The loss of fluorescence was used as a measure of DNA damage. 
'Reaction of riboflavin with calf thymus DNA and digestion with 
single strand-specific nuclease' 
Reaction mixtures (0.5 ml) containing 500 ng of native calf thymus DNA 
prepared in 10 mM Tris-HCl was incubated in white light for 60 minutes with 
varying amoimts of riboflavin/drug/both as indicated in the legends. After 
incubation for a fixed time period at room temperature, nuclease digestion was 
performed. The assay determines the acid soluble nucleotides released from 
DNA if any as a result of damage caused by the additives. The reaction mixture 
for nuclease digestion contained in a total volume of 1 ml, 0.1 M Tris-HCl, pH 
7.4, 0.001 M MgCl2, distilled water and enzyme. The reaction mixture was 
incubated for 2 hours at 37 °C. At the end of incubation the reaction was stopped 
by adding 0.2 ml of 10 mg/ml BSA and mixed tiioroughly by shaking. 1 ml of 
prechilled 14% perchloric acid was added then. The tubes were left in ice for at 
least half an hour before centrifugation at 2500 rpm for 10 minutes at room 
temperature to remove the imdigested DNA and precipitated protein. Acid 
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soluble nucleotides were determined in the supernatant using the diphenylamine 
method of Schneider (1957). To a 1 ml aliquot, 2 ml diphenylamine reagent 
(freshly prepared by dissolving 1 gm of recrystallised diphenylamine in 100 ml 
of glacial acetic acid and 2.75 ml of concentrated sulfuric acid) was added. The 
tubes were heated in a boiling water bath for 20 minutes. The intensity of blue 
color was read at 600 nm. 
'Detection ofhydroxyl radical' 
In order to compare the rate of hydroxyl radical production by increasing 
concentrations of riboflavin/riboflavin in the presence of drug, the method of 
Quinlan & Gutteridge (1987) was followed. Calf thymus DNA (100 |ig) was used 
as a substrate and the malondialdehyde generated from deoxyribose radicals 
was assayed by recording the absorbance at 532 nm. 
'Detection of superoxide anion' 
Superoxide was detected by the reduction of nitroblue tetrazohum (NBT) 
essentially as described by Nakayama et al. (1983). A typical assay mixture 
contained 50 mM soditun phosphate buffer pH 8.0, 33 jiM NBT, 100 ^M EDTA 
and 0.06% Triton X-100 in a total volimie of 3.0 ml. The reaction was started by 
the addition of drug. After mixing, absorbance was recorded at 560 nm at 
different time intervals, against a blank which did not contain the compotmd. To 
confirm the formation of superoxide anion, SOD was added to the solution, in a 
control tube, before the addition of the compoimd. 
'Isolation of lymphocytes' 
Heparinized blood samples (2 ml) from healthy donors were obtained by 
venepuncture and diluted suitably in Ca2+ and Mg2+ free PBS. Lymphocytes were 
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isolated from blood using Histopaque 1077 (Sigma Diagnostics, St Louis, USA) 
and the cells were finally suspended in RPMI1640. 
'Treatment of lymphocytes with riboflavin and drugs' 
Lymphocytes (IxlO^ cells) were exposed to different concentrations of 
riboflavin/drug/both in a total reaction volume of 1 ml (400 nl RPMI, PBS Ca^ * 
and Mg2+ free and indicated concentrations of the additives). Incubation was 
performed for 60 minutes under white light unless specified otherwise. After the 
incubation, the reaction mixtiu-e was centrifuged at 4000 rpm, the supernatant 
discarded and pelleted lymphocytes resuspended in 100 |xl PBS and processed 
further for comet assay. 
'Viability assessment of lymphocytes' 
Riboflavin photoinduced cytotoxicity of lymphocytes was assayed by 
trypan blue exclusion test (Pool-Zobel et al., 1993) and assessed by cell mortality. 
Cells were divided in a no treatment group, a riboflavin alone group, a drug 
alone group and a cotreatment with riboflavin and drug group. All the groups 
were incubated for 60 minutes vmder white light tmless otherwise stated. After 
the exposure, an equal volume of 0.4% trypan blue solution was added and the 
percentage of stained cells to the total cells was calculated using a 
hemocytometer. The viability test relies on breakdown in membrane integrity 
determined by the uptake of a dye (trypan blue) to which the cell is 
impermeable. 
'Alkaline single cell gel electrophoresis/Comet assay' 
Comet assay was performed imder alkaline conditions essentially according 
to the procedure of Singh et al. (1989) with slight modifications. Fully frosted 
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microscopic slides precoated with 1% normal melting agarose at 50 °C (dissolved 
in Ca^ * and Mg2+ free PBS) were used. Approximately 10,000 cells were mixed 
with 75 ^ il of 1% LMPA to form a cell suspension and pipetted over the first layer 
and covered immediately by a cover slip. The slides were placed on a flat tray 
and kept on ice for 10 minutes to solidify the agarose. The coverslips were 
removed and a third layer of 0.5% LMPA (75 |al) was pipetted and coverslips 
placed over it and allowed to solidify on ice for 5 minutes. The coverslips were 
removed and the slides were immersed in cold lysing solution containing 2.5 M 
NaCl, 100 mM EDTA, 10 mM Tris, pH 10 and 1% Triton X-100 that was added 
just prior to use from 1 hour to 4 hours at 4 °C. After lysis DNA was allowed to 
unwind for 30 minutes in alkaline electrophoretic solution consisting of 300 mM 
NaOH, 1 mM EDTA, pH>13. Electrophoresis was performed at 4 °C in field 
strength of 0.7 volts/cm and 300 mA current. The slides were then neutralized 
with cold 0.4 M Tris, pH 7.5, stained with 75 nl EB (20 ng/ml) and covered with a 
, coverslip. The slides were placed in a humidified chamber to prevent drying of 
the gel and analyzed the same day. Slides were scored using an image analysis 
system (Komet 5.5, Kinetic Imaging, Liverpool, UK) attached to a Olympus 
(CX41) fluorescent microscope and an integrated CC camera (equipped with a 
510-560 run excitation and 590 nm barrier filters). Comets were scored at lOOX 
magnification. Images from 50 cells (25 from each replicate slide) were analyzed. 
The parameter taken to assess lymphocytes DNA damage was tail length 
(migration of DNA from the nucleus, ^meters) and was automatically generated 
by Komet 5.5 image analysis system. 
'Determination of TEARS' 
Thiobarbituric acid reactive substances (TBARS) were determined 
according to the method of Ramanathan et al. (1994). A cell suspension (IxlO^/ml) 
was incubated as indicated in the legends and then centrifuged. The cell pellet 
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was washed twice with phosphate buffered saline (Ca^ ^ and Mg^* free) and 
suspended in 0,1 N NaOH. This cell suspension (1.4 ml) was further treated with 
10% TCA and 0.6 M TBA (thiobarbituric acid) in boiling water bath for 10 
minutes. The absorbance was read at 532 nm. 
'Preparation ofRBC and scanning electron microscopy^ 
Red Blood cells (RBC) were prepared from fresh himian blood collected in 
acid citrate dextrose by centrifugation at 1500 xg for 10 minutes at room 
temperature. The cells were washed three times with 5 volumes of isotonic NaCl 
solution. The packed RBC were suspended in 3 ml of 10 mM Tris-HCl, pH 7.4 
containing 0.15 M NaCl and varying amounts of additives' as indicated in the 
legends to give 0.5% hematocrit. The reaction mixture was incubated in light for 
60 minutes. After incubation RBC from different reactions were applied on glass 
slides washed with alcohol and dried. The glass slides were then coated with 
gold by a sputter cotter and the micrographs were taken using scanning electron 
microscope. Philips, Japan. 
'Statistical analyses' 
The statistical analysis was performed as described by Tice et al. (2000) 
and is expressed as ± SEM of three independent experiments. A student's t-test 
was used to examine statistically significant differences. Analysis of variance was 
performed using ANOVA. P values < 0.05 were considered statistically significant 
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''Unit Kay 
'Protein modification 
studies' 
J 
(Ia)l. ''BSA fragmentation'' 
Semm albumin is the most abundant circulatory protein that plays vital 
physiological functions. Binding of photosensitizer to serum albumin facilitates 
uptake of the photosensitizer (Pandey et al., 1997) and may alter the photophysical 
and photochemical properties of photosensitizer (Aveline et al., 1995). 
Investigations verify that riboflavin binds to proteins and modifies tiiem 
photochemically. Fig. l(i) compares the kinetic behavior of BSA fragmentation 
reaction by riboflavin in the presence and absence of light. TCA soluble free 
amino group was assayed by the method of Snyder and Sobocinski (1975). The 
method determines the formation of acid soluble amino groups by TNBS. In the 
influence of light there was an initial sharp spurt followed by a gradual increase 
in tiie production of acid soluble material. However, this effect was not observed 
in the absence of light. The time dependent fragmentation of BSA in the presence 
of riboflavin and light as given in fig. l(ii) witnesses a rise in the amount of acid 
soluble amino acid groups up to 60 minutes of incubation. Fragmentation 
reaction was progressive with time and plateaued between 60 and 70 minutes. 
Increasing time of incubation over 60 minutes did not result in any appreciable 
increase in the fragmentation of BSA and therefore 60 minutes was used for 
stadymg the dependency of BSA fragmentation reaction on riboflavin concentration. 
For subsequent experiments, incubation was carried out in fluorescent light for 
60 minutes unless oflierwise stated. 
Among the key chemotherapeutic agents, platinum compoimds are the 
most sought after for cancer cure (Loehrer & Einhom, 1984) and cisplatin has 
been the primary platinum based drug (Pil & Lippard, 1997). It was suggested 
that cisplatin, acts mainly through DNA imwinding exerting antitumor effect by 
binding via crosslinks and interfering with replication and transcription of tumor 
DNA (Takahara et al, 1995; Fichtinger-Schepman et al., 1985). There is, however, 
substantial biomedical evidence as well as chemical reasons to support the 
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involvement of non DNA targets that could determine the antitumor activity of 
platinum group metallodrugs, including cisplatin. From a pxu'ely chemical point 
of view, these metals act as 'soft' lewis acids and should be expected to form 
stable complexes with S or N donors in peptides and proteins. This binding 
eventually leads to altered protein conformation and changes in biological 
activity, especially when enzymatic reactions are affected. Coupled to drug 
antitumor activity are many severe toxic side effects, such as protein structural 
alteration and enzymatic changes implicated in its mechanism of action 
(Aggarwal, 1993). The reactions of cisplatin with substances other than DNA are 
of no lesser biological importance because these interactions play central role in 
modulating the activity of platinum based antitumor drugs (Neault & Tajmir-
Riahi, 1998). Among the possible non DNA targets is albumin (Esposito & Najjar, 
2002). Fig. l(iii) demonstrates tiie effect of cisplatin alone on protein 
fragmentation. There is a slight concentration dependent enhancement in protein 
fragmentation in the presence of light. Importantly, photoactivated excited-state 
metal complexes often possess enhanced chemical reactivity compared to the 
ground state (Bednarski et al., 2006). Further, increasing concentrations of 
cisplatin brought about an iiJiibition of riboflavin mediated fragmentation as 
perceived in fig. l(iv) indicating the protective effect of drug in photodynamic 
reaction. 
(Ia)2. "Carbonylformation" 
Spectrophotometric assay of protein carbonyls are used as markers of 
protein oxidation in vivo and in vitro (Shacter, 2000). Expressing carbonyl 
formation as ratio of two absorbance provides more reliable and accurate result 
by eliminating the uneven loss of total protein content during the process of 
assay. Absorbance at 360 nm is due to protein carbonyls and absorbance at 280 
nm is due to protein content in the final measuring solution. Extent of protein 
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damage was assayed by measuring the protein carbonyl content both in the 
presence and absence of photoilluminated riboflavin (Fig. 2(i)). Carbonyl content 
of BSA irradiated in visible light alone exhibit no change in the absorbance ratio 
of A360/A280; while carbonyl formation increases with increasing concentration of 
riboflavin when irradiated in visible light for fixed time period of 60 minutes. 
Formation of carbonyl groups in the presence of drug and/or riboflavin 
was assayed on the basis of covalent reaction of carbonyl groups with DNPH as 
performed above. The result is comprehensible in fig. 2(ii). Cisplatin (in light) at 
the concentration range of 50-150 nM, had significant effect on the carbonyl level 
^in BSA. Irrespective of the self induced reaction, cisplatin appreciably abridged 
riboflavin mediated carbonylation of proteins as viewed in fig. 2(iii). The 
implication of this finding is that cisplatin confers a protective consequence at the 
specified concentrations; in presence of riboflavin and on activation by visible 
light. The proclivity of riboflavin to photodecompose is well documented. 
Riboflavin can be exploited as a photodegradation sensitizer of several 
compounds in aqueous solution. Conversely, Larson et al. (1992) have reported 
that its use as a sensitizer is limited due to its rapid photodecomposition. 
According to the author, the ribose chain of riboflavin facilitates its 
photodegradation and also influences the yield and lifetime of its triplet excited 
state. Analogs of riboflavin with comparatively enhanced photochemical stability 
such as 3-methyl-riboflavin tetraacetate have been considered in recent times to 
overcome this impediment (Insinska-Rak et al., 2007). The result in fig. 2(iii) 
reveals tiie inhibitory potential of the specified concentrations of cisplatin. 
Cisplatin inactivates the photodynamic reaction of riboflavin plausibly by 
curbing its sensitization and hence degradation intent. 
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Figure l(i): Kinetics of protein fragmentation by riboflavin in the 
presence and absence of light. 
BSA (2 mg/ml) with indicated concentrations of riboflavin in a 
total reaction volume of 1.0 ml containing 10 mM potassium 
phosphate buffer (pH 7.5) was incubated in fluorescent light (o) 
or in the dark (•) for 60 minutes. Acid soluble amino groups 
were estimated as described in "Methods". Results are expressed 
as mean ± SEM of three independent experiments. 
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Figure l(ii): Kinetics of protein fragmentation by riboflavin in 
light as a function of time. 
BSA (2 mg/ml) with riboflavin (50 ^M) in a total reaction 
volimae of 1.0 ml containing 10 mM potassium phosphate buffer 
(pH 7.5) was incubated in fluorescent light for the indicated time 
intervals. Add soluble amino groups were estimated as described 
in "Methods". Results are expressed as mean ± SEM of three 
independent experiments. 
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Figure l(iii): Kinetics of protein fragmentation by cisplatin in the 
presence and absence of light. 
BSA (2 mg/ml) with indicated concentrations of cisplatin in a 
total reaction volume of 1.0 ml containing 10 mM potassium 
phosphate buffer (pH 7.5) was incubated in fluorescent light (D) 
or in the dark (•) for 60 minutes. Acid soluble amino groups 
were estimated as described in "Methods". Results are expressed 
as mean ± SEM of three independent experiments. 
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Figure l(iv): Effect of cisplatin on riboflavin mediated protein 
fragmentation. 
BSA (2 mg/ml) with indicated concentrations of cisplatin and 
riboflavin (50 nM) in a total reaction volume of 1.0 ml containing 
10 mM potassium phosphate buffer (pH 7.5) was incubated in 
fluorescent light for 60 minutes. Acid soluble amino groups were 
estimated as described in "Methods". Results are expressed as 
mean ± SEM of three independent experiments. 
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Figxire 2(i): Carbonyl formation by riboflavin in the presence and 
absence of light. 
BSA (2 mg/ml) with indicated concentrations of riboflavin in a 
total reaction volume of 1.0 ml containing 20 mM phosphate buffer 
(pH 7.4) was irradiated in fluorescent light (o) or incubated in the 
dark (•) for 60 minutes. Carbonyl formation was monitored as 
described in "Methods". Results are expressed as mean ± SEM of 
three independent experiments. 
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Figure 2(ii): Carbonyl formation by cisplatin in the presence and 
absence of light 
BSA (2 mg/ml) with indicated concentrations of cisplatin in a 
total reaction volume of 1.0 ml containing 20 mM phosphate buffer 
(pH 7.4) was irradiated in fluorescent light (D) or incubated in 
the dark (•) for 60 minutes. Carbonyl formation was monitored 
as described in "Methods". Results are expressed as mean ± SEM 
of three independent experiments. 
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Figure 2(iii): E££ect of cisplatin on riboflavin induced carbonyl 
formation. 
BSA (2 mg/ml) with indicated concentrations of cisplatin and 
riboflavin (50 ^ iM) in a total reaction volume of 1.0 ml containing 
20 mM phosphate buffer (pH 7.4) was irradiated in fluorescent 
light for 60 minutes. Carbonyl formation was monitored as 
described in "Methods". Results are expressed as mean ± SEM of 
three independent experiments. 
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(Ia)3. "Protein degradation // 
Photodynamic protein oxidation is known to produce high molecular 
weight crosslinked products. In view of their abundance in the cell, proteins 
comprise as major targets for photod)niamic damage (Bose & Dube, 2006). 
Formation of high molecular weight crosslinked products and/or fragmentation 
of protein following photoactivation by riboflavin were investigated by SDS-
PAGE. For all PAGE experiments 2 mg/ml BSA concentration was used. The 
degradation product of BSA was analyzed on 6% polyacrylamide with 4% stacking. 
The result in fig. 3(i) confirms the fragmentation of BSA. At the 68 KDa BSA 
monomer position, there is visible degradation on exposure to riboflavin (lanes c-
g). This is possibly due to non-specific fragmentation of protein. No high 
molecular weight crosslinked products were formed. Photosensitizer alone in the 
absence of light did not show BSA fragmentation (lane b) when compared to the 
control sample. The increasing concentrations of riboflavin resulted in lightening 
of the band intensity confirming that BSA is degraded by riboflavin in presence 
of light (Fig. 3(i)). It is therefore suggestive that riboflavin in its photodynamic 
action towards protein led to conformational changes, which enhanced the 
susceptibility to oxidation and degradation. Reactive oxygen species may lead to 
biophysical, biochemical and functional changes in the protein (Davies, 2003). 
Protein oxidation may generate new reactive species (protein bound reactive 
moieties and hydroperoxides) that can give rise to additional radicals vmder 
physiological conditions (Davies et al., 1995; Davies, 1996). Keeping in mind that 
some of the oxidation products of proteins can sustain chain reaction, 
photodynamic protein damage could be highly detrimenteJ to cell contributing 
to cell death (Bose & Dube, 2006). 
The effect of cisplatin on riboflavin mediated degradation was also 
demonstrated on polyacrylamide gel electrophoresis in fig. 3(ii). This was done 
to be assertive of the results enumerated above. The degradation exhibited by 
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riboflavin (lane b) is almost completely inhibited when cisplatin at the 
concentration of 150 jiM is included in the reaction (lane e). The inhibition at 
lower concentrations is also apparent (lanes c-d). In simimary, cisplatin imparts 
concentration dependent hindrance on photoexcitation of riboflavin. 
(Ia)4. "Complexformation" 
Fig. 4(i) shows the UV measurements of BSA in the presence and absence 
of riboflavin made in the range of 250-300 nm. The spectriun of BSA (10 \xM) was 
measured with riboflavin concentration in the range 10-50 ^M. Though complex 
formation between albumin and riboflavin was also evident from UV-VIS 
absorption spectral data, the effect was more pronounced by photoillumination 
providing furlher insight into the photodynamic action of riboflavin and its 
consequent binding to albumin as in fig. 4(ii). The UV absorption intensity of 
BSA decreased with the variation in riboflavin concentration. 
Fig. 4(iii) defines per se the effect of photoilluminated riboflavin and 
riboflavin in its native state on the spectral analysis of albumin. As a global result 
it can be concluded safely that riboflavin binds to albumin and causes photo-
degradation. It is noteworthy to mention the binding is stringent in the case of 
photoilltuninated riboflavin compared to when riboflavin is in its native form. 
Attempts were made to investigate cisplatin binding on albumin and its 
answer on riboflavin binding. Albumin is the major protein component of blood 
plasma (52% of proteic composition) but it is also distributed in the interstitial 
fluid of the body tissues. In normal individuals, albumin is present in the 
concentrations of 40 mg/ml (~0.6 mM; Mr=66 KDa) (Kratz, 1993). Albumin binds 
to a number of the relatively insoluble endogenous/exogenous compounds such 
as imesterified fatty acids, hormones, amino acids, metal cations, bilirubin and a 
wide variety of drugs; is involved with their transport, metabolism and 
distribution (Carter & Ho, 1994). It offers the important possibility of dissolution 
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in the biological medium for highly hydrophobic substances (Curry et al., 1999). 
Albumin plays a central role in the molecular pharmacology of drugs used in 
cancer chemotherapy (Trynda-Lemiesz & Luczkowski, 2004). The binding of 
drugs to albumin is particularly important because it affects both the activity of 
drugs and their disposition. The reaction of cisplatin with albumin attracts 
attention since the drug is usually administered intravenously and protein 
binding may decrease effective concentration of the free drug, which is 
responsible for the antitumor activity (Trynda-Lemiesz & Luczkowski, 2004). 
Indeed, a day after rapid intravenous infusion of cisplatin, 70-90% of platinum in 
blood plasma is protein bound (Bednarski, 1995). Mechanisms of cellular cisplatin 
resistance include inter alia drug inactivation by protein. This protein bound 
complex is believed to be imavailable for therapeutic purposes (Bernhardt et al., 1999). 
Fig. 4(iv) specifies binding of cisplatin to albumin. As far as the biological 
importance of albtmun-cisplatin is concerned, despite suggestions that this rather 
irreversible adduct would not constitute a drug reservoir for therapeutic 
purposes (Cole & Wolf, 1980), a number of reports show evidence of positive 
clinical effects of cisplatin-serum albimiin (Holding et al., 1992). Fig. 4(v) reaffirms 
the cisplatin binding effect on riboflavin-BSA complex. The observation indicated 
interference by cisplatin on the protein structure and ligand binding ability 
towards riboflavin. In the combinatorial evaluation above it can be seen that 
changes in the composition of ligands has dramatic effects on the binding and 
consequently the cytotoxicity of the parent compotmd. Strategically, if combination 
therapy/a combination of different therapies such as photodynamic and chemo-
therapy are used as paradigms; the binding of one drug to the protein can 
encroach on the association of the other one with the protein. This may instigate 
xmdesirable/desirable side effects. Simultaneously, it is tacit that cisplatin binds 
to albiunin strongly. There is a formation of weak cisplatin-BSA-riboflavin complex 
which is transient and gets distorted in a dose dependent manner with respect to 
cisplatin. Seemingly, with rise of the number of botmd cisplatin molecules there 
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Figure 3(i); Degradation of BSA induced by riboflavin, 
2 mg/ml BSA with indicated concentration of riboflavin was 
irradiated in fluorescent light/incubated in the dark for 60 minutes. 
Electrophoresis was performed as mentioned in "Methods". 
Lane a 
Laneb 
Lane c-g 
BSA alone 
BSA-riboflavin (50 MM; dark) 
BSA-riboflavin (10-50 i^M; light) 
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Figure 3(ii): Inhibition of riboflavin induced degradation by 
cisplatin. 
2 mg/ml BSA with riboflavin (50 nM) and indicated concentration 
of cisplatin was irradiated in fluorescent hght for 60 minutes. 
Electrophoresis was performed as mentioned in "Methods". 
Lane a 
Laneb 
Lanec-e 
BSA alone 
BSA-riboflavin (50 ^ M) 
BSA-riboflavin-cisplatin (50-150 ^ iM) 
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Figure 4(i): Absorption spectra of BSA with increasiiig 
coricentration of riboflavin. 
Spectra were recorded 1 min after mixing reagents in the 
spectrophotometer cuvette. All reactions were carried out in 10 mM 
phosphate buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : BSA alone (10 nM) 
Trace 2-6 : BSA: riboflavin (molar ratio 1:1,1:2,1:3,1:4,1:5) 
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Figure 4(ii): Absorption spectra of BSA with increasing 
concentration of riboflavin on photoillununation. 
Spectra were recorded after incubation of each reaction sample 
in fluorescent light for 60 minutes respectively. All reactions were 
carried out in 10 mM phosphate buffer pH 7.5. 
Traces from top to bottom tire 
Trace 1 : BSA alone (10 i^M) 
Trace 2-6 : BSA: riboflavin (molar ratio 1:1,1:2,1:3,1:4,1:5) 
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Figure 4(iii): Absorption spectra of BSA in presence of riboflavin 
before and after illumination. 
Spectrum of reaction mixture containing riboflavin (50 nM) and 
BSA was read before and after illumination in fluorescent light 
for 60 minutes. All reactions were carried out in 10 mM phosphate 
buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 
Trace 2 
Trace 3 
BSA alone (10 i^M) 
BSA: riboflavin (—) (molar ratio 1:5; dark) 
BSA: riboflavin (••) (molar ratio 1:5; light) 
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Figure 4(iv): Absorption spectra of BSA in presence of cisplatin. 
Spectrum of reaction mixture containing cisplatin (50 nM) and 
BSA was read before and after illumination in fluorescent light 
for 60 minutes. All reactions were carried out in 10 mM phosphate 
buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : BSA alone (10 nM) 
Trace 2 : BSA: cisplatin (—) (molar ratio 1:5; dark) 
Trace 3 : BSA: cisplatin (• • •) (molar ratio 1:5; light) 
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Figure 4(v): Absorption spectra of BSA with riboflavin in the 
presence of increasing concentration of cisplatin. 
The reaction mixture containing BSA, riboflavin (50 piM) and 
increasing concentration of cisplatin was incubated. The spectrum 
was read after illumination in fluorescent light for 60 minutes. 
All reactions were carried out in 10 mM phosphate buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : BSA alone (10 ^ M) 
Trace 2-5 : BSA: riboflavin: cisplatin (molar ratio 1:5:15, 
1:5:10,1:5:5,1:5:2.5) 
Trace 6 : BSA: riboflavin (• • •) (molar ratio 1:5) 
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is a diminution in affinity of albumin towards riboflavin. As seen in fig. 4(iii) 
enhanced binding by riboflavin is attributed to its sensitization. A perturbation 
in excitation of the sensitizer would possibly be the reason for the observed 
decrease in binding potential in presence of cisplatin. 
(Ia)5. ^^Fluorescence spectroscopy'^ 
When a ligand binds to protein it may quench its native fluorescence. The 
fluorescence quenching technique has been widely appUed in biochemical 
problems owing to its high sensitivity, reproducibility and convenience. Intrinsic 
fluorescence of albumin is generally excited at 280 or 290 nm. Most of the 
emissions are due to the excitation of tryptophan residues and a few emissions 
are due to tyrosine and phenylalanine residues (Lakowicz, 1983). Quenching of 
albumin's natural fluorescence is an important method to monitor the protein's 
structural changes and to study its interaction with various substances (Bi et al., 
2005). It can reveal the accessibility of quenchers to albumin's fluorophore groups; 
help understanding albvmiin's binding mechanisms to drugs and provide clues to 
the nature of the binding phenomenon (Zhao et al., 2006). BSA has two tryptophan 
residues (Trp 134 and Trp 212) located in subdomain I A and II A, respectively 
(Kragh-Hansen, 1981). The emission spectrum at Xexc=280 run was similar to that 
of Xexc-290 nm whereas the intensities were just about half compared to that of 
Aexc~280 rmi. The excitation wavelength of 280 was chosen and the emission 
wavelength was read at 300-400 nm. The concentration of protein was stabilized at 
1 \iM and the concentrations of riboflavin varied from 10 nM to 50 nM. Fig. 5(i) 
shows the changes in the fluorescence emission spectrvmi of BSA in the presence 
of increasing molar ratios of riboflavin and fig. 5(ii) depicts flie marked difference 
in binding in the presence of light, with the same concentration of riboflavin. 
Fluorescence quenching may result from a variety of processes such as excited 
state reactions, energy transfer, ground state complex formation and collisional 
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processes. Collisional or dynamic quenching refers to a process that the 
fluorophore and the quencher come into contact during the lifetime of the excited 
state whereas static quenching refers to fluorophore quencher complex formation 
(Zhao et al., 2006). Of both tryptophans in BSA, Trp 134 is more exposed to a 
• hydrophilic environment whereas Trp 212 is deeply buried in the hydrophobic 
loop. It means the principal region of ligand binding to albumin is located in 
hydrophobic cavities in subdomains HA and niA (Ghuman et al., 2005). It is 
apparent from fig. 5(ii) fluorescence quenching is augmented with increasing 
riboflavin concentration, without change in tiie emission maxima and shape of 
the peaks. The results are consistent with the finding that riboflavin binds to 
albumin, which is enhanced in the influence of Ught and hitherto illustrating 
exacerbated degradation. 
Trp 212 fluorescence is the most frequently examined among the aromatic 
fluorophores in albumin molecules to obtain information about conformational 
changes of the protein. Fig. 5(iii) shows typical changes in fluorescence intensity 
of the reaction mixture in which cisplatin and protein were incubated. No change 
in the fluorescence intensity was observed for the control albimiin solution over 
this period. Effective quenching is observed in the case of cisplatin. The strong 
quenching of Trp 212 fluorescence clearly identifies that the confirmation of the 
hydrophobic binding pocket in subdomain IIA is significantly affected by 
cisplatin binding. The result validates the fluorescence quenching in terms of 
increasing concentrations of cisplatin. The relative fluorescence intensity decreases 
with increasing concentrations. Ligand binding to one domain (I & II) stimulates 
distinct conformational changes in the other domain as both domains share a 
common interface. Thus, the binding of a particular drug molecule to serum 
albumin may change considerably the binding abilities of albumin towards other 
molecules (Trynda-Lemiesz et al., 1999). The results shown in fig. 5(ii) and fig. 5(iv) 
clearly indicate that cisplatin botmd to albiunin distinctly modifies the strong 
binding affiiuty for riboflavin. The experimental results demonstrate that 
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riboflavin binding results in quenching of fluorescence in BSA. The increase in 
fluorescence intensity observed for riboflavin modified albumin at increased 
cisplatin to protein molar ratios obtained in pH huffier 7.5, insinuates changes in 
the microenviron aroimd Trp in IIA domain. The wide variation in environ of 
protein fluorophores in the presence of drug induces change in relative 
fluorescence due to an energy transfer from Trp to the chromophore in drug 
(Sulkowska et al., 2003). By evaluation it can be safely understood that cisplatin 
binding affects binding potential of riboflavin. This grants affirmative substantiation 
for further understanding the inhibition by cisplatin on photodynamic process 
and riboflavin ser«itized damage on proteins. 
(Ia)6. "Structural modifications as deduced by Circular 
Dichroism spectroscopy' ,rr 
The molecular interactions are often maintained by spectroscopic 
techniques because these methods are sensitive and relatively easy to use. CD is 
a sensitive technique frequently employed to monitor the conformational 
modification in proteins. Fig. 6(i) affirmatively demonstrates that riboflavin 
induces conformational changes upon binding to albumin. From the quantitative 
analysis data of CD spectra, the a-helix of 40% in free BSA decreased to 30% in 
albumin-riboflavin complex. The loss of a-helicity upon interaction was 
indicative of secondary structure alteration induced by riboflavin due to its 
photosensitizing feature. Riboflavin at a concentration of 50 nM was used for CD 
measurements. The CD spectrum of protein in the presence of riboflavin in 
photoilluminated condition is shown in fig. 6(i). No changes were observed with 
vitamin in its native state. BSA showed two negative bands in the UV region at 
208 and 222 nm, characteristic of a a-helical structure of protein (Hu et al., 2005). 
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Figure 5(i): Effect of increasing concentration of riboflavin on 
the fluorescence emission spectrum of BSA. 
The reaction mixture containing riboflavin and BSA in 10 mM 
phosphate buffer (pH 7.5) was incubated. BSA was excited at 280 
nm and the emission spectra were recorded between 300 and 400 
nm. The emission slit was 10 nm. 
Traces from top to bottom are 
Trace 1 : BSA alone (1 ^M) 
Trace 2-6 : BSA: riboflavin (molar ratio 1:25,1:50,1:75,1:100 
and 1:125) 
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Figure 5(ii): Effect of riboflavin on the fluorescence emission 
spectrum of BSA before and after illumination. 
The reaction mixture containing riboflavin (50 nM) and BSA in 
10 mM phosphate buffer (pH 7.5) was read before and after 
illimiination in fluorescent light for 60 minutes. 
BSA was excited at 280 run and the emission spectra were recorded 
between 300 and 400 nm. The emission slit was 10 nm. 
Traces from top to bottom are 
Trace 1 
Trace 2 
Trace 3 
BSA alone (1 ^M) 
BSA: riboflavin (—) (molar ratio 1:50; dark) 
BSA: riboflavin (•••) (molar ratio 1:50; light) 
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Figure 5(iii): Effect of increasing concentration of cisplatin on 
the fluorescence emission spectrum of BSA. 
The reaction mixture containing cisplatin and BSA in 10 mM 
phosphate buffer (pH 7.5) was incubated. BSA was excited at 280 
nm and the emission spectra were recorded between 300 and 400 
nm. The emission slit was 10 nm. 
Traces from top to bottom are 
Trace 1 : BSA alone (1 jiM) 
Trace 2-10 : BSA: cisplatin (molar ratio 1:10,1:25,1:50, 
1:75,1:100,1:125,1:150,1:175 andl:200) 
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Figure 5(iv): Effect of increasing concentration of cisplatin on 
the fluorescence emission spectrum of riboflavin (50 |nM) treated 
BSA after illumination in fluorescent light for 60 minutes. 
BSA was excited at 280 nm and the emission spectra were recorded 
between 300 and 400 nm. The emission slit was 10 nm. 
Traces from top to bottom are 
Trace 1 : BSA alone (1 ^M) 
Trace 2-8 : BSA: riboflavin: cisplatin (molar ratio 1:50:200, 
1:50:150,1:50:125,1:50:100,1:50:75,1:50:50 and 1:50:25) 
Trace 9 : BSA: riboflavin (•••) (molar ratio 1:50) 
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Figure 6(i): CD spectra of BSA-riboflavin-light system. 
The reaction mixture containing BSA and riboflavin (50 \iM) was 
irradiated in fluorescent light for 60 minutes. The spectrum was 
obtained in 0.1 M phosphate buffer of pH 7.4 at room temperature. 
Traces from top to bottom are 
Trace 1 : BSA: riboflavin (molar ratio 1:25) 
Trace 2 : BSA alone (2 ^ M) 
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Figure 6(ii): The a-helical content of BSA under different 
conditions. 
The reaction mixture containing BSA was incubated in 
fluorescent light for 60 minutes under different conditions. The 
spectrum was obtained in 0.1 M phosphate buffer of pH 7.4 at 
room temperature. Results are expressed as mean ± SEM of three 
independent experiments. 
Barl 
Bar 2 
Bar 3 
Bar 4 
Bar 5 
Bar 6 
Bar 7 
BSA alone (2 i^M) 
BSA: riboflavin (molar ratio 1:25) 
BSA: cisplatin (molar ratio 1:75) 
BSA: riboflavin: cisplatin (molar ratio 1:25:12.5) 
BSA: riboflavin: cisplatin (molar ratio 1:25:25) 
BSA: riboflavin: cisplatin (molar ratio 1:25:50) 
BSA: riboflavin: cisplatin (molar ratio 1:25:75) 
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Figure 6(iii): CD spectra of BSA-riboflavin-cisplatin-light system. 
The reaction mixture containing BSA, riboflavin (50 nM) and 
increasing concentration of cisplatin (25-150 \iM) was irradiated in 
fluorescent light for 60 minutes. The spectnmi was obtained in 
0.1 M phosphate buffer of pH 7.4 at room temperature. 
Traces from top to bottom are 
Trace 1 : BSA: riboflavin (molar ratio 1:25) 
Trace 2 : BSA: riboflavin: cisplatin (molar ratio 1:25:12.5) 
Trace 3 : BSA; riboflavin: cisplatin (molar ratio 1:25:25) 
Trace 4 : BSA: riboflavin: cisplatin (molar ratio 1:25:50) 
Trace 5 : BSA: riboflavin: cisplatin (molar ratio 1:25:75) 
Trace 6 : BSA alone (2 nM) 
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The CD results were expressed m terms of mean residue ellipticity (MRE) in deg 
cm2 dmoH. 
According to Hushcha et al. (2000), the interaction of albumin with low 
molecular weight drugs induces conformational changes in tiie protein. These 
changes appear to have a bearing on the secondary and tertiary structure of 
albumin. In other words, ligand binding changes the geometry structure of 
albumin due to hydrophobic contacts of tiie chromophore within the protein 
interior where the quencher can penetrate. Fig. 6(ii) clearly indicates a decrease 
of a-helical content by about 10% implying considerable change induced in the 
protein secondary structure by cisplatin. Previous studies have demonstrated 
that interaction of cisplatin with albumin cause distinct variation in protein 
conformation, including a decrease of a-helical structure and a change of 
albumin binding capabilities towards other molecules (Ohta et al., 1995). The 
distortion caused by riboflavin in the CD spectrum is inhibited to an appreciable 
degree by increasing concentrations of cisplatin. Fig. 6(iii) demonstrates the 
procxiring effect of cisplatin on conformational alteration by riboflavin in a 
concentration dependent manner. It is visualized by restoration of the a-helical 
content from 30% to 36%. The evasion of photodecomposition of riboflavin and 
for that reason degradation of the protein could be wielded for this inhibition; in 
support of the results obtained. 
(Ia)7. "Enzyme activity" 
To further substantiate the results obtained from servmi albumin-
riboflavin combination and the procuring action of cisplatin, similar experiments 
were performed with trypsin as the target molecule. The activity of trypsin was 
monitored after incubating the enzyme with increasing riboflavin concentrations. 
A progressive decrease was observed with rise in concentration of the sensitizer 
as notable in fig. 7(i). The effect of cisplatin alone and in combination with 
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riboflavin was determined in a parallel experiment. Apart from the cisplatin 
induced inactivation which was slightly increased in the presence of light in fig. 7(ii), 
riboflavin mediated reaction was inhibited to a significant extent in fig. 7(iii) by 
the presence of drug in the reaction medium. The corresponding gel electrophoresis 
results notifying damage by activated riboflavin and concentration dependent 
consequence of cisplatin on the aforesaid reaction is apparent in fig. 7(iv) and fig. 7(v). 
The data reclaims the participation of cisplatin on aversion of photodecomposition 
of riboflavin and is in consistence wifli previous results. 
In contrast with the cisplatin induced inactivation of protein, the drug 
convenientiy hinders the riboflavin mediated photodamaging reaction. In view 
of the above results, it can be propoimded that cisplatin causes a photoinitiated 
change which makes the compound of riboflavin sensitization and for this reason 
free radical production difficult. Decreased sensitization implies decrease in 
binding. The partial blocking of binding has foremost influence on the aversion 
of photodecomposition flius leading to decreased degradation motivated by 
riboflavin. On the other hand, correlated administration of cisplatin and 
riboflavin may decrease the drug toxicity, especially that induced by tmbovmd 
drug in the blood plasma. Since cisplatin is a DNA target drug, evaluation of 
'cisplatin-riboflavin-radiation' with DNA would be fundamental and is 
described in the following chapter. 
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Figxire 7(i): Trypsin inactivation by riboflavin in presence and 
absence of light. 
Reaction mixture in a total volume of 1 ml containing 15 ng trypsin 
and indicated concentrations of riboflavin were incubated for 60 
minutes in fluorescent light (o) or in the dark (•). Enzyme activity 
was measured as described in "Metiiods". Results are expressed 
as mean ± SEM of three independent experiments. 
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Figure 7(ii): Trypsin inactivation by cisplatin in presence and 
absence of light. 
Reaction mixture in a total volume of 1 ml containing 15 ^ g trypsin 
and indicated concentrations of cisplatin were incubated for 60 
minutes in fluorescent light (n) or in the dark (•). Enzyme activity 
was measxured as described in "Methods". Results are expressed 
as mean ± SEM of three independent experiments. 
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Figure 7(iii): Effect of cisplatin on enzyme inactivation by riboflavin 
on photoillumination. 
Reaction mixture in a total volume of 1 ml containing 15 ^g trypsin 
with indicated concentrations of cisplatin and riboflavin (50 jiM) were 
incubated for 60 minutes in fluorescent light. Enzyme activity was 
measured as described in "Methods". Resvdts are expressed eis mean 
± SEM of three independent experiments. 
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Figure 7(iv): Trypsin degradation induced by riboflavin. 
50 ng trypsin per reaction sample with indicated concentration of 
riboflavin was irradiated in fluorescent light for 60 minutes. 
Electrophoresis was performed as mentioned in "Methods". 
Lane a : Trypsin alone 
Lane b-e : Trypsin-riboflavin (20-50 (xM) 
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Figure 7(v): Cisplatin induced inhibition on riboflavin mediated 
degradation. 
50 ng trypsin per reaction sample with riboflavin (50 ^M) and 
indicated concentration of cisplatin was irradiated in fluorescent 
light for 60 minutes. Electrophoresis was performed as mentioned 
in "Methods". 
Lane a : Trypsin alone 
Lane b : Trypsin-riboflavin (50 ^M) 
Lane c -f : Trypsin-riboflavin-cisplatin (25-150 nM) 
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''Unit Khy 
'DNA binding 
and 
degradation' 
The irradiation of riboflavin with visible light, under aerobic conditions triggers 
a cascade of photoprocesses and the origination of ROS and radical RF species 
(Kumari et al., 1996; Frati et al., 1997), It is known that RF^ in solution generates 
both 02 and 02" upon visible light irradiation with reported quantum yields of 
0.48 and 0.009, respectively (Krishna et al., 1991). The damaging effect of these 
ROS on multifarious biological macromolecules is well documented (Naseem et al., 
1993; Jazzar & Naseem, 1994). Oxidative modification of cellular constituents 
including lipids, proteins and nucleic acids has been implicated in the etiology of 
different pathological conditions and in ageing (Halliwell, 1987). Breakage of calf 
thymus DNA, supercoiled plasmid DNA, degradation of BSA, inactivation of 
enzymes, increase in protein crosslinking and destruction of amino acids are a 
few conspicuous consequences of ROS mediated damage. They induce strand 
breaks and set off oxidative modification of DNA bases (Cerutti, 1985). During 
oxidative stress, MDA or other aldehydes are formed in biological systems which 
react with amino acids and DNA resulting in alterations in replication, 
transcription and leading to tumor formation. Damaged DNA results in 
impaired ability of cells to repair or prevent disease (Hoeijmakers, 2001). 
Riboflavin is an important constituent of our daily diet. It is found in free 
and conjugated forms in almost all biological tissues and fluids. Since photo-
djmamic therapy is being increasingly used with great success for the treatment of a 
range of tumor and cancers and attempts are being made to extend its use in the 
treatment of other clinical conditions (Levy & Obochi, 1996; Bonnett & Martinez, 
2001; Huang, 2005); the genotoxic potency of omnipresent substances cannot be 
overpassed. Therefore, the risk of free radical mediated damage to tissue increases 
during phototherapy of different clinical disorders. Overview of related 
toxicologies has been the mainstay in the elaboration/assessment of a particular 
treatment therapy. In detail, it forms ground work to the purview of toxicological 
sciences. Albeit, intensive investigations have been performed on the photodynamic 
modifications proliferated by riboflavin in vitro; it is necessary to evaluate its role 
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in cell damage at molecular level. On account of this, expounding the quantum 
of destruction instigated 'in situ' at cellular DNA level would be decisive. 
(Ib)8. "Spectral properties with respect to calf thymus DNA // 
Nucleic acid botind molecules (often termed "ligand") generally exhibit 
marked changes in absorbance and fluorescence properties as compared to their 
spectral characteristics when free in solution. Ethidium ion (Eth) displays a 
bathochromic shift and hypochromicity of its visible absorption band as well as a 
dramatic enhancement of its fluorescence efficiency when intercalated into DNA 
(Waring, 1965). An experimental strategy for determining binding stability for 
'unknown' ligand molecules based on quenching of ethidium fluorescence via a 
competition for binding sites in DNA has become a standard method in nucleic 
acid chemistry (Liu et al., 1998). Fig. 8(i) puts on view changes in fluorescence 
intensity of calf thymus DNA (EB bound) with increasing concentrations of 
riboflavin. On the basis of quenching observed, it can be grasped that the 
replacement of the DNA bound ethidium by riboflavin results in a decrease of 
the DNA-EB luminescence intensity. The fluorescence intensity with/without 
illimiination at the same concentration of the sensitizer was remarkably distinct 
as seen in fig. 8(ii). Fig. 8(iii) shows the effect of addition of increasing base pair 
molar ratios of calf thymus DNA on tiie fluorescence emission of riboflavin. Such 
an addition resulted in a dose dependent quenching of fluorescence. There was 
however no shift in the Amax emission suggesting a simple mode of binding of 
DNA to riboflavin. The control, native DNA alone, when excited at the same 
wavelength did not interfere with the emission spectrum of riboflavin 
alone/riboflavin-DNA thus confirming the binding results. These results 
demonstrate the ability of riboflavin to bind to DNA. In a previous report it has 
been suggested, that binding of riboflavin to DNA may occur in the absence of 
light (Alvi et aL, 1984) but as observed above the process is enhanced in its presence. 
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No luminescence was observed for cisplatin solution either with/without 
the presence of calf thymus DNA. So the binding of cisplatin and DNA can not 
be directly presented in the emission spectra; and the binding of EB is employed 
as above. The emission spectra of EB boimd to DNA in the absence/presence of 
cisplatin is given in fig. 8(iv). The addition of cisplktin complex to DNA 
pretreated with EB causes appreciable reduction in the emission intensity. This is 
indicative of stronger and stringent binding with increase in concentration, with 
no significant change on illumination. Fluorescence quenching experiments were 
conducted by adding the drug at different concentrations (25-150 \xM) to the 
samples containing 4 \iM EB and 25 \iM DNA, All samples were excited at 340 
lun and emission intensity was recorded between 500-600 run. 
Flavins are knov^ m to form complexes with several aromatic and hetero-
aromatic compounds (Datta et aL, 2005). Since riboflavin binds to DNA and cisplatin 
as investigated, it was of interest to determine whether a complex involving 
riboflavin, cisplatin and DNA is formed. It is worth mentioning that earlier 
studies in this laboratory have demonstrated the formation of a complex of 
riboflavin-Cu(II)-protein (Jazzar & Naseem, 1994). As seen in fig. 8(v), the formation 
of a complex is favorable. It is apparent that addition of cisplatin to riboflavin 
treated DNA resulted in formation of a complex riboflavin-cisplatin-DNA; but 
the significant increment in the fluorescence intensity upon addition of cisplatin, 
indicated that the DNA (EB boimd)-riboflavin complex loses its characteristic. As 
observed this complex displays an increase in fluorescence intensity in a 
concentration dependent fashion. The dramatic increase in fluorescence intensity 
indicates that the increased concentration of cisplatin weakens the excitation 
phenomenon of riboflavin and consequently weakened binding to DNA. In contrast, 
the fluorescence intercity of riboflavin-DNA (Fig. 8(ii)) was markedly different. 
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(Ib)9. '^Absorption Spectroscopy" 
Fig. 9(i) shows the time trace at A260 from a series of reactions between 
DNA and different concentrations of riboflavin. All reactions with riboflavin 
have been conducted witii illumination imless otherwise mentioned. Akin to 
above trials, the binding was foimd to be intense in the case of excited riboflavin 
than that of native. It is evident from fig. 9(i) that a hypochromic effect occurs in 
the initial period of the reaction. The larger the concentration of riboflavin, 
stronger is the hypochromic effect. In the whole period of reacting process 
hyperchromism does not appear. 'Hypochromic' and 'hyperchromic' effect are 
the spectral features of DNA concerning its doable helix structure (Yang et al., 
1993). Hypochromism of DNA arises by binding to the DNA backbone and thus 
many contractions in the helix axis of DNA (Li et al., 1996). Therefore, the above 
results are suggestive of riboflavin binding to DNA and causing a contraction 
and conformational change in DNA. It must be cited with alacrity that binding of 
riboflavin to DNA in light, is a condition favorable to the formation of free radicals. 
As a means of further exploring the association of riboflavin and cisplatin 
with respect to DNA, the kinetics of interaction between DNA and riboflavin 
was monitored in presence of cisplatin. Photodegradation of riboflavin alone and 
hence binding to DNA occxirred very rapidly as notable in fig. 9(i). In the 
presence of cisplatin the reaction proceeded but at a reduced rate. With cisplatin 
in the reaction medium as identified in fig. 9(ii), riboflavin is markedly sheltered 
from photodecomposition thereby remains in its native form, binds minimally to 
DNA and the degradative outcome is hindered. 
The absorption spectra of the interaction of riboflavin/cisplatin with calf 
tiiymus DNA have been recorded for a constant DNA and riboflavin/cisplatin 
concentrations in different conditions. The representative UV spectrum of 
riboflavin-DNA/cisplatin-DNA is shovm in fig. 9(iii). The changes observed in 
the absorption spectra of calf thymus DNA after association with riboflavin 
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Figure 8(i): Emission spectra of EB bound to DNA in the presence 
of riboflavin. 
Calf thymus DNA (in Tris-HQ, pH 7.4) was excited at the Aexc of 340 nm 
and the emission spectra was recorded between 500 and 600 nm. 
Traces from top to bottom are 
Trace 1 : DNA alone (25 ^ iM) 
Trace 2-6 : DNA: riboflavin (molar ratio 1:0.4,1:0.8,1:1.2,1:1.6 
and 1:2) 
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Figure 8(ii): Emission spectra of EB bound to DNA with riboflavin 
before and after illumination. 
The reaction mixture containing riboflavin (50 \iM) and calf 
thymus DNA was incubated and the spectrum was read before 
and after illumination in fluorescent light for 60 minutes. Calf 
thymus DNA (in Tris-HCl, pH 7.4) was excited at the Aexc of 340 nm 
and the emission spectra was recorded between 500 and 600 nm. 
Traces from top to bottom are 
Trace 1 
Trace 2 
Trace 3 
DNA alone (25 jiM) 
DNA: riboflavin (—) (molar ratio 1:2; dark) 
DNA: riboflavin (•••) (molar ratio 1:2; light) 
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Figure 8(iii): Effect of calf thymus DNA on the fluorescence 
intensity of riboflavin. 
Emission spectrum of riboflavin was read in the absence and 
presence of calf thymus DNA. Riboflavin was excited at the Xexc of 
330 nm and the emission spectra was recorded between 480 and 
540 nm. 
Traces from top to bottom are 
Trace 1 ; riboflavin alone (50 \iM) 
Trace 2-6 : riboflavin: DNA (molar ratio 1:0.2,1:0.3,1:0.4,1:0.5 
and 1:1) 
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Figure 8(v): Em j^ssion spectra of riboflavin treated DNA in the 
presence of cisplatin. 
The reaction mixture containing calf thymus DNA, riboflavin (50 (xM) 
and increasing concentration of cisplatin was incubated. The spectnmi 
was read after illumination in fluorescent light for 60 minutes. Calf 
thymus DNA (in Tris-HQ, pH 7.4) was excited at the Xexc of 340 nm 
and flie emission spectra was recorded between 500 and 600 nm. 
Traces from top to bottom are 
Trace 1 : DNA alone (25 i^M) 
Trace 2-6 : DNA: riboflavin: cisplatin (molar ratio 1:2:6,1:2:4, 
1:2:3,1:2:2 and 1:2:1) 
Trace 7 : DNA: riboflavin (• • •) (molar ratio 1:2) 
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Figure 9(i): Time trace of the interaction of riboflavin with DNA. 
Calf thymus DNA (25 \iM in Tris-HCl, pH 7.4) was treated with 
riboflavin imder different conditions and was read at A260. 
Results are expressed as mean ± SEM of three independent 
experiments. 
Traces from top to bottom are 
Trace 1 : CDNA/CR=1:2 (•) (dark) 
Trace 2 : CDNA/CR=1:1.2 (O) (light) 
Trace 3 : CDNA/CR=1:1.6 (O) (light) 
Trace 4 : CDNA/CR=1:2 (O) (light) 
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Figure 9(ii): Time trace of riboflavin treated DNA with cisplatin. 
Calf thymus DNA (25 ^M in Tris-HCl, pH 7.4) was treated with 
riboflavin ad cisplatin with illumination of different time intervals and 
was read at A260. Results are expressed as mean ± SEM of three independent 
experiments. 
Traces from top to bottom are 
Trace 1 : CDNA/CR=1:2 (•) (dark) 
Trace 2 : CDNA/CR/CC=1:2:8 (O) 
Trace 3 : CDNA/CR/CC=1:2:6 (O) 
Trace 4 : CDNA/CR/CC=1:2:4 (O) 
Trace 5 : CDNA/CR/CC=1:2:2 (O) 
Trace 6 : CDNA/CR=1:2 (O) 
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Figure 9(iii): Absorption spectra of calf thymus DNA with 
riboflaviiVcispIatin. 
Calf thymus DNA (in Tris-HCl, pH 7.4) was treated with 
riboflavin/cisplatin imder different conditions. 
Traces from top to bottom are 
Trace 1 : DNA alone (25 nM) 
Trace 2 : CDNA/CR=1:2 (—) (dark) 
Trace 3 : CDNA/CC=1:2 (•) (dark) 
Trace.4 : CDNA/CC=1:2 (D) (hght) 
Trace 5 : CDNA/CR=1:2 (• • •) (Hght) 
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Figure 9(iv): Absorption spectra of riboflavin treated calf thymus 
DNA with cisplatin. 
Calf thymus DNA (in Tris-HCl, pH 7.4) was incubated with 
riboflavin and increasing concentrations of cisplatin and irradiated 
for 60 minutes in fluorescent light. 
Traces from top to bottom are 
Trace 1 
Trace 2 
Trace 3 
Trace 4 
Trace 5 
Trace 6 
DNA alone (25 ^M) 
CDNA/CR/CC=1:2:8 
CDNA/CR/CC=1:2:6 
CDNA/CR/CC=1:2:4 
CDNA/CR/CC=1:2:2 
CDNA/CR=1:2(---) 
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denotes the formation of a complex with DNA, with enhanced binding of 
photoexcited riboflavin. The nature of interactions of a metal complex with DNA 
is determined by the characteristic of that complex (Mongelli et al., 2006). 
Cisplatin binding is observed in fig. 9(iii) with a minor difference when 
incubated with light. Photochemistry of various platinum complexes has 
revealed exaggerated cytotoxicity when these complexes were irradiated with 
light (Mackay et al., 2006) and for this reason it is plausible for cisplatin to 
perform in an atypical manner when in light. The efficiency of cisplatin as an 
inhibitor of photodecomposition of riboflavin was tested with the same reaction 
conditions above. In brief, fig. 9(iv) is in accordance with results attained above 
and provides reclamation to the cisplatin inhibitory answer. It is feasible that 
cisplatin interacting with riboflavin itself could hamper the process of 
photosensitization. 
(Ib)lO. "Agarose gel electrophoresis" 
Riboflavin is known to undergo photoreactions with nucleic adds (Martin et aL, 
2002; Martin et al., 2002). To validate the above mentioned observations, riboflavin 
has been studied for its light activated interaction with plasmid DNA. DNA 
scission occurs either through direct/indirect cleavage. Direct cleavage occurs 
typically through guanine oxidation or hydrogen abstraction from the sugar 
backbone (Mongelli et al., 2006)/photogeneration of reactive oxygen species that 
eventually cause strand scission (Fleisher et al., 1986). Photocleavage of DNA by 
riboflavin was probed employing agarose gel electophoresis with pUC 18 
circular plasmid DNA as the target The samples were photoactivated for the 
same length of time as used previously, with control stored in the dark. Circular 
plasmid DNA is ideally suited to exanune cleavage agents as the DNA exists in a 
supercoiled state in its native form and converts to a relaxed form upon single 
strand cleavage that exhibits an altered migration rate during agarose gel 
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electrophoresis. The electrophoretic pattern of DNA is shown in fig. 10(i). Lane a 
is the DNA control showing pUC 18 DNA contains primarily supercoiled (form 
I) DNA. Lane b is riboflavin with DNA dark control illustrating riboflavin does 
not modify DNA in the dark. Lanes c-g show that photocleavage occurs when 
riboflavin and DNA were photoilluminated signifying riboflavin as an active 
photosensitizer and DNA photocleavage agent. The degree and efficiency of this 
cleavage increases in a dose dependent fashion as perceived from lanes c-g. 
Further and large, photogenerated ROS has the ability to cause strand scission of 
dsDNA. And hence DNA is cleaved by riboflavin in aqueous solution upon 
excitation with low energy visible light. 
Fig. lO(ii) shows concentration dependent effects of cisplatin in the 
cleavage reaction catalyzed by riboflavin in its activated state. The results reveal 
that cisplatin hinders the cleavage reaction dramatically. Increasing the 
concentrations resulted in inhibition of breakage reaction (lanes c-f). The 
protection was nearly complete at the highest concentration tested (lane f). 
Oxidative stress caused by ROS induces apoptosis (Yuhong et al., 2002) 
characteristically identified by cell shrinkage and DNA fragmentation (Higuchi, 
2004). The mechanism of cisplatin induced toxicity has been postulated as follows; 
cisplatin accumulation in normal cells is concomitantly involved with ROS 
generation thereby making cells susceptible to oxidant stress, resulting in 
cytotoxicity and cell death. Cisplatin is identified to induce apoptosis (Okuda et 
al., 2000). The result in fig. lO(iii) reveals that cisplatin is capable of accelerating 
DNA cleavage. Accordingly, ROS from cisplatin may have evoked DNA 
cleavage under our conditions. 
(Ib)ll. "Ethidium bromide quenching assay" 
Calf tiiymus DNA damage was validated by using the EB binding assay 
(Stoewe & Prutz, 1987). The loss of fluorescence was used as a measure of DNA 
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Figure 10(i): Agarose gel electrophoretic pattern of EB stained 
pUC 18 DNA after treatment with riboflavin in the absence and 
presence of light. 
Each reaction mixture containing 0.50 \ig pUC 18 DNA, 10 mM 
Tris-HCI (pH 7.5) and indicated concentration of riboflavin was 
irradiated in fluorescent light/incubated in the dark for 60 
minutes. Electrophoresis was performed as mentioned in 
"Methods". SC, supercoiled DNA; OC, open circular. 
Lane a 
Laneb 
Lane c-g 
DNA alone 
DNA-riboflavin (50 nM; dark) 
DNA-riboflavin (10-50 jiM; light) 
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Figure lO(ii): Agarose gel electrophoretic pattern of EB stained 
pUC 18 DNA after treatment with riboflavin and cisplatin in 
the presence of light. 
Each reaction mixture containing 0.50 ng pUC 18 DNA, 10 mM 
Tris-HCl (pH 7.5), riboflavin (50 p-M) and indicated concentration 
of cisplatin was irradiated in fluorescent Ught for 60 minutes. 
Electrophoresis was performed as mentioned in "Methods". SC, 
supercoiled DNA; OC, open circular. 
Lane a 
Laneb 
Lane c-f 
DNA alone 
DNA-riboflavin (50 ^ M) 
DNA-riboflavin-cisplatin (50-150 nM) 
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Figure lO(iii): Agarose gel electrophoretic pattern of EB stained 
pUC 18 DNA after treatment with cisplatin in the absence and 
presence of light. 
Each reaction mixture containing 0.50 ng pUC 18 DNA, 10 mM 
Tris-HCl (pH 7.5) and indicated concentration of cisplatin was 
irradiated in fluorescent Hght/incubated in the dark for 60 
minutes. Electrophoresis was performed as mentioned in 
"Methods". SC, supercoiled DNA; OC, open circular. 
Lane a 
Laneb 
Lane c-f 
DNA alone 
DNA-cisplatin (50 |xM; dark) 
DNA-cisplatin (50-150 nM; light) 
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Figure 11: Extent of calf thymus DNA damage induced by riboflavin, 
cisplatin and riboflavin in the presence of cisplatin. 
Calf thymus DNA (25 jiM in Tris-HCl, pH 7.4) was incubated in fluorescent 
light for 60 minutes under different conditions. Results are expressed as mean 
± SEM of three independent experiments. 
Barl 
Bar 2 
Bar 3 
Bar 4 
Bar 5 
Bar 6 
Bar 7 
DNA: cisplatin (molar ratio 1:6) 
DNA: riboflavin (molar ratio 1:2) 
DNA: riboflavin: cisplatin (molar ratio 1:2:1) 
DNA: riboflavin: cisplatin (molar ratio 1:2:2) 
DNA: riboflavin: cisplatin (molar ratio 1:2:4) 
DNA: riboflavin: cisplatin (molar ratio 1:2:6) 
DNA: riboflavin: cisplatin (molar ratio 1:2:8) 
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damage. This assay has been one of the fundamental techniques employed by 
researchers to evaluate DNA damage, in recent times (Zheng et al., 2006). A 
solution containing all reagents and DNA except riboflavin was used as the 
control of 100% fluorescence and zero fluorescence was assessed in a solution 
identical to the control except DNA. The assay is based on the formation of a 
complex between DNA and EB that enhances iiie fluorescence of EB. DNA 
damage interferes witii the binding of EB to DNA, in consequence decreasing the 
native fluorescence. Several forms of DNA damage, including strand breakage 
and base oxidation are believed to contribute to the loss of fluorescence (Milne et al., 
1993; Buettner, 1986); hence this assay detects a broad range of DNA damages. 
As monitored in fig. 11, CT DNA was damaged remarkably in the presence of 
excited riboflavin. Nonetheless, the presence of cisplatin demotes the damage as 
visualized by decrease in the amoimt of damaged DNA in a concentration 
dependent manner. The shielding of riboflavin incited degradation obtained 
from this experimentation is consistent with that acquired from the strand 
breakage of pUC DNA by gel electrophoresis system. Fig. 11 is a depiction of 
fluorescence in terms of DNA damage. Intriguingly, the amount of DNA 
damaged by riboflavin and cisplatin (tested at its therapeutic dose) cumulatively 
is relatively lesser than cisplatin at this concentration alone. 
(Ib)12, ''DNA breakage" 
Riboflavin is shown to generate single strand nuclease sensitive sites in 
CT-DNA indicating the formation of strand breaks (Naseem et al., 1993). The 
reaction was assessed by recording the proportion of DNA converted to acid 
soluble nucleotides by the nuclease. An-incubation temperature of 48 °C was 
used in order to expose the relatively less stable regions of DNA to the enzyme. 
Riboflavin causes extensive DNA fragmentation upon photoexcitation. Fig. 12(i) 
briefly depicts the dose response curve of this reaction. Control experiment 
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established that heat denatured DNA and dsDNA tmderwent 100% and 5% 
hydrolysis following the treatment with nuclease. Effect of increasing concentrations 
of cisplatin on riboflavin fragmentation reaction was resolved by measuring 
percent DNA hydrolyzed in the absence of cisplatin and percent hydrolysis in its 
presence. In the presence of increasing cisplatin, a sharp decrease in the CT-DNA 
nuclease sensitive sites was distinguished in fig. 12(ii). The iithibitory activity of 
cisplatin plateaud at a concentration of 150 i^M reinforcing that cisplatin is 
essentially involved in rendering protection against riboflavin mediated degradation. 
Cisplatin induced degradation is notable in fig. 12(iii). 
"Generation of reactive oxygen species" 
(Ib)13. 'Kydroxyl radical generation' 
Albeit the presence of a metal ion for instance Cu(II) has been shown to 
exaggerate, photoexcited riboflavin alone is as well ascertained to produce 
hydroxyl radical significantly (Jazzar & Naseem, 1994). In view of that, the 
capacity of excited state riboflavin to generate OH radicals in the presence of 
cisplatin was compared utilizing CT DNA as reaction substrate. The assay is 
based on the principle that degradation of DNA by hydroxyl radicals results in 
the release of TBA (thiobeirbituric acid) reactive substances which forms a colored 
adduct with TBA absorbing at 532 nm (Quinlan h: Gutteridge, 1987). Fig. 13(i) 
plainly explains that increasing concentrations of photoilluminated riboflavin 
direct a progressive increase in the formation of OH radicals. As can be seen in 
fig, 13(ii), presence of cisplatin in the reaction reduced the generation of OH 
radical. Hence, it can be prestuned safely that ROS production by photoexcited 
riboflavin is hampered by cisplatin. It is suggestive of decreased decomposition 
of riboflavin. 
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(Ib)14. ^Superoxide production' 
Riboflavin is a daylight-absorber sensitizer present naturally in most 
living organisms (Heelis, 1982). The mechanism of action of this sensitizer is 
rather complex with the concomitant involvement of reactive oxygen species 
(Krishna et al., 1991). The activation of riboflavin on illiunination and its 
simultaneous photodegradation occurs via formation of its singlet and triplet 
excited states. The resultant generation of superoxide anion is well established. 
Riboflavin has been identified as one of the intracellular sources of superoxide 
when irradiated with solar light (Cxmningham et al., 1985). In fact, superoxide 
generation by photoirradiated riboflavin imderlies the common method of gel 
staining for superoxide dismutase activity (Beauchamp & Fridovich, 1971). The 
relative contribution of singlet oxygen and superoxide/hydrogen peroxide 
pathways to the damage of biological targets by photosensitized riboflavin has 
been, however, a subject of controversy (Grzelak et al., 2001). Formation of 
superoxide has been demonstrated by the method of Nakayama et al. (1983) 
which involves reduction of NBT to formazan by riboflavin. The time dependent 
generation of superoxide anion by 50 \iM riboflavin as evidenced by an increase 
in absorbance at 560 nm is shown in fig. 14. 
In recent years, the mechanism of cisplatin induced nephrotoxicity has 
gradually been elucidated. Studies have shown an increase in lipid peroxides in 
the renal tissue and a decrease in glutathione levels (Husain et al., 1998) in 
animals treated with cisplatin. These changes have been considered to result 
from the generation of ROS. Cisplatin generates reactive oxygen species such as 
superoxide anion and hydroxyl radical (Masuda et al., 1994; Yoshida et al., 2003). 
Fig. 14 is reminiscent of cisplatin being an efficient producer of superoxide radical 
. in NBT reduction assay. In contrast, Hara et aL (1990) indicated a suppressive effect on 
superoxide anion production in polymorphonuclear leucocytes in the presence of 
cisplatin. Production of superoxide by polymorphonuclear leucocytes is a 
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Figure 12(i): Degradation of calf thymus DNA by riboflavin with/without 
light as measured by the degree of single strand specific nuclease digestion. 
Calf thymus DNA (500 \ig) and indicated concentrations of riboflavin in 0.5 ml 
reaction mixtures containing 10 mM Tris-HCl (pH 7.5) were incubated in 
fluorescent light (o) or in the dark (•) for 60 minutes. Single strand specific 
digestion was performed as described in "Methods". Results are expressed 
as mean ± SEM of three independent experiments. 
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Figure 12(ii): Cisplatin mediated inhibition of photo-induced cleavage of 
calf thymus DNA by riboflavin as measured by the degree of single strand 
specific nuclease digestion. 
Calf thymus DNA (500 ng), riboflavin (50 nM) and increasing concentrations 
of cisplatin in 0.5 ml reaction mixtures containing 10 mM Tris-HCl (pH 7.5) 
were incubated in fluorescent light for 60 minutes. Single strand specific 
digestion was performed as described in "Methods". Results are expressed as 
mean ± SEM of three independent experiments. 
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Figure 12(iii): Degradation of calf thymus DNA by cisplatin witVwithout 
light as measured by the degree of single strand specific nuclease digestion. 
Calf thymus DNA (500 ]ig) and indicated concentrations of cisplatin in 0.5 ml 
reaction mixtures containing 10 mM Tris-HQ (pH 7.5) were incubated in 
fluorescent light (D) or in the dark (•) for 60 minutes. Single strand specific 
digestion was perfr)rmed as described in "Methods". Results are expressed 
as mean ± SEM of three independent experiments. 
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Figure 13(i): Hydroxyl radical generation by riboflavin in the presence of 
light. 
Reaction mixture (0.5 ml) containing calf thymus DNA (100 ng) as substrate 
with indicated concentrations of riboflavin was incubated in fluorescent light 
for 60 minutes. Hydroxyl radical formation was measured by determining 
the TBA reactive material as described in "Methods". Results are expressed 
as mean ± SEM of three independent experiments. 
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Figure 13(ii): Hydroxyl radical generation by riboflavin in the presence of 
cisplatin; with Ught. 
Reaction mixture (0.5 ml) containing calf thymus DNA (100 ng) as substrate 
was incubated in fluorescent light for 60 minutes under different conditions. 
Hydroxyl radical formation was measured by determining the TBA reactive 
material as described in "Methods". Results are expressed as mean ± SEM of 
three independent experiments. 
Bar 1 : cisplatin alone (150 nM) 
Bar 2 : riboflavin alone (50 \iM) 
Bar 3 : riboflavin: cisplatin (molar ratio 1:0.5) 
Bar 4 : riboflavin: cisplatin (molar ratio 1:1) 
Bar 5 : riboflavin: cisplatin (molar ratio 1:1.5) 
Bar 6 : riboflavin: cisplatin (molar ratio 1:2) 
Bar 7 : riboflavin: cisplatin (molar ratio 1:3) 
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Figure 14: Photogeneration of superoxide anion by riboflavin alone and in 
the presence of cisplatin on illumination under fluorescent light as a 
function of time. 
Details of the reaction are given in "Methods". The samples were placed 10 cm 
from ti\e light source. Results are expressed as mean ± SEM of three independent 
experiments. 
Traces from top to bottom are 
Trace 1 : riboflavin alone (o) (50 jiM) 
Trace 2 : cisplatin alone (n) (150 |iM) 
Trace 3 : riboflavin: cisplatin (o) (molar ratio 1:3) 
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fvindamental element for its bactericidal activity (Babior, 1978). Though the 
authors implied an unknown mechanism for this repressive effect, a direct 
interaction of the drug with cell membranes could not be ruled out according to 
them. Regardless of the mechanism involved, interaction mediated consequences 
can primarily modify xmdesirable attributes into discreet beneficial manifestations. 
Under the experimental conditions employed, cisplatin attenuated the rise in 
ROS production by riboflavin as empirical in fig. 14. The fact that NBT was 
genuinely assaying superoxide was confirmed by SOD (100 ^ig/ml) inhibiting 
the reaction. 
"Jfi/mflw peripheral blood lymphocytes-rihoflavin-cisplatin-
photoillumination" 
Cisplatin has been shown to react differently with DNA in intact cells 
compared to purified DNA (Sanderson et al., 1996). This behavior was associated 
to the packaging of DNA as chromatin in intact cells that may influence the reactivity 
and/or accessibility of the sites of potential adducts and damage. As genomic 
DNA is generally accepted as the ultimate target of platintun based agents, 
handling human cells was a requisite for better know-how into the action that 
conducts inhibitory potential of cisplatin in terms of riboflavin induced cytotoxicity. 
(Ib)15. ^Viability assay' 
The viability of human lymphocytes after treatment with photoactive 
riboflavin and/or cisplatin was corroborated by trypan blue exclusion assay. 
Most viability tests rely on a breakdown in membrane integrity determined by 
the uptake of a dye to which the cell is normally impermeable (e.g., trypan blue). 
Fig. 15 illustrates the effect of cisplatin on cell mortality after the exposure of 
lymphocytes to riboflavin. The cell mortality was 30% higher in the riboflavin 
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group than in tiie no treatment group. However, the cell mortality in the group 
cotreated with riboflavin and cisplatin was lessened appreciably as compared to 
the riboflavin group. 
(Ib)16. 'Single Cell Gel Electrophoresis' 
The single cell gel electrophoresis assay is used in genetic toxicology, 
radiation biology, oncology and in environmental research (Dobrzynska, 2005). 
The SCGE/comet assay is a rapid, easy and reproducible method to detect 
genotoxic activity of chemical and physical agents in vitro and in vivo. This technique 
is sensitive enough to detect low levels of DNA damage in individual cells and 
has potential application to virtually all eukaryotic cell types. The comet assay 
can potentially measure DNA lesions in any organ/tissue even in the absence of 
mitotic activity. Cells are examined using fluorescent microscope. Cells look like 
comets with a bright fluorescent head and tail, the length and intensity of which 
are related to the number of strand breaks (Dobrz)mska, 2005). 
Traditionally, PBL have been preferred because they are regarded as 
sentinel cells being early warning signals for adverse health effects (Tice et al., 
2000). The assay involves treatment of a small number of cells with the test agent, 
layered on glass slides and sandwiched between layers of agarose. Furthermore, 
agarose embedded cells are lysed to generate a nucleoid body composed of 
nuclear DNA stripped of some attached protein and its histones. These nucleoid 
bodies are then subjected to limited electrophoresis that causes the damaged 
DNA to migrate away from the xmdamaged DNA forming a "comet", in which 
the 'head' of the comet is the imdamaged DNA and the 'tail' the damaged DNA. 
Therefore, the more damaged a cell's DNA is, the greater the amount of DNA in 
the tail (often measured as OTM or tail length) (Almeida et al., 2006). The size of 
the comet and the distribution of fluorescence within it is correlated 
quantitatively with the frequency of DNA breaks (Fairbairn et al., 1995). 
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Increasing concentrations of riboflavin (10-50 }iM) in the presence and 
absence of radiation were tested for DNA breakage in isolated human peripheral 
lymphocytes using the comet assay. In the dark, riboflavin at any of the doses 
tested did not damage the lymphocyte DNA whereas, riboflavin in conjunction 
with light prompted DNA damage. The damage increased linearly with dose. 
Fig. 16(i) shows photographs of comets (lOOX) observed with increasing 
concentrations of riboflavin in the presence of light. The corresponding tail 
length is plotted as a function of increasing riboflavin concentration in fig. 16(ii). 
Untreated lymphocyte controls were identical to riboflavin in the absence of light 
as in fig. 16(i)(R0) and no cellular DNA breakage could be distinguished in both 
of these category treatments. The results implied that riboflavin-light system is 
capable of DNA breakage in lymphocytes. Photoactive riboflavin perturbs the 
cellular DNA and incites breaks/fragmentation or simply, exerts cytotoxic effects 
in human cells. Although 'genotoxicity' is a useful term whose precise definition 
is elusive, there is no doubt that DNA damage plays a pivotal role in most 
. mechanisms underlying genotoxicity. It seems reasonable to recognize riboflavin 
as a genotoxic agent in its active form. DNA damage induced by chemicals, 
including anticancer drugs, appears primarily in the form of alterations of the 
phosphate backbone, sugar or base modifications such as alkylations, crosslinks or 
formation of bulky DNA adducts, which are substrates for DNA repair 
mechanisms. Transient DNA breaks arise in the second step as a consequence of 
repair and can be considered as important markers of genotoxicity (Eastman & 
Barry, 1992). Fig. 16(iii) indicates dose-dependent damage induced by cisplatin. 
Genotoxicity of anticancer drugs belongs to their most serious side effects due to 
the possibility of inducing secondary malignancies (Ferguson & Pearson, 1996). 
Riboflavin induced DNA breakage is reduced markedly by cisplatin as noticed in 
fig. 16(iv), The representative comet photographs displaying the protective effect 
of drug are shown in fig. 16(v). 
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Figure 15: Effect of cisplatin on riboflavin induced cell mortality. 
The mortality of human lymphocytes in suspension in the presence of 
cisplatin/riboflavin/riboflavin-cisplatin was compared with that in the no 
treatment group (control) as assessed by trypan blue exclusion assay. Results 
are expressed as mean ± SEM of three independent experiments. 
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Figure 16(i): DNA breakage by photoilluminated riboflavin in human peripheral 
lymphocytes as measured by comet assay. 
Reaction mixture (1 ml) containing IxlO^ cells, RPMl (400 ^il), PBS (Ca2+ dnd Mg2+ 
free) with increasing concentrations of riboflavin was irradiated in fluorescent 
l ight/ incubated in the dark for 60 minutes. The reaction mixture was processed 
further for comet assay as described in "Methods". 
Photographs of comets (lOOX) obtained after the above treatment of lymphocytes. 
{C} : untreated lymphocyte 
{RO} : riboflavin (50 nM; dark) 
{R1-R5} : riboflavin (10-50 ^iM; hght) 
i i ; 
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Figure 16(ii): DNA breakage by photoilluminated riboflavin in human 
peripheral lymphocytes as measured by comet assay. 
Reaction mixture (1 ml) containing IxlQs cells, RPMI (400 \il), PBS (Ca2+ and 
Mg2+ free) with increasing concentrations of riboflavin was irradiated in 
fluorescent light for 60 minutes. The reaction mixture was processed further 
for comet assay as described in "Methods". 
Comet tail length ((Ameters) plotted as a function of increasing concentrations 
of riboflavin (10-50 \iM). Results are expressed as mean ± SEM of three 
independent experiments. 
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Figure 16(iii): DNA breakage by cisplatin in human peripheral lymphocytes 
as measured by comet assay. 
Reaction mixture (1 ml) containing 1x1 Qs cells, RPMI (400 nl), PBS (Ca^ * and 
Mg2+ free) with increasing concentrations of cisplatin was irradiated in 
fluorescent light for 60 minutes. The reaction mixture was processed further 
for comet assay as described in "Methods". 
Qjmet tail length (^meters) plotted as a function of increasing concentrations of 
cisplatin (25-150 \iM). Results are expressed as mean ± SEM of three 
independent experiments. 
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Figure 16(iv): Inhibition of riboflavin induced DNA breakage by cisplatin in 
human peripheral lymphocytes as measured by comet assay. 
Reaction mixture (1 ml) containing IxlQS cells, RPMI (400 nl), PBS (Ca^^ and 
Mg2+ free), riboflavin (50 p.M) and indicated concentrations of cisplatin was 
irradiated in fluorescent light for 60 minutes. The reaction mixture was 
processed further for comet assay as described in "Methods". 
Comet tail length (^meters) plotted as a function of increasing concentrations of 
cisplatin (25-150 nM) in the presence of 50 i^M riboflavin. Results are 
expressed as mean ± SEM of three independent experiments. 
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Figure 16(v): Inhibition of riboflavin induced DNA breakage by cisplatin in 
human peripheral lymphocytes as measured by comet assay. 
Reaction mixture (1 ml) containing 1x10^ cells, RPMI (400 ^il), PBS (Ca2+ and Mg2+ 
free), riboflavin (50 nM) and indicated concentrations of cisplatin was irradiated 
in fluorescent light for 60 minutes. The reaction mixture was processed further for 
comet assay as described in "Methods". 
Photographs of comets (lOOX) obtained after the above treatment of lymphocytes. 
{C} : untreated lymphocyte 
{R5} : riboflavin (50 ^M) 
{RC1-RC4} : riboflavin: cisplatin (molar ratio 1:1,1:2,1:2.5 and 1:3) 
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(Ib)17/ TEARS as a measure of oxidative stress in lymphocytes' 
As mentioned it is presumed that lymphocyte DNA breakage is the 
consequence of the generation of reactive oxygen species in situ; formed by the 
photoexcitation of riboflavin. Oxygen radical damage to DNA is considered to 
give rise to TBA reactive material (Quinlan & Gutteridge, 1987). We have 
therefore determined the formation of TBA reactive substance (TEARS) as a measure 
of oxidative stress in lymphocytes with increasing concentrations of riboflavin 
and cisplatin. A clear positive dose dependent relationship was observed in fig. 
17(i) that achieved statistical significance mainly at higher concentrations tested. 
However, in fig. 17(ii) when cells were incubated with cisplatin and riboflavin 
simultaneously there was a considerable decrease in the rate of formation of TBA 
reactive substance by riboflavin; and surprisingly by cisplatin as well. 
Exposure of cells to ROS generated in the development of tumors and 
during chemotherapy is associated with cell damage (Olas et al., 2006). Owing to 
numerous literature it is relatively easy to speculate reactive oxygen species as 
the locus of cisplatin induced cytotoxicity towards normal cells. However, 
cisplatin displayed an inhibitory activity against the production of ROS by 
riboflavin, in blood cells. This association influences cisplatin toxicity and 
exemplifies desirable interaction. It suppresses the formation of thiobarbituric 
acid reactive substances; as measured at the same concentration of cisplatin alone 
and in combination with riboflavin. On the basis of our observation, photoillu-
minated riboflavin may be a promising candidate for the future evaluation of its 
pharmacologic activity associated with its photodjmamic action. The concurrent 
protective potential of cisplatin against the celltdar oxidative stress induced by 
riboflavin could be due to aversion of photodecomposition of the sensitizer. It is 
plausible that the interactive mechanism involving sensitizer-drug photo-
transforms cisplatin into an inactive form which encumbers the native abilities 
coupled with the drug and also repressed photoexcitation and ROS production 
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Figure 17(i): TEARS generated by incubation of lymphocytes with photo-
illuminated riboflavin. 
The isolated cells (1x10 )^ suspended in RPMI 1640 with the indicated 
concentrations of riboflavin were incubated in fluorescent light for 60 minutes. 
After pelleting, the cells were washed twice with PBS (Ca^ * and Mg2+ free) 
before proceeding as described in "Methods". Results are expressed as mean 
± SEM of three independent experiments. 
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Figure 17(ii): TBARS generated by incubation of lymphocytes with photo-
illuminated riboflavin and cisplatin. 
The isolated cells (IxlO^) suspended in RPMI 1640 were incubated in 
fluorescent light for 60 minutes under different conditions. After pelleting, the 
cells were washed twice with PBS (Ca^ * and Mg^* free) before proceeding as 
descriT?ed in "Methods". Results are expressed as mean ± SEM of three 
independent experiments. 
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: riboflavin: cisplatin (molar ratio 1:1.5) 
: riboflavin: cisplatin (molar ratio 1:2) 
: riboflavin: cisplatin (molar ratio 1:3) 
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from riboflavin. Riboflavin induced phototransformation is an extension to 
photodynamic therapy (Ramu et al., 2000; Massad et al., 2004; Eubanks et al., 
2005; Yang etal., 2007). 
Doubtlessly, these consequences are a result of an array of molecular 
reactions and interactions v^hich cumulatively transform equitoxic compounds. 
' A comparison of these results with those of the preceding chapter suggests that 
the mechanism of DNA breakage reaction by photoilluminated riboflavin is 
identical to protein fragmentation reaction. Cisplatin exhibits an inhibitory 
activity on both of these aspects through an analogous photoinhibition reaction. 
Subsequently, as per tlie results realized cisplatin-riboflavin association could 
enlarge the therapeutic window of riboflavin in photodynamic therapy and is 
biologically relevant. 
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Riboflavin is a naturally occurring compound and an essential human nutrient. It 
is a planar, conjugated ring structure with a sugar side chain that confers water 
solubility. The planar portion is capable of absorbing light in the visible and near 
UV regions. Riboflavin must be present in the body for good health; and is non-
toxic in the native conditions. For an entire toxicity profile of a particular 
substance, it is important to assess the toxicity of not only the compoimd 
individually but also the result of various biochemical reactions/interactions that 
are likely to occur with substances present in the blood stream in normal or out 
of the ordinary conditions. The photodegradation of riboflavin in the body is 
clearly shown by the decrease in its concentration in neonates who are treated 
with intense visible light for the breakdown of circulating bilirubin which their 
immature livers can not yet handle. When activated by light, photosensitizers 
can damage cells and organisms by their effects on critical biomolecules. Because 
of riboflavin's known photoreactions, questions were raised about potential 
mutagenic/carcinogenic effects of neonatal phototherapy (Schuyler, 2001). 
This investigation was undertaken in order to supply an insight into the 
possible photoreactions of riboflavin with the title molecules and their 
cumulative influence on biomolecules. This helps to predict the degradative fate 
and effect of drug on riboflavin. Categorically, anticancer agents belonging to 
diflierent kind following dissimilar mechanism of efficacy and limitations have 
been prudently chosen. 5-Fluorouracil and cisplatin are drugs falling into two 
different subtypes of chemotherapeutic agents. Hence, their respective 
interactions with compounds such as photosensitizers are expected to be different 
5-Fluorouracil has been widely used for chemotherapy of head and neck 
cancer and is known to affect the cell cycle and induce apoptotic death of cancer 
cells (U et aL, 2004). The cytotoxic effect of 5-fluorouracil is attributed to inhibition 
of thymidylate synthase (TS; EC 2.1.1.45) by 5-fluoro-2'-deoxyuridine-5'-mono-
phosphate (FdUMP), an active metabolite of 5-fluorouracil (Spears et al., 1982). 
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Serum albumin, the most abundant protein in the blood stream is a major 
circulatory protein of known structure (Peter, 1996). In the blood circulation, the 
presence of drug has two forms; free and reversibly boimd to a protein. It is 
widely accepted that the effect of a drug is related to the exposure of a patient to 
the free concentration of the drug in plasma rather than its total concentration. 
Most drugs travel in plasma and reach the target tissue by binding to serum 
albumin. Therefore, binding to serum albumin strongly influences the free drug 
concentration in plasma and has a large impact in the transfer of drugs to the 
tissue. Additionally, serum albumin allows solubilization of hydrophobic compovmds 
which helps to a more homogenous and buffers distribution of drugs through 
out the body, and prolongs the duration of the drug action. So, drug-serum 
albumin complexes in plasma serve as a reservoir for the free drug, as the free 
drug is easier to be removed from the body by various elimination processes. 
Quantitative investigation of drug-serum albumin binding is essential for drug 
development and for determiiung drug's safety clinically (Liu et al., 2006). Bovine 
and human serum albumin display approximately 76% sequence homology. The 
three dimensional structure of bovine serum albumin is believed to be similar to 
that of human serum albumin (Zhao et al, 2006). 
(na)18. ''BSA fragmentation'' 
Understanding the 5-fluorouracil induced alterations in the molecular 
dynamics of photoinitiated reactions might be useful for the clinical application 
of this drug. In terms of the photochemistry of 5-fluorouracil, the principle 
photoproduct (80%) is a hydration product, 5-fluoro-6-hydroxy-hydrouracil 
(FlK)h%Ura), when aqueous solution of 5-fluorouracil is irradiated with 253.7 nm 
light (Lozeron et al., 1964). Photolysis of l,3-dimethyl-5-fluorouracil initially 
yields a photohydrate which upon further irradiation gives 1J5- dimethylbarbituric 
acid by elimination of hydrogen fluoride. The effect of 5-fluorouracil on riboflavin 
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mediated BSA fragmentation was analyzed. Analyses of data from fig. 18(i), 
5-fluorouraciI displayed an inhibitory effect in the lower concentrations but 
no effect at higher concentrations. Fig. 18(ii) shows BSA fragmentation pattern in 
the presence of 5-fluorouracil alone. It is apparent through the investigated range 
of stoichiometries that the effect of 5-fluorouracil alone on BSA as the reaction 
substrate is nil in comparison to riboflavin; though it is noteworthy that the effect 
is diminished with the photoilluminated drug. Nevertheless, the participation of 
5-fluorouracil on riboflavin mediated reaction is significant in lower concentrations 
with insignificant impact at the higher molar ratios. It must be accounted that as 
the ratio of riboflavin: 5-fluorouracil increases from 1:1, the effect of 5-fluorouracil 
becomes trivial. Even at 1:1 molar ratio there is no change in riboflavin-induced 
damage. The concentration below 10 jxM was also investigated and the effect was 
similar in the range of 1-10 \iM. These trends of concentration dependent activity 
have also been observed for quercetin and rutin displaying protective effects on 
damage induced by mitomycin C (Undeger et al., 2004). 
(IIa)19. "Carhonyl estimation n 
To determine the level of carbonyl groups, 2,4-dinitrophenyl hydrazine 
(DNPH) method was used (Butterfield et al., 1998). Carbonyl groups (CO) are 
known as markers of oxidative damage in proteins. The focus of this study was 
to evaluate the effect of riboflavin (in its excited state) in the presence of 5-fluoro-
uracil on protein. Riboflavin in its photosensitized state produces CO groups in 
piroteins as formerly deduced in fig. 2(i). Reactive oxygen species are respor\sible 
for these protein oxidative effects. According to the data obtained from the fig. 19(i), 
the rise in the carbonyl groups reached a certain level and remained regular even at 
increasing concentrations of the drug (alone). The trend observed on photoillumination 
was corresponding to that observed at 5-fluorouracil concentrations in the 
previous information. The effect of drug as in fig. 19(ii) on riboflavin-induced 
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Figure 18(i): Effect of 5-fluorouracil on riboflavin mediated 
protein fragmentation. 
BSA (2 mg/ml) with indicated concentrations of 5-fluorouracil 
and riboflavin (50 (iM) in a total reaction volume of 1.0 ml 
containing 10 mM potassium phosphate buffer (pH 7.5) was 
incubated in fluorescent light for 60 minutes. Acid soluble amino 
groups were estimated as described in "Methods". Results are 
expressed as mean ± SEM of three independent experiments. 
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Figure 18(ii): Kinetics of protein fragmentation by 5-fluorouracil 
in the presence and absence of light. 
BSA (2 mg/ml) with indicated concentrations of 5-fluorouracil in 
a total reaction volume of 1.0 ml containing 10 mM potassium 
phosphate buffer (pH 7.5) was incubated in fluorescent light (a) 
or in the dark (•) for 60 minutes. Acid soluble amino groups 
were estimated as described in "Methods". Results are expressed 
as mean ± SEM of three independent experiments. 
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Figure 19(i): Carbonyl fonnation by 5-fluorouracil in the presence 
and absence of light. 
BSA (2 mg/ml) with indicated concentrations of 5-fluorouracil in a 
total reaction volume of 1.0 ml containing 20 mM phosphate buffer 
(pH 7.4) was irradiated in fluorescent light (D) or incubated in the 
dark (•) for 60 minutes. Carbonyl formation was monitored as 
described in "Metiiods". Results are expressed as mean ± SEM of 
three independent experiments. 
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Figure 19(ii): Effect of 5-fluoroviracil on riboflavin induced carbonyl 
formation. 
BSA (2 mg/ml) with indicated concentrations of 5-fluorouracil and 
riboflavin (50 |iM) in a total reaction volume of 1.0 ml containing 20 mM 
phosphate buffer (pH 7.4) was irradiated in fluorescent light for 60 
minutes. Carbonyl formation was monitored as described in "Methods". 
Results are expressed as mean ± SEM of three independent experiments. 
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protein carbonyl groups is similar to that observed formerly. Notably, the effect 
is biphasic that is inhibition observed for concentration ranging from 1 to 50 ^M 
followed by a no increase/decrease pattern in oxidative damage above 50 jiM. 
These observations demonstrate the possibility of some action between riboflavin 
and 5-fluorouracil (at lower concentratior«) which contributes to a decrease in 
toxicity of riboflavin. 
(IIa)20. "Protein degradation" 
It has been shown that drug-biomolecule interactions in the blood stream 
strongly affect the distribution, free concentration and the metabolism of various 
drugs. This type of interaction can also influence the drug stability and toxicity of 
the therapeutic process (ICandagal et al., 2006). The interactive forces between a 
drug and a biomolecule may include hydrophobic forces, electrostatic 
interactions, van der Waal's interactions and hydrogen bonds (Hu et al., 2005). 
Hu et aL (2005) suggested that the binding of Carmofur and BSA is mainly 
entropy driven and hydrophobic forces played major role in the reaction. 
Carmofur (1-Hexyl carbamoyl-5-fluorouracil) is developed as a derivative of 
5-fluorouracil and is well known to release 5-fluorouracil spontaneously (Kobari et al., 
1981). The effect of 5-fluorouracil on riboflavin mediated degradation was also 
deduced on PAGE. The neat result in fig. 20 leads us to imply that 5-fluorouracil 
imparts inhibition on photodamage by riboflavin in a concentration dependent 
marmer. 
(na)21. "Absorption spectroscopy" 
The mechanism of action of a drug is largely determined by its physico-
chemical properties in solution. Thus, spectroscopic and thermodynamic studies 
on drug molecules are of great relevance in pharmacokinetics (Kandagal et al., 2006). 
The ability of 5-fluorouracil to complex with sertun albumin is well known (Hu et al.. 
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Figure 20: Inhibition of riboflavin induced degradation by 
5-fluorotuacil. 
2 mg/ml BSA with riboflavin (50 nM) and indicated concentration 
of 5-fluorouracil was irradiated in fluorescent light for 60 minutes. 
Electrophoresis was performed as mentioned in "Methods". 
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BSA alone 
BSA-riboflavin (50 nM) 
BSA-riboflavin-5-fluorouracil (10-50 \iM) 
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Figure 21 (i): Absorption spectra of BSA in presence of 5-fluorouracil. 
Spectrum of reaction mixture containing 5-fluorouracil (50 fxM) and BSA 
was read before and after illumination in fluorescent light for 60 minutes. 
All reactions were carried out in 10 mM phosphate buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : BSA alone (10 \iM) 
Trace 2 : BSA: 5-fluorouracil (—) (molar ratio 1:5; dark) 
Trace 3 : BSA: 5-fluorouracil (• • •) (molar ratio 1:5; light) 
129 
250 260 270 280 
Wavelength (nm) 
290 300 
Figure 21 (ii): Absorption spectra of BSA with riboflavin in the presence 
of increasing concentration of 5-fluorouraciL 
The reaction mixture containing BSA, riboflavin (50 jiM) and increasing 
concentration of 5-fluorouracil was incubated. The spectrum was read after 
illumination in fluorescent light for 60 minutes. All reactions were carried 
out in 10 mM phosphate buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : BSA alone (10 \iM) 
Trace 2-4 : BSA: riboflavin: 5-fluorouracil (molar ratio 1:5:1,1:5:2,1:5:3) 
Trace 5 : BSA: riboflavin (• • •) (molar ratio 1:5) 
Trace 6-8 : BSA: riboflavin: 5-fluorouracil (molar ratio 1:5:4,1:5:5,1:5:6) 
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2005). Fig. 21 (i) suggests that the drug actually binds to albumin. The change in 
BSA spectra upon binding with constant riboflavin and increasing 5-fluorouracil 
ratios is revealed in fig, 21(ii). It seems that fluorouracil-riboflavin-albumin 
combination depends on the concentration of 5-fluorouracil and riboflavin. It is 
plausible that at lower concentrations of 5-fluorouracil, riboflavin molecules are 
concentrated around 5-fluorouracil molecules by some forces and this interaction 
prevents riboflavin from being photoexcited. This interactive network retards the 
production of reactive oxygen species and hence damage is lowered at lower 
concentrations. Reading the photochemistry of 5-fluorouracil alone, the 
formation of FlUra dimers was suggested in the photolysis of poly [FU] (Wang, 
1976). When poly [FU] is irradiated at wavelength >270 run in a pH 5.6 phosphate 
buffered solution, the absorption of poly [FU] atXmax decreased in first order. The 
irradiated solution largely restored the original absorption when acidified to IN 
HCl and heated to 125 °C for 90 min (Fikus et aL, 1962). Wang (1976) suggests Q-
cycbdimerization of FlUra for poly [FU]. The occurrence of photocyclodimerization 
explains the behavior of 5-fluorouracil at higher concentratioiK. As the 
concentration of this drug increases, the possibility of interaction of 5-fluorouracil 
molecules with each other (dimerization) becomes more relevant than interaction 
with riboflavin and hence the observed trend. 
(na)22. ^fluorescence spectroscopy" 
Fluorescence method is sensitive and convenient to use in the study of 
intermolecular interactions (Sulkowska et al., 2003). For macromolecules, 
fluorescence measurements can give ample information on binding of small 
molecular substances to proteins. Natural fluorophores in protein are uniquely 
sensitive to quenching by a variety of substances. The fluorescence of serum 
albumin is due to tyrosine and tryptophan residues. The change in the relative 
fluorescence of serum albumin can be correlated with changes in its structure as 
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the ligand concentration increased (Eftink & Ghiron, 1981). Binding of a drug 
may alter the fluorescence characteristics of protein. The change in BSA emission 
properties upon binding of the drug is shown in fig. 22(i). The examined drug 
binds to serum albumin with increasing affinity directly proportional to its 
concentration. The effect of 5-fluorouracil concentrations on BSA fluorescence 
(riboflavin tieated) was also considered using fluorescence spectra. Fig. 22(ii) 
shows BSA fluorescence (riboflavin treated) in the presence of 5-fluorouracil. 
Clearly, the binding is strongly dependent on the illumination of riboflavin and 
is greatiy influenced by the concentration of 5-fluorouracil. The fluorescence data 
and results achieved formerly complement each other. The quenching effect by 
riboflavin was abated by 5-fluorouracil at lower concentratioiw than at higher 
molar ratios. 5-flu6rouracil at higher concentrations did not show significant 
differences in the quenching effect of BSA fluorescence with riboflavin in the 
concentration range investigated. 
(IIa)23. "Circular Dichroism spectroscopy" 
It is well known that riboflavin is photolabile. Ipso facto, main advantage 
of riboflavin as a photosensitizer is represented by its capacity to interact with a 
suitable substrate in the absence of molecular oxygen. Structural modification 
and degradation of proteins by photoactivated riboflavin has already been 
deduced. To shed further light on the outcome of 5-fluorouraciI on structural 
modification of serum albumin by riboflavin, circulcir dichroism spectrum was 
employed. As is expected for a protein that is predominantiy a-helical, the CD 
spectrum shows a strong negative ellipticity at 208 and 222 nm. In fig. 23(i) the 
addition of small amount of 5-fluorouracil causes the distortion of CD spectrum, 
indicative of disordered form of a-helix. However, further addition of the drug 
causes restoration of the spectrum. It is rational to expect the structural changes 
in biomolecules when in contact with a reactive substance as drug. In contrast to 
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Figure 22(i): Effect of maeasing concentration of 5-fluorouracil on the 
fluorescence emission spectrum of BSA. 
The reaction mixture containing 5-fluorouracil and BSA in 10 mM 
phosphate buffer (pH 7.5) was incubated. BSA was excited at 280 nm and 
the emission spectra were recorded between 300 and 400 nm. The emission 
slit was 10 nm. 
Traces from top to bottom are 
Trace 1 : BSA alone (1 ^ M) 
Trace 2-10 : BSA: 5-fluorouracil (molar ratio 1:10,1:20,1:30,1:40,1:50, 
1:60,1:70,1:80 and 1:90) 
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Figure 22(ii): Effect of increasing concentration of 5-fluorouracil on the 
fluorescence emission spectrum of riboflavin (50 jiM) treated BSA after 
illumination in fluorescent light for 60 minutes. 
BSA was excited at 280 nm and the emission spectra were recorded between 
300 and 400 run. The emission slit was 10 nm. 
Traces from top to bottom are 
Trace 1 : BSA alone (1 jiM) 
Trace 2-6 : BSA: riboflavin: 5-fluorouracil (molar ratio 1:50:10,1:50:20, 
1:50:30,1:50:40 and 1:50:50) 
Trace? :BSA: riboflavin(•••)(molarratio 1:50) 
Trace 8-10 : BSA: riboflavin: 5-fluorouracil (molar ratio 1:50:60,1:50:70 
and 1:50:80) 
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Figure 23(i): The a-helical content of BSA under different conditions. 
The reaction mixture containing BSA was incubated in fluorescent light for 
60 minutes tmder different conditions. The spectrum was obtained in 0.1 M 
phosphate buffer of pH 7.4 at room temperature. Results are expressed as 
mean ± SEM of three independent experiments. 
Barl 
Bar 2 
Bar 3 
Bar 4 
Bar 5 
Bar 6 
Bar 7 
: BSA alone (2 \iM) 
BSA: riboflavin (molar ratio 1:25) 
: BSA: 5-fluorouracil (molar ratio 1:5) 
BSA: 5-fluorouracil (molar ratio 1:25) 
BSA: riboflavin: 5-fluorouracil (molar ratio 1:25:5) 
BSA: riboflavin: 5-fluorouracil (molar ratio 1:25:15) 
BSA: riboflavin: 5-fluorouracil (molar ratio 1:25:25) 
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Figure 23(ii): CD spectra of BSA-riboflavin-S-fluorouracil-light 
system. 
The reaction mixture containing BSA, riboflavin (50 (AM) and 
increasing concentration of 5-fluorouracil (10-60 nM) was irradiated 
in fluorescent light for 60 minutes. The spectrum was obtained in 
0.1 M phosphate buffer of pH 7.4 at room temperature. 
Traces from top to bottom are 
Trace 1 
Trace 2 
Trace 3 
Trace 4 
Trace 5 
Trace 6 
BSA: riboflavin (molar ratio 1:25) 
BSA: riboflavin: 5-fluorouracil (molar ratio 1:2530) 
BSA: riboflavin: 5-fluorouracil (molar ratio l:25i25) 
BSA: riboflavin: 5-fluorouracil (molar ratio 1:25:15) 
BSA: riboflavin: 5-fluorouracil (molar ratio 1:25:5) 
BSA alone (2 nM) 
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5-fluorouracil, the change induced by riboflavin has oxidative origin, at least in 
part In fig. 23(ii), the structural change brought about by riboflavin is reduced by 
5-fluorouracil at the lowest concentration tested. Additionally, at higher 
concentrations there was no change in the structural diffierence brought about by 
riboflavin or 5-fluorouracil individually. Taken as a whole, the lowest concentrations' 
ranging fi"om 1 to 50 JAM interacts with riboflavin and hinders tiie photoactivation 
phenomenon marginally. The drug gives an iota of obstruction in the photoexcitation 
and consequently curtails the photodamage. Although a 5-fluorouracil molecule 
on photoactivation tends to interact with another 5-fluorouracil molecule in the 
vicinity. The latter reaction is preferable when the drug is in higher concentrations. 
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''UnitlKhy 
^DNA binding 
and 
degradation^ 
Riboflavin and its derivatives have particularly rich and complex photochemistry 
both in the presence and absence of other substrates and imder aerobic and 
anaerobic conditions (Mancini et al., 2000). Riboflavin can also act as a 
photochemical sensitizer, provoking the degradation of molecules that do not 
absorb visible light. In view of the increasingly expanding utilization of 
photosensitized processes for the treatment of selected diseases especially in the 
oncological field (Jori, 1996); investigations are tmderway to open the use of 
riboflavin and its analogues as phototherapeutic agents (Edwards et al., 1999). 
Irradiation of tumor cells in culture containing riboflavin induces cell death 
(Edwards et aL, 1994). It must also be emphasized that the main cellular constituents 
such as proteins, saturated or imsaturated lipids, nucleic acids and carbohydrates 
display a very different susceptibility to photosensitized oxidation (Wilson & 
Patterson, 1986); and also the photochemical behavior of a tissue is strictiy 
dependent on its biochemical composition and physiological properties (Wilson 
& Patterson, 1986), for instance, since the photodynamic action by any sensitizer 
occurs via photo oxidative steps, the local concentiation of antioxidants may play 
a major role (Jori, 1992). 
Under irradiation with light or ionizing radiation in the presence of a 
photoseiTsitizer, DNA support several modifications including chain breaks, 
DNA-protein crosslinks, abasic sites and oxidized DNA bases which have been 
shown to be able to induce point mutations (Zhang et al., 1997; Purmal et al., 
1994; Oieng et al., 1992). The production of DNA damage by radiation involves 
two mecharusms, direct and indirect effects. Direct effect leads to ionization and 
excitation of DNA molecules while indirect effect is due to interaction of reactive 
species in particular, hydroxyl radicals OH" produced by water radiolysis, which 
targets the DNA (Krisch et al., 1991). The processes involving DNA are affected 
by photodynamic therapy. When the DNA backbone is broken in photodynamic 
therapy by radiation, the ends contains 3' terminal phosphoglycoaldehydes or 3' 
terminal phosphates which can not act as substrates for DNA polymerase I or 
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DNA ligase (Ion et al., 2001). For a larger view of photodynamic therapy induced 
modifications the possible beneficial or harmftil associations of photosensitizers 
with substances needs to be evaluated. Drugs belong to this class of invaluable 
compounds. 
(nb)24. "Ethidium bromide quenching assay" 
The emission intensity of ethidium bromide (EB) in the presence of DNA 
is greatly enhanced due to strong intercalation between the adjacent base pairs. 
This enhanced fluorescence can be quenched partially by the addition of a 
second molecule. The extent of the quenching of fluorescence of ethidium 
bromide bound to DNA is used to determine the extent of binding between the 
second molecule and DNA (Baguley & Le Bret, 1984). The fluorescence spectra of 
ethidium bromide bound to DNA in the absence and presence of 5-fluorouracil is 
given in fig. 24(i). The emission band of tiie DNA-EB system decreases in 
intensity with an iiKrease in the concentration of 5-fluorouracil. This quenching 
of EB bound to DNA by 5-fluorouracil is in good agreement with the principle of 
the quenching assay. It suggests the partial replacement of EB-DNA by drug 
resulting in a decrease in the fluorescence intensity. The fluorescence intensity of 
riboflavin-DNA (EB boiuid) containing varying concentrations of 5-fluorouracil 
has been measured after they are mixed and reacted in light. The plot of 
fluorescence intensity is shown in fig. 24(ii). The results illustrate that flie 
intensity of the curves with lower concentrations of 5-fluorouracil is more than 
that of the curves with higher concentration of the drug. This indicates complex 
formation. Apart from complex formation there is visible increment in riboflavin 
mediated lowering of fluorescence intensity of calf thymus DNA possibly due to 
minor retention of the native characteristic of DNA. Complex formation and 
stringent binding is relevant at higher molar ratios of the drug also but is not 
accompanied with rise in intensity. Perchance, the binding is stronger at ratios 
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greater than 1:1 ratio of riboflavin:5-fluorouracil, but the drug at these 
concentrations is not effective in restraining excited riboflavin. 
(IIb)25. ^^Binding of 5-fluorouracil to rihoflavin-DNA" 
In order to determine the DNA binding characteristics of riboflavin in the 
perspective of 5-fluorouracil, the interaction was monitored using absorption 
spectroscopy of DNA with fixed concentration of riboflavin and increasing 
concentration of 5-fluorouracil. The absorption spectra were characterized by 
enhancement in absorbance at 10-50 jiM of 5-fluorouracil as seen in fig. 25. 
Within each series of experiment, with the addition of an increasing 
concentration of 5-fluorouracil to DNA-riboflavin the spectra showed no shift in 
absorbance maxima but an initial increase followed by a regular decrease in 
absorbance (hypochromicity). In contrast to higher molar ratios, the spectra of 5-
fluorouracil (at lower molar ratios) upon titration with DNA-riboflavin exhibited 
hyperchromism. The hyperchromism observed supports the possibility of 5-
fluorouracil interceding with riboflavin binding to DNA. However, the drug at 
higher concentrations does not affect riboflavin binding. 
(IB)26. "Cleavage ofplasmidpUC 18 DNA'' 
In agarose gel electrophoresis of treated plasmid DNA, supercoiled DNA 
migrates faster than open circular DNA and linear DNA migrates in an 
intermediate position between supercoiled and open circular DNA (Stagos et al., 
2005). Riboflavin induced DNA nicking activity has been formerly verified. Gel 
electrophoresis experiments using pUC 18 plasmid DNA were performed with 5-
fluorouracil in the presence and absence of photoactivated riboflavin as an 
oxidant. At the concentration of 10 fiM, the drug exhibited significant reduction 
in cleavage activity of riboflavin as in fig. 26 (lane c). The nicking actjvity is 
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Figure 24(i): Emission spectra of EB bound to DNA in the presence of 
5-fluorouracil. 
Calf thymus DNA (in Tris-HCl, pH 7.4) was excited at the Xexc of 340 nm 
and the emission spectra was recorded between 500 and 600 nm. 
Traces from top to bottom are 
Trace 1 : DNA alone (25 jiM) 
Trace 2-6 : DNA: 5-fluorouracil (molar ratio 1:0.4,1:0.8,1:1.2,1:1.6 and 
1:2) 
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Figure 24(ii): Emission spectra of riboflavin treated DNA in the presence 
of 5-fluorouracil. 
The reaction mixture containing calf thymus DNA, riboflavin (50 \iM) and 
increasing concentration of 5-fluorouracil was incubated. The spectrum 
was read after illumination in fluorescent light for 60 minutes. Calf 
thymus DNA (in Tris-HCl, pH 7.4) was excited at the Xexc of 340 nm and 
the emission spectra was recorded between 500 and 600 nm. 
Traces from top to bottom are 
Trace 1 : DNA alone (25 nM) 
Trace 2-6 : DNA: riboflavin: 5-fluorouracil (molar ratio 1:2:0.4,1:2:0.8, 
1:2:1.2,1:2:1.6,1:2:2) 
Trace 7 : DNA: riboflavin (• • •) (molar ratio 1:2) 
Trace 8-9 : DNA: riboflavin: 5-fluorouracil (molar ratio 1:2:2.4 and 
1:2:2.8) 
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Figure 25: Absorption spectra of riboflavin treated calf thymus DNA with 
5-fluorouracil. 
Calf thymus DNA (in Tris-HCl, pH 7.4) was incubated with riboflavin and 
increasing concentrations of 5-fluorouracil and irradiated for 60 minutes in 
fluorescent light. 
Traces from 
Trace 1 
Trace 2 
Traces 
Trace 4 
Trace 5 
Trace 6 
Trace 7 
Trace 8 
Trace 9 
top to bottom are 
: DNA alone (25 fiM) 
: CDNA/CR/CF=1:2:0.4 
:CDNA/CR/CF=1:2:0 .8 
: CDNA/CR/CF=1:2:1.2 
: CDNA/CR/CF=1:2:1.6 
:CDNA/CR/CF=1:2 :2 
: C D N A / C R = 1 : 2 ( - ) 
: CDNA/CR/CF=1:22 .4 
:CDNA/CR/CF=1:2:2 .8 
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Figure 26: Agarose gel electrophoretic pattern of EB stained pUC 18 
DNA after treatment with riboflavin and 5-fluorouracil in the 
presence of light. 
Each reaction mixture containing 0.50 \ig pUC 18 DNA, 10 mM Tris-
HCl (pH 7.5), riboflavin (50 nM) and indicated concentration of 
5-fluorouracil was irradiated in fluorescent light for 60 minutes. 
Electrophoresis was performed as mentioned in "Methods". SC, 
supercoiled DNA; OC, open circular. 
Lane a 
Laneb 
Lane c-g 
Laneh 
DNA alone 
DNA-riboflavin (50 nM) 
DNA-riboflavin-5-fluorouracil (10-50 \iM) 
DNA-5-fluorouracil (50 \iM) 
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trivially affected by the incorporation of 5-fluorouracil (higher concentrations) in 
the reaction medium. Free radicab pcirticipate in the oxidation of the deoxyribose 
moiety, followed by hydrolytic cleavage of the sugar phosphate backbone 
(Marfey & Robinson, 1981). With 5-fluorouracil behaving in a biphasic pattern, it 
is inappropriate to assume tiie drug scavenging free radicals produced by 
riboflavin. This implies that inhibition/no effect on DNA cleavage by 5-fluorouracil 
is dictated by mechanism distinct from scavenging of free radicals. The binding 
of 5-fluorouracil alone to DNA is appreciably strong. It does not present cleavage 
activity towards DNA (fig, 26, lane h). Henceforth, it can be concluded that its 
therapeutic efficiency seems not to come from the damage to DNA but from the 
high affinity of the drug towards DNA, From the above cited results, it can be 
imderstood that the drug when used in lower concentrations retards the 
photoexcitation potential of riboflavin. Nevertheless, a differing occurs with drug 
at higher ratios. It is possibly related to the intermolecular interaction of 5-
fluorouracil molecules rather than with riboflavin. 
(nb)27, ''Breakage of calf thymus DNA" 
Riboflavin decreased the melting temperature of DNA suggesting DNA 
degradation, in the presence of light (Ion et al., 2001). To gain more information 
on the nature of protection 5-fluorouracil imparts to riboflavin mediated 
degradation, DNA hydrolysis was recorded after addition of increasing amounts 
of 5-fluorouracil. A representative DNA hydrolysis profile obtained after addition 
of increasing amoimts of 5-fluorouracil to riboflavin-DNA samples is specified in 
fig. 27. The destabilization of DNA double helix caused by riboflavin was 
significantly lowered over the tested concentration range of 10-50 fiM, A clear 
decrease in the initial stage of the reaction continued by a regular and less 
pronoimced increase was noticed. Though this increase detected was lower than 
the riboflavin treated DNA. In terms of 5-fluorouracil alone, DNA hydrolysis 
145 
was not substantial. From inspection of this data it can be inferred that 5-
fluorouracil alone does not induce destabilization of DNA double helix. In 
addition, it provides hindrance to riboflavin mediated reaction. This inhibition is 
not favorable at higher ratios of the drug. 5-Fluorouracil when used in the 
concentration range of 1-10 pM led to information similar to that observed at 10 nM. 
There was a change in the pattern only after the concentration increased; at 60 jiM 
and further this change is negligible and remains constant compared to % 
hydrolysis noted in riboflavin treated DNA. These results reinforce the behavior 
of 5-fluorouracil in case of proteins and is in good accordance with them. 
(IIb)28. "Generation of hydroxylradicaV' 
DNA strand breakage by reactive oxygen species (ROS) is considered to 
be involved in severe pathologies (Cerutti, 1991). ROS include singlet oxygen QOi), 
superoxide anion (Oj), hydrogen peroxide (H2O2) and hydroxyl radical (OH") 
that are generated by enzymatic and non-enzymatic reaction in cells (Halliwell & 
Gutteridge, 1999). It is notable to mention here that photosensitized DNA 
damage participates in solar-UV carcinogenesis, photogenotoxicity and photo-
toxicity. Some of these species are less reactive than others, for instance H2O2 and 
O 2 react with few molecules in the human body while OH is very reactive. As 
the OH radical has a short half life in the range of 7x10-^ ° seconds, location of the 
formation of OH radical in the cell, is therefore of utmost importance. OH is 
considered to be the ultimate specie responsible for DNA damage. Thus, a 
possible inhibitor of such damage may serve as a preventive agent (Ames et al, 
1995). Riboflavin upon illumination produces OH radical In fig. 28, 5-fluorouracil 
displayed an inhibition in OH generation capacity of riboflavin. It explains that 
5-fluorouracil diminishes photodegradation of proteins and DNA by an analogous 
series of reactions. As seen, 5-fluorouracil at lower concentratioiis masks the 
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Figure 27: S-Fluorouracil mediated inhibition of photo-induced cleavage 
of calf thymus DNA by riboflavin as measured by the degree of single 
strand specific nuclease digestion. 
Calf thymus DNA (500 ng) and increasing concentrations of 5-fluorouraciI 
in 0.5 ml reaction mixtures containing 10 mM Tris-HCl (pH 7.5) were 
incubated in presence (o) or absence (n) of riboflavin (50 \iM) in fluorescent 
light for 60 minutes. Single strand specific digestion was performed as 
described in "Methods". Results are expressed as mean ± SEM cf three 
independent experiments. 
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Figure 28: Hydroxyl radical generation by riboflavin in the presence of 
5-fluorouracil; with light. 
Reaction mixture (0.5 ml) containing calf thymus DNA (100 (xg) as 
substrate, riboflavin (50 nM) with indicated concentrations of 5-fluorouradl 
was incubated in fluorescent light for 60 minutes. Hydroxyl radical 
formation was measured by determining the TBA reactive material as 
described in "Methods". Results are expressed as mean ± SEM of three 
independent experiments. 
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photoexcitation of riboflavin. The behavior is apparently biphasic when in 
mixture with photoilluminated riboflavin. 
(IIb)29. ^T>NA breakage in lymphocytes as measured by 
comet assay' . " 
Riboflavin is a direct acting genotoxic agent in its active state. This was 
demonstrated with comet assay previously (Fig. 16). In screening of human 
lymphocytes by comet assay, 5-fluorouracil alone did not cause any damage per 
se with 60 minutes of incubation but there was a minor rise with increase in time 
of incubation in fig. 29(i). Cells treated with riboflavin and 5-fluorouracil showed 
various results: while lower ratios reduced DNA damage considerably as in fig. 
29(ii), higher ratios apparently had no effect as evident in fig. 29(iii). In fig. 29(ii), 
an increase in time of incubation gave a slight but regular increase in damage as 
anticipated. Decreased damage is associated with decreased tail DNA content 
and indicates a protective eff^ ect of pretreatment. This denotes that lower doses of 
drug may be more beneficial than higher doses for reducing serwitizer mediated 
damage. When the ratio of drug:riboflavin increases from 1:1, the combination 
operates in a pattern it would in the absence of 5-fluorouracil. It is possible that 
the imbalance generated by riboflavin does not allow the intervention of 5-
fluorouracil (higher ratios) and consequentiy leads to damage. It is also 
maiiifested from this information that the incubation length (in Ught) of a 
mixture of 5-fluorouracil, riboflavin and subsfrate is equally pertinent. For this 
reason, the 60 minutes incubation time used is relevant and effective in curtailing 
the phototoxicity of riboflavin. These results put forward a modulated role of 5-
fluorouracil in the genotoxic cause of riboflavin. In situ data is in agreement with 
in vitro experiments attained earlier. This modulated effect on DNA damage has 
been observed previously wherein vitamin C (at lowest dose) reduced DNA 
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damage induced by methyl methanesulfonate but higher doses had no effect 
(Franke et al., 2005). In this case a vitamin had an unexplained effect on an 
alkylating agent mediated imbalance whereas in our studies the prejudicial 
action of vitamin was impeded within limits by the drug. 
(IIb)30. ^T>etemiination of TEARS as a measure of oxidative 
stress in lymphocytes' -// 
The microbiological trials conducted by Yamane et al. (1993) elucidated 
that the growth of Arthrobacter sp. was inhibited by 5-fluorouracil and the 
inhibition was reversed by riboflavin. Their studies were indicative of 
concentration dependent pattern towards each other. Oxidant challenge can 
stimulate potentially mutagenic DNA damage for instance by direct action of 
ROS on DNA or indirectly via aldehydic lipid peroxidation degradation products 
(Collins, 1999). To establish the production of ROS at cellular levels, the 
formation of TEARS was analyzed. Although 5-fluorouracil alone did not lead to 
considerable formation of TEARS in the presence of light, the combination of 
riboflavin and 5-fluorouracil was discrete. The dose independent impact in fig. 30 
was in accordance with prior radical formation study in vitro. 
Studies have shown that dietary riboflavin and a-tocopherol enhances the 
repair enzyme activity and modulates the carcinogen induced DNA damage. 
Ansari et al. (2006) have suggested by utilizing comet assay that a combination of 
riboflavin and a-tocopherol provides protection against argemone oil/sanguinarine 
induced genotoxicity. Cellular constituents can display beneficial/noxious effiects 
depending on cellular conditions. A chemo-prevention of photosensitized DNA 
damage is one of the most important methods for curtailing phototoxic effects 
(Hirakawa et al., 2005). As well, it augments the pharmacological span of drugs. 
150 
5n 
E 3H 
3. 
c 2 
1 ; 
; - - ' ^ 
,,^ -i 
--A 
/ 
a— 
f i——i 
— I — 
10 
— I — 
20 
— I — 
30 
— I — 
40 50 
5-Fluorouracil {\M) 
Figure 29(i): DNA breakage by 5-fluorouracil in human peripheral 
lymphoq^tes as measured by comet assay. 
Reaction mixture (1 ml) containing IxlQs cells, RPMI (400 id), PBS 
(Ca2+ and Mg2+ free) was incubated with indicated concentrations of 
5-fluorouracil for 60 minutes (—) or 12 hrs (-—). The reaction mixture was 
incubated at 37 °C for 30 minutes and processed hirther for comet assay 
as described in "Methods". 
Comet tail length (fimeters) plotted as a function of increasing 
concentrations of 5-fluorouracil (10-50 jiM). Results are expressed as 
mean ± SEM of three independent experiments. 
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Figure 29(ii): Inhibition of riboflavin induced DNA breakage by 
5-fluorouracil in htunan peripheral lymphocytes as measured by 
comet assay. 
Reaction mixture (1 ml) containing IxlQs cells, RPMI (400 \il), PBS 
(Ca^ * and Mg^ * free), riboflavin (50 nM) and indicated concentrations of 
5-fluorouracil was irradiated in fluorescent light for 60 minutes (~) or 
12 hrs (—). The reaction mixture was processed further for comet assay 
as described in "Methods". 
Comet tail length (funeters) plotted as a function of increasing 
concentrations of 5-fluorouracil (10-50 \iM) in the presence of 50 nM 
riboflavin. Results are expressed as mean ± SEM of three independent 
experiments. 
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Figure 29(m): Riboflavin induced DNA breakage in the presence of 
S-fluoroiuracil in human peripheral lymphocytes as meastu-ed by 
comet assay. 
Reaction mixture (1 ml) containing IxlQS cells, RPMI (400 \LI), PBS 
(Ca2+ and Mg^ ^ free), riboflavin (50 (xM) and indicated concentrations of 
5-fluorouracil was irradiated in fluorescent light for 60 minutes. The 
reaction mixture was processed further for comet assay as described in 
"Methods". 
Comet tail length ([imeters) plotted as a function of increasing 
concentrations of 5-fluorouracil (50-200 nM) in the presence of 50 |xM 
riboflavin. Results are expressed as mean ± SEM of three independent 
experiments. 
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Figure 30: TBARS generated by incubation of lymphoqrtes with photo-
illuminated riboflavin and 5-fluorouracil. 
The isolated ceUs (IxlQS) suspended in RPMI 1640 were incubated in 
fluorescent light for 60 minutes imder different conditions. After pelleting, 
the cells were washed twice with PBS (Ca^ and Mg^ free) before proceeding 
as described in "Methods". Results are expressed as mean ± SEM of three 
independent experiments. 
Barl 
Bar 2 
Bar 3 
Bar 4 
Bar 5 
Bar 6 
Bar 7 
Bar 8 
: control 
: riboflavin alone (50 fiM) 
: 5-fluorouracil alone (50 nM) 
: riboflavin: 5-fluorouracil (molar ratio 1:0.2) 
: riboflavin: 5-fluorouracil (molar ratio 1:0.4) 
: riboflavin: 5-fluorouracil (molar ratio 1:0.6) 
: riboflavin: 5-fluorouracil (molar ratio 1:0.8) 
: riboflavin: 5-fluorouracil (molar ratio 1:1) 
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There is an assortment of intracellular mechanisms for DNA protection 
(Yu, 1994). Direct interaction between the test agent and DNA. Also, indirect 
DNA protection mediated via interaction \vith intracellular components for 
iiwtance, by activation of intracellular enzymes, intracellular modification of test 
agent or scavenging of ROS may play a role. The result is decreased cell burden 
of genotoxic products. Taken together, it is quite likely that the modulated role of 
5-fluorouracil against riboflavin induced genotoxicity could be due to 
intracellular processes involving interaction/modification of light activated 
riboflavin by 5-fluorouracil. Possibly, the photosensitization reaction is inhibited 
curbing the normal cascade of photoreactions followed by riboflavin and 
lesserving the genotoxic effiect in turn. 5-Fluorouracil at higher levels does not 
cooperate in vitro/cellular adaptation towards oxidant challenge. 
The existence of correlation between photo- and chemo-therapy could 
have an outcome of important clinical implications which would tailor the choice 
of therapy to individuals, increasing the potential for antitumor activity while 
reducing unnecessary toxicity in those who are unlikely to benefit. The momentous 
current need and significance of photo- and chemo-therapy could be benefited 
but with due care to the toxic potentials of both. 
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/ / CHAPTER Iir 
^Riboflavin & Drugs^ 
(111)31. ^Hiboflavin absorption character^' 
Spectroscopy and photophysics of flavin related compounds deserve 
much attention from a variety of points of view. This parameter is the one most 
drastically changed by photoexcitation as compared to the ground state. All 
flavins show strong absorption in the blue and ultraviolet region of the spectrum. 
It is well known that riboflavin in aqueous medium gives an absorption 
spectrum consisting of 4 peaks at 220, 266, 373 and 440 run (Zhao et aL, 2006). 
Distinct changes occur in the spectrum of riboflavin upon photosensitization as 
noticed in fig. 31 (i). It reflects the occurrence of chemical alteratior\s due to 
photodecomposition of riboflavin. No spectral changes were observed in the 
absence of light 
For analyzing the effect of cisplatin on riboflavin, the spectrum was 
recorded by titrating riboflavin with cisplatin. Fig. 31(ii) is the representation of 
riboflavin-cisplatin in the dark conditions. In fig. 31(iii), the absorption spectrum 
of riboflavin suffers a number of perturbations in the presence of cisplatin 
(examined up to 150 ^M cisplatin) that do not obey to the simple addition of the 
individual spectra of both components of the mixture. It is perceptible from fig. 
31(iii) that there is a concenfration dependent elevation in the peak of the 
mixture. The resultant specfra reveals that the two absorption bands of riboflavin 
in the visible region at 370 and 440 nm increase in inteiisity with increase in 
concenfration of cisplatin. The species absorbing in this region should be 
ascribed to the complex riboflavin-cisplatin. Perchance, the photodecomposition 
of riboflavin is plausibly inhibited or simply inactivation of the photosensitizer 
via interaction. Similar changes in the spectrum of riboflavin are caused by 
phenol and its derivatives-adenosine, caffeine and other compounds which show 
complexing ability towards riboflavin (Datta et al., 2005). The outcome reached is 
in good agreement with the data jot down previously and further authenticates 
the reduction in decay of riboflavin. Complex formation was also evident in the 
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case of 5-fluorouracil in the dark in fig. 31 (iv). In fig. 31 (v), lower concentrations 
of 5-fluorouracil reduced the photosensitization of riboflavin while the higher 
concentrations had no significant effect. The result is in accord with the data 
observed in protein and DNA damage. 
(111)32. ^^Riboflavin fluorescence character" 
Flavins exhibit an intense greenish yellow fluorescence and this property 
is widely used for their characterization and determination. The fluorescence 
emission spectra of flavins are a broad, structure less band with maxima of about 
530 run, slightiy shifted for individual flavin species. The fluorescence intensity 
of flavins is restricted by many factors; cumulatively termed as "quenching". It is 
noteworthy to bring into consideration the formation of complexes between 
flavins and other species as the most relevant judgement inferred from the 
quench observed. Fig. 32(i) is a clear indication of riboflavin being 
phototransformed with increasing length of time. 
Binding of cisplatin to riboflavin was studied by the effiect of increasing 
cisplatin molar ratios on the fluorescence emission spectrum of riboflavin. The 
result in fig. 32(ii) describes binding action as addition of cisplatin causes 
quenching of fluorescence. These results are in support of the absorption studies 
conducted above wherein formation of riboflavin-drug complex was demonstrated. 
Taking into account the emission spectium of riboflavin in its photoilluminated 
state and cisplatin, the progressive rise in intensity in fig. 32(iii) implies 
illumination mediated stionger binding and prominent reversion towards the 
native fluorescence of riboflavin. Fig. 32 (iv) is a representation of riboflavin and 
5-fluorouracil interaction demonstrated in dark conditions. In the presence of 
radiation in fig. 32 (v), 5-fluorouracil presented a concentration dependent minor 
reversion to native state of riboflavin. 
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Figure 31(i): Absorption spectra of riboflavin under different conditions. 
Spectrum of riboflavin alone (50 fiM) was read before and after 
illumination in fluorescent light for 60 minutes. The spectrum was 
recorded between 300-500 nm. AH reactions were carried out in 10 mM 
phosphate buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : Zero time 
Trace 2 : 60 minutes 
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Figure 31(ii): Absorption spectra of riboflavin with cisplatin. 
The reaction mixture containing riboflavin (50 \iM) and increasing 
concentration of cisplatin was incubated. The spectrum was recorded 
between 300-500 nm. All reactions were carried out in 10 mM phosphate 
buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : riboflavin: cisplatin (1:3) 
Trace 2 : riboflavin alone (—) 
Trace 3 : riboflavin: cisplatin (1:2) 
Trace 4 : riboflavin: cisplatin (1:1) 
Trace 5 : riboflavin: cisplatin (1:0.5) 
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Figure 31(iii): Absorption spectra of riboflavin with cisplatin on photo-
illumination. 
The reaction mixture containing riboflavin (50 \iM) and increasing 
concentration of cisplatin was incubated. The spectrum was recorded 
between 300-500 nm after illumination in fluorescent light for 60 minutes. 
All reactions were carried out in 10 mM phosphate buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : riboflavin: cisplatin (1:3) 
Trace 2 : riboflavin: cisplatin (1:2) 
Trace 3 : riboflavin: cisplatin (1:1) 
Trace 4 : riboflavin: cisplatin (1:0.5) 
Trace 5 : riboflavin alone 
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Figure 31(iv): Absorption spectra of riboflavin with 5-fluorouracil. 
The reaction mixture containing riboflavin (50 \JM) and increasing 
concentration of 5-fluorouracil was incubated. The spectrum was 
recorded between 300-500 nm. All reactions were carried out in 10 mM 
phosphate buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : riboflavin: 5-fluorouracil (1:1) 
Trace 2 : riboflavin: 5-fluorouracil (1:0.8) 
Trace 3 : riboflavin: 5-fluorouracil (1:0.6) 
Trace 4 : riboflavin: 5-fluorouracil (1:0.4) 
Trace 5 : riboflavin: 5-fluorouracil (1:0.2) 
Trace 6 : riboflavin alone 
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Figure 31(v): Absorption spectra of riboflavin with 5-fluorouracil 
on photoillumination. 
The reaction mixture containing riboflavin (50 fiM) and increasing 
concentration of 5-fluorouracil was incubated. The spectrum was 
recorded between 300-500 nm after illumination in fluorescent light 
for 60 minutes. All reactions were carried out in 10 mM phosphate 
buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : riboflavin: 5-fluorotiracil (1:0.2) 
Trace 2 : riboflavin: 5-fluorouracil (1:0.4) 
Trace 3 : riboflavin: 5-fluorouracil (1:0.6) 
Trace 4 : riboflavin alone 
Trace 5 : riboflavin: 5-fluorouracil (1:0.8) 
Trace 6 : riboflavin: 5-fluorouracil (1:1) 
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Figure 32(i): Fluorescence spectra of riboflavin under different conditions. 
Spectrum of riboflavin alone (50 nM) was read after illumination in 
fluorescent light for different time intervals. Riboflavin was excited at the Xexc 
of 330 nm and the emission spectra recorded between 480 and 540 run. 
Traces from top to bottom are 
Trace 1 
Trace 2 
Trace 3 
Trace 4 
Trace 5 
: Zero time 
: 15 minutes 
: 30 minutes 
: 45 minutes 
: 60 minutes 
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Figure 32(ii): Fluorescence spectra of riboflavin with cisplatin. 
The reaction mixture containing riboflavin (50 i^M) and increasing 
concentration of cisplatin was incubated. Each sample was excited at the 
Xexc of 330 nm and the emission spectra recorded between 480 and 540 imi. 
Traces from top to bottom are 
Trace 1 : riboflavin alone 
Trace 2 : riboflavin: cisplatin (1:0.5) 
Trace 3 : riboflavin: cisplatin (1:1) 
Trace 4 : riboflavia* cisplatin (1:2) 
Trace 5 : riboflavin: cisplatin (1:3) 
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Figure 32(iii): Fluorescence spectra of riboflavin with cisplatin on 
photoillumination. 
The reaction mixture containing riboflavin (50 nM) and increasing 
concentration of cisplatin was incubated. The spectrum was read after 
illumination in fluorescent light for 60 minutes. Each sample was 
excited at the Xexc of 330 nm and the emission spectra recorded between 
480 and 540 nm. 
Traces from top to bottom are 
Trace 1 : riboflavin alone (dark) 
Trace 2 : riboflavin: cisplatin (1:3) 
Trace 3 : riboflavin: cisplatin (1:2) 
Trace 4 : riboflavin: cisplatin (1:1) 
Trace 5 : riboflavin: cisplatin (1:0.5) 
Trace 6 : riboflavin alone (• • •) (light) 
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Figure 32(iv): Fluorescence spectra of riboflavin with S-fluoroiuracil. 
The reaction mixture containing riboflavin (50 \iM) and increasing 
concentration of S-fluorouradl was incubated. Each sample was excited 
at the Xexc of 330 nm and the emission spectra recorded between 480 
and 540 nm. 
Traces from top to bottom are 
Trace 1 : riboflavin alone 
Trace 2 : riboflavin: 5-fluorouracil (1:0.2) 
Trace 3 : riboflavin: 5-fluorouracfl (1:0.4) 
Trace 4 : riboflavin: 5-fluorouracil (1:0.6) 
Trace 5 : riboflavin: 5-fluorouracil (1:0.8) 
Trace 6 : riboflavin: 5-fluorouradl (1:1) 
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Figure 32(v): Fluorescence spectra of riboflavin with 5-fluorouracil 
on photoillumination. 
The reaction mixture containing riboflavin (50 nM) and increasing 
concentration of 5-fluorouracil was incubated. The spectnun was read 
after illumination in fluorescent light for 60 minutes. Each sample was 
excited at the \e:.c of 330 nm emd the emission spectra recorded between 
480 and 540 nm. 
Traces from top to bottom are 
Trace 1 : riboflavin alone (dark) 
Trace 2 : riboflavin: 5-fluorouracil (1:0.2) 
Trace 3 : riboflavin: 5-fluorouracil (1:0.4) 
Trace 4 : riboflavin: 5-fluoroiu"acil (1:0.6) 
Trace 5 : riboflavin alone (• • •) Gight) 
Trace 6 : riboflavin: 5-fluorouracil (1:0.8) 
Trace 7 : riboflavin: 5-fluorouracil (1:1) 
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(111)33. "Cisplatin absorption character'^ 
Fig. 33(i) shows the absorption spectra of the drug cisplatiit in phosphate 
buffer (pH 7.5). The spectra shows intense absorption band in 200~300 nm (hence 
shown) and less intense bands at 425~445 nm. The spectrum depiction is in 
soimd accord with reference to previous spectroscopic work on platinum(II) 
complexes (Haider et al., 20ff/). In general, the d-shells o( transition Tneia\ ions axe 
a rich source of electronic transitions in the visible region of the spectrum. 
Particularly intense transitions can arise from ligand to metal or metal to ligand 
charge transfer (LMCT & MLCT) (Bednarski et al., 2006). 
Radiation therapy has been the mainstay of nonsurgical treatment of 
cancer for over a century (Bemier et al., 2004), whereas chemotiierapy has 
developed more recently (Bengtson & Rigas, 1999). It is over a quarter of a 
century since potential interactions between radiation and chemotiierapy were 
initially described (Steel, 1979), yet precis mechanisms imderlying the potentiation of 
radiation by chemotherapeutic agents are still not fully understood. Despite 
these gaps in knowledge, combination of radiation and chemotiierapy have 
become the standard of care for the majority of patients with solid tumors based 
on improvements in loco regional disease control and siuvival (Wilson et aL, 2006). 
Cisplatin is the most widely used anticancer agent in combination with radiation 
(Wilson et al., 2006). Combination therapy with cisplatin arid radiation appears 
to be more effective than radiotherapy alone (Ho et aL, 2006). Photoactivation of 
cisplatin was reported to elicit an extra number of DNA breaks that stimulate 
RAD51-mediated repair pathways (Corde et al., 2003). There is active clinical 
research investigating the combination of radiation with platinum analogs (Singh 
& Turro, 2004). Side effects of platinum anticancer agents have been avoided by 
employing light to cause photochemical changes in non-toxic platinum pro-
drugs that release active antitumor agents (Kratochwil et al., 1996). Photo-
activated trans-diammine platinimi complex has been foimd to be non-toxic to 
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human skin ceUs (keratinocytes) in the dark, but were as q^totoxic as cisplatin on 
irradiation for a short time (50 min), as detected by DNA damage using comet 
assay (Mackay et al., 2006). 
Platinum(n) complexes such as cisplatin offer possible reactivity such as 
interactions leading to photochemical sensitivity (Kratochwil et al., 1996). 
Photochemical transformations are monitored by UV spectroscopy. The effect of 
light on the stability of the complex was investigated. The drug was stable in 
phosphate buffer (pH 7.5) in the dark at 37 °C (fig. 33(i)) but negUgible variation 
arose in the presence of light. The effect was prominent in the presence of 
riboflavin. Riboflavin with radiation led to enhanced complexation and 
photoinitiated alteration of cisplatin in fig. 33(ii). Photoinactivation by riboflavin 
is analogous to photodynamic therapy and has been used by several research 
groups for instance the photosei«itization of pyocyanin, the virulence factor of 
Pseudomonas aeruginosa (Reszka et al., 2006) and ophthalmic drugs Timolol, 
Pindolol (Criado & Garcia, 2004), Mitomycin C (Yajima & Mizunoya, 1981). The 
use of cisplatin is limited because of its toxicity in normal tissues (Rosenberg, 
1985). Many anticancer agents are tmable to distinguish tumor cells from normal 
cells which leads to their serious deleterious effect of killing both normal and 
cancer cells and perhaps responsible for their observed toxicity. Recently, various 
methods have been reported for protecting normal cells from cytotoxicity of 
chemofherapeutic agents. The decreasing intensity in fig. 33(ii) is possibly due to 
photoinactivation of drug. The nub of toxicity could be curtailed if the drug is 
rendered inactive in normal cells; consequently the drug losing its characteristic 
properties including cytotoxicity. It has been reported earlier that the interaction 
between drugs and radiation is usually dose and time dependent and rarely 
specific to tumor cells (Wilson et al., 2006), Thus, riboflavin induced 
photoinactivation of cisplatin would not reduce the therapeutic effectiveness of 
the drug in tumor cells as the modality is restricted to normal cells. Some of the 
most successful future cancer therapy regimen will likely involve photod)mamic 
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therapy with sensitizers of diverse types. Simplifying, riboflavin possibly photo-
complexes cisplatin into an inactive form which impedes the core capacity 
assigned with the drug and hence the reduced production of radical species 
observed in fig. 17 (ii). This inactive mode restrained photoexcitation and ROS 
production from riboflavin as perceived in the preceding chapters. 
(111)34, ^^5-Fluorouracil absorption character" 
Untreated 5-fluorouracil has an absorbance maximum at 265 nm as seen in 
fig. 34(i). Irradiation of neat 5-fluorouracil led to significant alteration in its 
absorption spectra. The drug displays a wide blue shift from 265 run to 200 nm. 
The variation in absorption is dependent on the length of incubation. 
Categorically, the change in maxima is notable at 12 hrs and only decrease in 
curve intensity occurs in 1 hr. For additiorial investigation the spectrum was 
recorded in the presence of sensitizer. There is visible complex formation but no 
major increase/decrease in intensity states no significant effect is caused by 
irradiating drug with riboflavin as illustrated in fig. 34(ii). The drug operated in a 
manner it would in the absence of riboflavin. 
(UI)35. "Treatment of red blood cells" 
The mammalians red blood cell (RBC) affords a simple, experimentally 
accessible and useful whole cell for the study of many biological processes. It 
originates from the bone marrow as nucleated precursor that loses all the 
organelles and several cytoplasmic proteins during maturation through an 
intricate process of differentiation. RBC represents a simple form of cell whose 
structure and function has been well established. Another striking feature of RBC 
that enabled us to use it as a model for studying the photosensitized riboflavin-
drug mediated consequences was due to the fact that exposure of cells to 
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Figure 33(i): Absorption spectra of cisplatin under different conditions. 
Spectrum of cisplatin alone (50 \iM) was read before and after illumination 
in fluorescent light for 60 minutes. The spectrum was recorded between 
200-300 nm. All reactions were carried out in 10 mM phosphate buffer 
pH 7.5. 
Traces from top to bottom are 
Trace 1 : Zero time 
Trace 2 : 60 minutes 
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Figure 33(ii): Absorption spectra of cisplatin with riboflavin. 
Spectrum of reaction mixture containing cisplatin (50 jiM) and riboflavin 
(50 jiM) was read before and after illiunination in fluorescent light for 60 
minutes. The spectrimi was recorded between 200-300 nm. All reactions 
were carried out in 10 mM phosphate buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : cisplatin alone 
Trace 2 : cisplatin: riboflavin (dark) 
Trace 3 : cisplatin: riboflavin (light) 
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Figure 34(i): Absorption spectra of 5-fluorouracil luider different conditions. 
Spectrum of 5-fluorouracil alone (50 \iM) was read before and after 
illumination in fluorescent light for 60 minutes. The spectrtun was recorded 
between 160-300 nm. All reactions were carried out in 10 mM phosphate 
buffer pH 7.5. 
Traces from top to bottom are 
Trace 1 : Zero time 
Trace 2 : 60 minutes 
Trace 3 :12 hrs 
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Figure 34(ii): Absorption spectra of 5-fluorouracil with riboflavin. 
Spectrum of reaction mixture containing 5-fluorouracil (50 nM) and 
riboflavin (50 \iM) was read before and after illmnination in fluorescent 
light for 60 minutes. The spectrum was recorded between 160-300 nm. 
All reactions were carried out in 10 mM phosphate buffer pH 7.5, 
Traces from top to bottom are 
Trace 1 : 5-fluorouracil alone 
Trace 2 :5-fluorouracil: riboflavin (dark) 
Trace 3 : 5-fluorouracil: riboflavin (light) 
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Figure 35(i): Scan electron microscopy of RBC. 
Reaction mixture containing RBC (0.5% hematocrit), riboflavin (50 M^M) a n d / 
or indicated concentration of cisplatin was irradiated in fluorescent light for 
60 minutes. The reaction mixture was processed further for SEM as described 
in "Methods". 
Photographs obtained after the above treatment of cells. 
{A} 
{B} 
{C} 
{D} 
untreated 
riboflavin (50 ^M) 
cisplatin (150 i^M) 
riboflavin: cisplatin (molar ratio 1:3) 
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Figure 35(ii): Scan electron microscopy of RBC. 
Reaction mixture containing RBC (0.5% hematocrit), riboflavin (50 ^M) a n d / 
or indicated concentration of 5-fluorouracil was irradiated in fluorescent light 
for 60 minutes. The reaction mixture was processed further for SEM as described 
in "Methods". 
Photographs obtained after the above treatment of cells. 
{A} 
{B} 
{C} 
untreated 
5-fluorouracil (10 \xM) 
riboflavin: 5-fluorouracil (molar ratio 1:0.2) 
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activated oxygen is an inevitable result of aerobic existence. The reaction of 
sensitizer with medicament attracts attention since drugs are usually administered 
intravenously. Furthermore, riboflavin-aminophylline has been found to induce 
hemolysis in human red blood cells ( M & Naseem, 2002). Aminophylline is a 
routinely used drug by asthmatic patients. Hence, drugs can enhance/deplete 
the photooxidative potential of the sensitizer. Fig. 35(i)(B) demonstrates the end 
result of active sensitizer on RBC. The illustrations are markedly different in 
morphology. There is an apparent structural change evidenced in terms of the size 
and aberrations. Fig, 35(i)(C) witnesses the change in cells by tieatment with 
drug cisplatin. The cells obtain a concave shape different from the regular 
circular shape as in control (fig. 35 (i)(A)). Change in contour length and slight 
overlapping is also displayed. Hematologic toxicity with changes in the 
biological functions of blood cells associated with cisplatin is well documented 
(Olas et aL, 2006). Fig. 35(i)(D) is the outcome observed with combined effect of 
platinum drug and sensitizer on the cell. RBC surface appears alike to that of 
control. The result is disparate when compared to riboflavin/drug alone which 
implies individual effects changing drastically by interaction dependent 
transformations. Fig. 35(ii)(B) is a representation of 5-fluorouracil acting alone on 
RBC. Though the size of the cell is relatively smaller than the control, the effect is 
slight Fig. 35(ii)(C) depicts 5-fluorouracil-riboflavin together, with insignificant 
pitting on the cell surface. The illustiations are in accordance with previous data. 
(111)36, ^^Attenuated Total Reflection spectrum" 
The hydrolytic reactions of Pt(II) complexes £u-e usually moiutored in 
aqueous solutions using Attenuated Total Reflection (ATR) since Infra Red (IR) 
spectroscopy suffers from strong vibrations of water. The ATR spectrum of pure 
riboflavin exhibits broad bands at 1700 cm-i due to the presence of carbonyl 
* 
"groups and two medium to stiong intensity bands in the 1608-1570 cm-^  region 
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due to u(C=N) pyrimidine and u(C=C) + o(C=N) composite bands. These bands 
suffer a slight red shift on photoillumination for the time period of 60 min (Table I). 
Nevertheless, when riboflavin (50 jiM) is photoilluminated with cisplatin 
in the reaction medium, a bathochromic shift is observed which decreases with 
increasing concentrations of cisplatin. A similar effect is observed for the 
pyrazinium and pyridinium nitrogen of riboflavin as seen in table I. Few medium 
to weak intensity bands are also observed in the far IR-region on addition of 
cisplatin. A medium to weak intensity band is observed at 506 cm-^  which may 
be attributed to the u(Pt-N) stretching vibrations. Similarly, a solitary broad band 
is observed at about 294 cm-^  which may be assigned to asymmetric u(Pt-Cl) 
stretching vibration. These bands are in close proximity with those observed by 
other workers (Michalska & Wysokinski, 2005). Moreover, these bands remain 
unaffected throughout. 
Diagnostic IR frequencies of 5-fluorouracil alone and its various mixtures 
with riboflavin, in the presence of light are given in table II. The intensity of 
characteristic bands of both drugs (alone) do not change on photoreaction. The 
ATR spectroscopy of neat 5-fluorouracil exhibits strong intensity bands at 1710 
and 1595 cm-i due to u(C2=0) and 0(0=0) groups respectively. In addition, two 
closely spaced sharp medium intensity bands were observed at 1512 and 1430 cm-i 
that may be ascribed to i)(Ni-H) and u(N3-H) groups and a sharp solitary band at 
1470 cm-^  assigned to u(C-F) group. From the table n it may be inferred that on 
addition of 5-fluorouracil, the bands observed for the mixture are comparable to 
that noticed for native riboflavin. It is also evident that this reaction is concentration 
specific and occurs at below/equimolar concentrations of 5-fluorouracil. 
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A natural daylight-absorbing pigment of particular interest is Vitamin B2 or 
riboflavin which is present in all aerobic cells. It serves as an efficient 
photosensitizer, presenting a complex photochemistry with toxic effect to the 
biomolecules ubiquitously present in the cell (Edwards & Silva, 2001). It has been 
postulated as a viable sensitizer for the in vivo photo-oxidative degradation of 
numerous naturally relevant/externally added substrates in diverse organisms 
(Heelis, 1982). The photodynamic action of riboflavin is generally considered to 
involve the generation of reactive oxygen species (Ali et aL, 2000). Irradiation of 
riboflavin produces several reactive oxygen species; riboflavin radicals through 
Type I reaction and singlet oxygen, superoxide, peroxide and hydroxyl radical 
through Type n reaction. Among them is hydrogen peroxide which has a long 
half life, relatively large diffusion radii which assists its penetration through the 
cell membranes freely (Edwards & Silva, 2001). Exposure of cells to oxygen 
radicals and the consequent damage is therefore, inseparably associated with the 
life processes. Antioxidant defense goes astray when the cells become deficient in 
enzymes that maintain reducing potential of the cell or when challenged with 
strong oxidants or under severe oxidative stress (Tabatabaie & Floyd, 1994). 
Reactive oxygen species have been suggested as causal factors in 
mutagenesis, carcinogenesis and tumor promotion and have been implicated in 
the etiology and pathophysiology of many human diseases. The combined effects 
of stimulatory factors (hormones, cytokines), stress mediators (oxygen radicals) 
and exogenous aggressions (viruses, radiation and xenobiotic compoxmds) can 
ii\fluence the control of cellular proliferation and lead to tissue transformation 
(Garry et al., 2000). Nevertheless, greater production of ROS has been shown to 
be causative of increased oxidative DNA damage. Indeed, DNA damage induced 
by oxidative stress and/or deficient DNA repair may have etiological or 
prognostic role in cancer development (Mussarat et al., 1996). 
There is considerable evidence that ultraviolet radiation (UV) from 
simlight is implicated in skin carcinogenesis. Solar light is the primary source of 
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UV radiation for all living systems (Svobodova et al., 2006). For a long time, 
ultraviolet B radiation (290-320 nm) has been considered to be more efficient 
wavelength in eliciting carcinogenesis in human skin. It is recognized in recent 
literature that UVA (320-400 nm), especially UVAl (340-400 run) also participates 
in photocarcinogenesis (Beani, 2001). Photooxidative stress is a key mechanism in 
UVA-induced skin photodamage. Photoexcited states of endogenous UVA 
chromophores such as porphyrins, melanin preciusors, riboflavin and pterin 
derivatives and cross-liiJs-fluorophores of skin collagen exert skin photodamage 
by direct reaction with substrate molecules (type I photosensitization) or 
molecular oxygen (type II), leading to formation of reactive oxygen species 
(Wondrak et al., 2005). Essentially endogenous chromophores in human skin 
serve as photosensitizers involved in skin photocarcinogenesis and photoaging. 
Absorption of solar photons, particularly in the UVA region, induces the 
formation of photoexcited states of photosensitizers with subsequent generation 
of reactive oxygen species, organic free radicals and other toxic photoproducts 
that mediate skin photooxidative stress (Wondrak et al., 2006). These highly 
reactive species can interact with cellular macromolecules such as DNA, 
proteins, fatty acids and saccharides causing oxidative damage. This could 
eventually lead to a number of harmful effects such as disrupted cell metabolism, 
morphological and ultrastructiual changes, deviation in regulation pathways 
and alterations in the differentiation, proliferation and apoptosis of skin cells. 
Processes like these can lead to erythema, svmbum, inflammation, 
imunosuppression, photoaging, gene mutation and development of cutaneous 
maUgrmncies (Svobodova et al., 2006). 
The complexity of endogenous skin photosensitizers with regard to 
molecular structure, pathways of formation, mechanisms of action and the 
diversity of relevant skin targets has hampered progress in the area of 
photodamage and most likely contributed to an underestimation of the 
importance of endogenous sensitizers in skin photodamage and related disorders. 
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Sensitized skin cell photodamage by bystander mechanism occurs after 
photoexcitation of sensitizers contained in skin structural proteins without direct 
cellular photon absorption thereby enhancing the potency and range of 
phototoxic UVA action in deeper layers of skin (Wondrak et al., 2006). 
Fortunately, the skin possesses a wide range of interlinked antioxidant defense 
mechanism to protect itself from damage by light induced reactive oxygen 
species. However the capacity of these systems is not unlimited, they can be 
overwhelmed by excessive exposure to UV radiation and then the generated free 
radicals can reach damaging levels (Beani, 2001). 
Riboflavin is one of the most important endogenous photosensitizers in 
human body (Heelis, 1982). The active oxygen species generated by the 
photoser\sitizer riboflavin are well known for their damaging effect on several 
biological molecules (Jazzar & Naseem, 1994; Jazzar & Naseem, 1996; Ali & 
Naseem, 2005; Ali et aL, 2005). In the present analysis the impact of photoactivated 
riboflavin has been elucidated in the presence of chemotherapeutic drugs cis-
diamminedichIoroplatinum(II) and 5-fluorouracil. The photochemical degradation 
of pharmaceutical compounds especially under daylight irradiation has received 
particular attention in the last decade (Castillo et al., 2007). Although most drugs 
with pharmaceutical relevance are transparent to daylight, the presence of other 
compounds able to absorb envirorunental light may affect the stability of 
pharmaceutical drugs. Nevertheless, during elaboration, storage, or in vivo after 
medicinal administration of the drugs, in presence of photosensitizing substances 
they might be able to absorb visible light and generate potentially aggressive 
species. These species can be transient entities consisting of the electronically 
excited states of a photosensitizer or some of the reactive oxygen species, 
generated from these excited states. Hence the so called photosensitized reactions 
are imperative. The photoreaction could give rise to products with different, null 
or even undesirable bioactivity. 
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The interaction of reactive species with pharmaceutical products is 
particularly important since, as a result of the photodamage, the drug can 
degrade either decreasing its original therapeutic activity or even worse, 
modifying its specific effects and/or eventually generating toxic products. 
Perchance a positive effect that can arise from the interaction of the drug with 
some photogenerated oxidative species is the eventual scavenging of the 
oxygeiwted species (Massad et al., 2005). Hitherto the effiect by certain biologically 
relevant endogenous/externally added compounds can inhibit/promote photo-
damage in living system. In this context an important class of these biologically 
active and commercially valuable compounds which would be potentially 
interactive with riboflavin in humans may be the externally administered drugs. 
Aminophylline in combination with riboflavin was foimd to augment degradative 
capacities of the sensitizer (Ali & Naseem, 2002), with aminophylline getting 
oxidized in the process (Hasan et al., 2006). In this study a conscious and plarmed 
effort was designed to explore not only the degree of these interactions and 
imderstanding the photoinhibition mechanism but also the concurrent influence 
on biologically relevant molecules. Chemotherapeutic drugs are an essential 
category of compounds that need to be probed in this milieu. With increasing use 
of drugs for treating cancer and radiotherapy being the current line of action, the 
potential interactions with endogenous photosensitizers such as riboflavin hold 
biological relevance and are needed to be considered. 
Since the vitamin and drugs can occupy common locations in complex 
biological systems, kinetic information about visible light promoted interaction 
between these compoimds can help to understand the behavior of riboflavin 
generated oxidative species in general, the potential in vivo or in vitro 
photoreaction of drugs in particular and the propensity of such processes to 
occur under given environmental conditions. Besides, mechanistic information 
on oxidative processes may be of great interest in pharmaceutical and medical 
fields to interpret possible photoreactions in the presence of photosensitizers that 
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are able to absorb daylight. As a consequence of these interactions there are also 
growing possibilities of 1) either of the compound amplifying/diminishing the 
outcome rendered by the other; 2) both proceeding synergistically exacerbating/ 
procuring individual effects incurred; and 3) contravening each others array of 
reactions. In view of the biological relevance, the risk-benefit ratio of such 
interactions and their onward impetus has to be considered. 
In the presence of riboflavin and visible light, significant amount of 
damage in terms of increased formation of TCA soluble amino groups in serum 
albimiin and decrease in percent activity of trypsin is observed. This effect is in 
agreement with a previous observation where it was shown that riboflavin alone 
induced protein degradation but the effect is enhanced with the presence of a 
metal ion Cu(n) (Jazzar & Naseem, 1994). It is well known that proteins are 
susceptible to oxidative stress in vitro and in vivo which may coherently lead to 
structural alteration and functional inactivation of many enzyme proteins 
(Davies, 2003). This is in congruity with our observation of riboflavin prompted 
a-helix reduction in circular dichroism spectroscopy. Evidence supporting the 
enhanced binding of riboflavin to protein in presence of light came from spectral 
studies performed under different conditions. This enhancing effect of light on 
the reaction involves generation of reactive species concomitantiy with exaggerated 
binding and thereby linearly increasing damage. 
The oxidative damage to proteins is reflected by increase in levels of 
protein carbonyls (Butterfield et al., 1998). Reaction of free radicals such as OH 
and Oj with the side chains of lysine, arginine, proline, threonine and glutamic 
acid, residues of proteins leads to the formation of carbonyl derivatives 
(Stadtman & Berlett, 1997). Furthermore, aldehydes such as 4-hydroxy-2-nonenal 
or malondialdehyde produced during lipid peroxidation can be incorporated 
into proteins by reaction with either the e-amino moiety of lysine or the sulfhydryl 
group of cysteine residues to form carbonyl derivatives (Uchida & Stadtman, 
1993). Therefore, protein carbonyl groups provide a reasonable marker for free 
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radical induced protein oxidation. Increase in protein carbonyls with increasing 
concentration of irradiated riboflavin depicts protein oxidative damage. Carbonyl 
compounds are known to possess toxic and carcinogenic properties and 
therefore their presence or elevated levels should be examined. Little is known 
about possible cellular defense mechanisms against protein carbonyl groups, 
except that some oxidized polypeptides are selectively degraded by the proteasome 
system (Brownson & Hipkiss, 2000). 
The highly reactive and genotoxic forms of oxygen (superoxide anion 
radical, hydrogen peroxide, hydroxyl radical, singlet oxygen) are produced from 
both endogenous and exogenous sources. In living cells, they can oxidize the 
major target molecules as proteins or DNA. They can generate DNA damage by 
producing single strand breaks, double strand breaks, alkali labile sites and 
oxidized purines and pyrimidines (Gachou et al., 1999). Reactive oxygen species 
are more effective at inducing oxidative DNA damage or lipid peroxidation than 
they are at modifying proteins. However, products of protein side chain 
oxidative modification are relatively stable, thus from a technical perspective, 
they serve suitable candidates as markers for oxidative stress (DaUe-Donne et al., 
2003). Accordingly, photodynamic protein oxidation was also analyzed with 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Non-specific fragmentation 
was induced following photodjniamic treatment of protein by illuminated 
riboflavin. Irradiation induces the formation of active oxygen species from 
riboflavin. Overproduction of reactive oxygen species/accumulation of reactive 
oxygen species due to the failure of antioxidant defense system to overcome the 
influx of reactive oxygen species leads to accretion of protein oxidation by-
products in vivo. Our restdts establish that exter\sive damage to proteins is caused 
by photodynamic treatment that could contribute to over all cell death. 
Energy in the visible and UVA (315-400 nm) region can be absorbed by 
endogenous flavins and transferred to biomolecules where it causes damage. 
Photosensitized damage to biomacromolecules such as DNA and proteins. 
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participates in phototoxicity, photogenotoxicity and solar UV-carcinogenesis. A 
chemoprevention of photosensitized damage is one of the most important 
methods to curtail the phototoxic effects of endogenous sensitizers. The 
aforementioned are a few phototoxic effects exhibited by riboflavin, the 
sensitizer. It is rational to postulate scientifically that an agent rendering 
protection/inhibition to the above would be entitled as a 'photochemoprotective 
agent' and the analysis 'photochemoprevention'. 
With the addition of cisplatin to the riboflavin-protein-light system, a 
protective effect against protein damage was observed. The inhibition was 
evident at lower concentrations which reached suggestive levels at higher 
concentrations. Co-treatment of cisplatin along with riboflavin led to a distinct 
decrease in the level of protein oxidative damage. The restoration of a-helix 
provides further verification to the protective shielding by cisplatin on structural 
alteration by riboflavin. Reaffirmation to the protective outcome was measured 
with trypsin activity. This was noticeable from increase in enzyme activity with 
increase in concentration of cisplatin. 
It is well known that absorption of peak at 280 run reflects the status of the 
microenvironment in the vicinity of protein. Primarily the spectral pattern of 
protein-riboflavin-light illustrated enhanced binding on sensitization of the 
sensitizer and consequently increased damage. Riboflavin displayed decreased 
binding in the presence of cisplatin as seen in the experimental results. Keeping 
this in mind, the summation of the spectral changes leads to an important 
possibility. That is, the sensitization of riboflavin is curbed in protein-riboflavin-
cisplatin-light combination. Simultaneously, the binding and damage to protein 
are curtailed. 
The species responsible for photodegradation by riboflavin is proposed to 
be the free radicals formed from the triplet state, such as superoxide radical (O2 ) 
(Edwards & Silva, 2001). In a healthy cell imder normal conditions, the oxidative 
challenge begins with the generation of oxygen species, primarily superoxide 
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radical (Dean et al, 1997). It is believed to be generated in biological systems by a 
range of endogenous processes (enzymatic and chemical reactiorw) and exogenous 
stimuli (UV/visible light in the presence of sensitizer). Secondary reactions and 
particularly those involving reactive species originated from superoxide may 
play a key role in the induction of secondary damage (by-stander effects) in 
systems subject to photooxidation. Protein crosslinking, aggregation, fragmentation, 
inactivation of cellular enzymes and oxidation of other biological targets are by-
stander reactions induced by reactive oxygen species formed on photooxidized 
proteins (Halliwell & Gutteridge, 1984). In the experimental strategy employed, 
cisplatin exhibited strong inhibitory effects on superoxide radical production by 
riboflavin. Intriguingly, the radical production by cisplatin alone was also 
hampered in this interactive phenomenon. 
Decreased levels of protein oxidation could be suggestive of two 
possibilities. First, cisplatin directly reacting with reactive oxygen species 
generated by riboflavin that is, precisely scavenging free radicals. Second, an 
interactive mechanism between cisplatin and riboflavin could regulate the free 
radical productive nature of the system to prevent protein oxidation. It would be 
noteworthy that a mechanism by which cisplatin exerts its cytotoxicity is through 
the generation of ROS (Auersperg et al, 1998). The drug is able to generate 
reactive oxygen species, such as superoxide anion and hydroxyl radical at the 
concentration being studied as demonstrated in the analysis. An important side-
effect accomparued with the usage of this drug is the generation of free radicals 
in normal cells (Weijl et al., 1998). Hence, it is not feasible for the drug cisplatin to 
behave as a scavenger of free radicals. It is more likely that irradiation of 
riboflavin in the presence of cisplatin results in reduced photosensittzation of the 
vitamin, inhibiting free radical production and accordingly disturbing its 
catalytic activity. 
The spectral character of riboflavin in presence of cisplatin was used to 
evaluate tiie effect of drug on vitamin's photosensitizing character alone. 
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Absorption of riboflavin was neatly enhanced by cisplatin in the reaction 
medium, demonstrating the occurrence of interaction between the medicament 
and pigment. According to the data obtained, the concentrations employed in 
our experiments produced a diminution in the decomposition of riboflavin. This 
is in good agreement with the potential photoprotective effect of cisplatin 
towards photooxidizable biological targets. Taking into consideration, the 
fluorescence quenching information under dark conditions, it cotdd be inferred 
that a weak dark interaction occurs between riboflavin and cisplatin. However, 
the peak ascends with cisplatin in the reaction (in light) and the complex 
formation between riboflavin-cisplatin attains significance in a concentration 
dependent trend. It would be reasonable to assume that in presence of cisplatin 
the reduced photoseiwitization and ctirbed photodegradative intent of riboflavin 
discussed above is due to inactivation, precisely inactivation by complex 
formation. Under the conditions in use, possibly riboflavin is retained in the 
reaction medium with its native characteristics. Our results are comparable to the 
findings of Massad et al. (2005) wherein a sympathomimetic drug, phenylephrine 
was shown to have inhibitory action towards photogenerated oxygen active 
species originated by riboflavin. 
Proteins are one of the many biological molecules sensitive to photo-
oxidation by flavins (Taylor & Radda, 1971). The next critical target molecule for 
the action of free radicals is DNA; therefore DNA damage has been recognized at 
the onset of many diseases, such as cancer. DNA damage could be a useful 
biomarker of oxidative status (Riso et aL, 1999). The composition and vulnerability 
of DNA makes it an apt candidate for exploring riboflavin-cisplatin combination 
in detail. DNA is a simple structure in comparison to proteiiis which makes it 
susceptible to the potential hazards of aerobic enviromnents (Gachou et al., 1999). 
Although the cells are certainly endowed with a number of antioxidants and 
repair mechanisms, their ability to detoxify oxygen radicals is limited (Tabatabaie 
& Floyd, 1994). Calf thymus DNA was used as a target molecule and pea seed 
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nuclease as a probe to explore DNA damage. DNA, when exposed to photo-
illuntinated riboflavin alone showed hydrolysis which was substantially reduced 
on inclusion of cisplatin in the reaction. DNA damage described was investigated 
using plasmid nicking assay. In accordance with the aforementioned, the drug 
diminished the DNA nicking activity of activated riboflavin. The protective 
performance by cisplatin was dose dependent. 
The term 'photocisplatin reagents' was coined for rhodium and related 
metal complexes that are thermally inert, need activation by light to mimic the 
thermal chemistry between cisplatin and target molecule (Loganathan & 
Morrison, 2005). Evidence supporting the enhanced efficiency of cisplatin on 
irradiation came from an amplified protein oxidation in light conditioiw. The 
activity profile of the drug on photoactivation differed in intercity from the 
cluiracteristics displayed in Ae native conditions. It was in agreement with the 
finding wherein photoactivation of cisplatin was reported to elicit an extra 
niunber of strand breaks (Corde et al., 2003). 
In view of the biochemical importance (Massey, 2000; Hefti et al., 2003), 
light sensitivity (Karrer et aL, 1934) and pharmaceutical implications (DeRitter, 
1982), riboflavin is one of the most widely studied compound since its discovery 
(Warburg & Christian, 1933). Because oxidative damage by riboflavin has been 
the focus of many researchers and the role played by antioxidants in diminishing 
free radical induced damage is of prime interest, our attention in this field has 
focused on interactive mechanisms of drugs, which have been studied extensively in 
a variety of research. The inorganic compoimd, cis-diamminedichtorop]atinum(II) 
commonly referred to as cisplatin or cis-DDP, is one such anticancer drug that 
falls into the DNA damaging class (Zamorano-Ponce et al., 2004). In fact, 
although this compound is an effective antineoplastic agent in the treatment of 
solid malignant tumors, it also has important side effects including reduction of 
antioxidant plasma levels and genotoxicity in normal cells (Yoshida et al., 2003). 
Albeit the toxicological properties of this drug have been investigated, interaction 
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dependent consequences in the provisos of cisplatin have not been well elucidated. 
In view of the pro-oxidant properties of riboflavin and cisplatin, the combination 
was expected to be deleterious to target biomolecules. Interestingly, the tested 
medicine behaved as a photoprotective agent towards photooxidizable targets as 
evident in results. In particular, evidence for a protective role of this compotmd 
against photosensitized damage is lacking. This subject merits further investigation 
and has relevance in biochemical pharmacology. 
Delivery of toxins, genes, chemotherapeutic agents, antisense oligonucle-
otides and enzymes into cells for medicinal purposes has been limited by the low 
permeabilities of the aforementioned molecules through the cells plasma 
membrane. As a corwequence, significant effort has been devoted to identifying 
cell surface ligands that might be availed to carry attached molecules into cells 
via the natural endocytosis pathways of their membrane bound receptors. 
Holladay et al. (1999) explored the possibilities of co-delivering an exogenous 
unrelated molecule by exploiting any of the possible riboflavin uptake routes. 
They observed a measurable uptake of riboflavin conjugates through a pathway 
distinct from the uptake of free riboflavin. It seems that riboflavin conjugate 
uptake pathway could be exploited for effective delivery of drugs complexed 
with riboflavin. In our investigation, riboflavin forms a complex with cisplatin in 
aqueous solutions (in the dark), which attains significance at relatively higher 
concentrations of the drug. Riboflavin-cisplatin (dark) could be applicable for a 
rapid and tissue selective drug targeting in vivo. In the presence of interacting 
species such as drug, the association could be a dark complexation between the 
drug and the vitamin which has been repeatedly reported for riboflavin with 
different types of substrates (Posadaz et aL, 2000; Massad et al., 2004). It seems 
likely that the drug would reach the nucleus of cancer cells intact and exhibit 
therapeutic efficacy. Albumin has a considerable impact on the activity of 
platinum antitumor compounds. The reaction of cisplatin with albumin attracts 
attention since the drug is usually administered intravenously and protein 
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binding may decrease effective concentration of the free drug, which is 
responsible for the antitumor activity. Indeed, a day after rapid intravenous 
infusion of cisplatin, 70-90% of platinum in blood plasma is protein bound. This 
protein bound complex is believed to be tmavailable for therapeutic purposes 
(Trynda-Lemiesz & Luczkowski, 2004). In agreement, the binding of riboflavin-
cisplatin as a complex if exercised in targeting drug delivery to tumor tissue 
would reduce if not abolish toxicity credited by cisplatin to normal cells. The 
effective concentration of the drug available for therapy in this case would be 
more than if transported with serum albumin/alone in the blood stream. It is 
already mentioned that cisplatin alone in the blood stream could be deleterious 
to normal tissues. Many anticancer agents including cisplatin are unable to 
distinguish tumor from normal cells, which is perhaps responsible for their 
observed toxicity. Therefore, specific and selective targeting of chemotherapeutic 
drug to the cancer and not normal cells could be of great benefit to cancer patients. 
For further clarification and understanding the behavioral aspect of the 
purported mechanism at in vivo level, human lymphocytes were assessed for 
riboflavin mediated damage. For that reason, a relatively simple technique called 
single cell gel electrophoresis (comet assay) was applied to quantify DNA 
degradation. Evidently, the damage increased with increase in dose of riboflavin. 
A mutagen is defined as an agent that causes permanent genetic change in a cell 
other than brought about by genetic recombination. In this context, it is 
reasonable to presume riboflavin as a mutagen in its "activated state" since its 
genotoxic potency which stems from free radical production in cells damages the 
DNA of the cell. Also, cisplatin decreased the damage as evidenced by decrease 
in tail length. The preventive phenomena reported in otu results differed 
strikingly from riboflavin treated cells suggesting that period of incubation and 
the concentration used were adequate. The molar range of platinum compound 
being used in our study corresponds to cisplatin plasma concentrations in 
patients imdergoing chemotherapy' and hence pharmacologically relevant. A 
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further increase in concentration of the drug leads to no decrease in tail length of 
DNA. Our study is analogous to Hirakawa et al. (2005) where the chemopreventive 
role of xanthone derivatives was deduced against photosensitized DNA damage. 
The morphological alterations associated with the sensitizer and/or drug were 
aimlyzed by employing scan electron microscopy in human red blood cells. The 
illustrations differ markedly in structure. Riboflavin-cisplatin apparently 
masked the effect rendered by each of them individually. 
With respect to genotoxicity, cisplatin proved to be able to induce increase 
in DNA strand breaks as detected by comet assay. In our experimental system, 
comet assay represented the most sensitive approach to evaluating DNA damage. 
The high sensitivity of comet assay was already reported (Gopalakrishna & Khar, 
1995). The possibility of assessing severely damaged cells detached from the 
substrate into the culture medium represents another advantage of this assay. On 
the other hand, cisplatin is a known crosslinker and as crosslinking agents such 
as formaldehyde and Mitomycin-C connect DNA with DNA and/or histone 
profeins they would be expected to cause no increase or even decreased DNA 
migration in the comet assay (Hartmaim & Speit, 1994). Our results are similar to 
that obtained by Zamorano-Ponce et al. (2004) wherein cisplatin was found to 
evoke genetic damage in mouse bone marrow cells as evaluated by comet assay. 
These results together with the production of reactive species within the 
cell measured by TBA reactive material at the end of treatment, suggest toxicity 
by cisplatin in normal ceUs; in line with ciurent knov/ledge on reactive oxygen 
species production by the drug in normal and tumor cells. Hematologic toxicity 
with changes in the biological functions of blood cells associated with cisplatin is 
well documented (Olas et aL, 2006). These results strengthen the hypothesis of 
oxygen species being responsible for cisplatin mediated damage. 
There exists a pivotal interpretation in specifications of cisplatin. The 
amount of damaged DNA and the TBARS produced in the cell by cisplatin alone 
at 150 fiM and that generated by riboflavin-cisplatin (at the same concentration of 
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cisplatin) is reduced. Thus it is anticipated that the combination mitigates the 
genotoxicity accompanied with the drug in addition to diminishing the sensitizer's 
phototoxic character. Corresponding to these studies, photodynamic therapy has 
emerged as an established modality for the treatment of solid tumors and other 
accessible lesions. Recent studies by Bertollo et aL (2006) have demonstrated a 
significant enhancement in the antinociceptive effect induced by morphine in the 
formalin test Although the mechanism ttiat contributes to this positive interaction 
between riboflavin and morphine are not clear, they indicate that this vitamin may 
represent an alternative to reduce the dose of drugs and consequently their side 
effects. This study is supportive of ova assessment. The present study implies that 
the excited state of riboflavin could also behave in a similar manner. The use of a 
drug in vitamin (riboflavin) photodynamic therapy or vice versa is a clear strength 
of our method, however, further study is required to determine if cisplatin could 
interact in a similar fashion with other endogenous sensitizers. These 
investigations could also open the way to the use of riboflavin or its analogs as 
phototherapeutic agents in view of the increasingly expanding utilization of 
photosensitized processes for the treatment of selected diseases or in the 
regulation of side-effects of certain treatments, especially in the oncological field 
(Dougherty, 1993; Jori, 1996). 
Owing to the effectiveness of cisplatin in chemotherapy, there is a 
growing interest in the development of strategies ciutailing the deleterious 
impact of this drug on healthy cells. It is a common practice to administer 
cisplatin together with one or more agents which could enhance the antitumor 
activity or which alleviate the deleterious effects accompanying platinum 
complexes therapy. Green tea polyphenols with cisplatin were found to protect 
normal epithelial cells from reactive oxygen species. An earlier study also 
showed epigallocatechin-3-gallate (EGCG) and cisplatin were effective in 
protecting the normal salivary gland cells from damage (Ho, 2006). Nevertheless, 
the use of protective agents during, before or after treatment with anticancer 
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agents in combination therapy has proven effective in the treatment. Similarly, 
the approval of photodynamic therapy and extra corporeal photopheresis in 
clinical practice and the general advantages of temporal and spatial specificity 
inherent in phototherapy have generated attention in the development of other 
light-dependent treatment modalities. Recently, light activated destruction of 
cancer ceU nuclei by Pt diazide complexes was analyzed (Bedrmrski et al., 2006). 
Platinum complexes are of potential in the therapy of hyperproliferative skin 
diseases and cancers (Featherstone et al., 1991). A normal himian fibroblast treated 
with cisplatin shows micronucleus formation and granular condensation of 
nuclear chromatin as morphological manifestations of DNA damage induced by 
the drug (Jirsova & Mandys, 1994). As an approach to the avoidance of toxic side 
effects, photodynamic therapeutic window of riboflavin could be enlarged by 
application in cisplatin therapy. This strategy could be useful in the treatment of 
tissues with localized cancers accessible to irradiation (skin, bladder, lung, 
esophagus). Since activation can be localized to the area of irradiation, this 
procedure can be limited to normal healthy cells susceptible to cisplatin toxicity 
without affecting the therapeutic effectiveness of the drug in cancerous tissue. 
We have proposed a riboflavin-cisplatin complex formation which retains 
riboflavin in its native state significantly. Considering tiiat if riboflavin is retained 
in its rmtive state in the presence of cisplatin (in a concentration dependent 
maimer) it can be argued that increase in the dose of cisplatin above 150 jiM 
should further display a protective trend reaching the basal levels as in imtreated 
proteins, calf thymus DNA, riboflavin itself and for that matter even in human 
cells. The presumable explanation to this paradoxical behavior is as follows; 
although a complex formation occurs but this happens later after a cascade of 
reactions initiated by light. It is credible that riboflavin produces free radicals in 
the reaction medium, irrespective of the substrate. These species transform 
cisplatin into an inactive entity and simultaneously also damage the target 
macromolecule and hence the data never reach the basal levels. However, this 
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inactive entity when present in a considerable concentration in the medium 
possibly interacts with the native riboflavin forming a complex which hampers 
its photoexcitation, free radical generation and degradation/structural alteration 
of biomolecules. The larger the concentration of cisplatin greater is its photo-
protective action, until all the riboflavin forms a complex. A simpler reason of 
complex formation between drug and sensitizer could also be debated with the 
above hypothesis. Nevertheless, the hypothesis is a preliminary study and merits 
detailed investigation as to whether a sensitizer mediated inactivation of drug or 
mere complex formation of sensitizer-drug is responsible for suppressed 
characteristics of both compounds. Keeping riboflavin as the nuclei of hypothesis, 
irradiated sensitizer remains in its photostable state in the presence of Pt(II) drug. 
This chain of reaction leads to repression of the characteristics endowed on the 
compounds individually. Since the reaction is mediated by light, the interactive 
consequences have relevance in context of photodynamic therapy. Further 
studies at the in vivo level and with other endogenous sensitizers would validate 
the observatior\s and expand their pharmacological application in photodynamic 
therapy. In this context, the prevalence of an association process is a desirable 
possibility since the final result is the elimination of the oxidative species without 
considerable loss of the scavenger (Massad et al., 2005). This would enlarge the 
conjimction of phototherapy and chemotherapy and lead to beneficial 
manifiestations with cautious approach to the toxic potential of both. 
In the present study, the second drug imder investigation was 5-
fluorouracil. 5-Fluorouracil a pyrimidine analog is an important anticancer drug 
used widely in the treatment of a variety of solid tumors such as colorectal, 
breast, stomach and liver carcinomas (Tobias, 1992). It is assumed that the 
cytotoxic action of the fluorinated pyrimidine is mediated primarily via inhibition 
of thymidylate synthetase (Santi et aL, 1974), the key enzyme that promotes the 
de novo synthesis of thymidylic acid which leads to the formation of dTTP, a 
substrate of DNA polyinerase. Perhaps, the potential properties of both drugs in 
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the presence of riboflavin as a sensitizer and the ongoing bearing of such 
interactions on biological molecules have not been inspected. The selection of 5-
fluorouracil helped to examine and differentiate the interaction dependent 
consequences of both drugs. To date, the most effective regimens have been 
combinations of 5-fluorouracil and leucovorin or cisplatin. The combination of 5-
fluorouracil and cisplatin, in particular, has been reported to result in high 
response rates in patients with head and neck cancer (Fonseca et al., 1997) and 
colorectal cancer (LoRusso et al., 1989). The curative potential of such treatment 
therapy could be influenced by the cimiulative impact of these putative interactions 
being discussed in the present assay. 
The susceptibility of riboflavin induced modification in presence of 5-
fluorouracil was investigated. Free radicals have been shown to be capable of 
damaging many cellular components such as DNA (Liu et al., 1996), proteins 
(Leeuwenburgh et al., 1999) and lipids (Alper et al., 1999). Indeed, damage to 
DNA and proteins may often be more important than damage to lipids in 
oxidative stress situations in vwo (Reznick & Packer, 1994). Oxidative modification 
of proteins in vivo may ciffect a variety of cellular functions involving proteins; 
receptors, sigrml transduction mechaiusms, transport systems and enzymes. The 
drug was found to behave in a biphasic pattern with lower concentrations 
inhibiting the photoinitiated reaction and the higher molar ratios displaying a nil 
effect Enzyme inactivation, protein degradation and structural alteration results 
were in accordance. Our studies are emalogous to microbiological trials conducted 
by Yamane et al. (1993) wherein the growth of Arthrobacter sp. was inhibited by 
5-fluorouracil and inhibition was reversed by riboflavin. These studies were 
indicative of concentration dependent pattern towards each other. Perchance the 
behavior continues in photodynamic reaction also. The cleavage efficiency of 
riboflavin on pUC 18 DNA with drug in the reaction medium followed the same 
outline. At the cellular level, reactive oxygen species were also measured in 
hiunan lymphocytes. The drug caused masking of photoreaction at specific ratios. 
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In context of photodynamic reaction, 5-fluorouracil in the presence of 
sensitizer riboflavin behaved in a manner which suggested activity at lower 
concentrations. The structural modification by drug alone at lower concentratioi\s as 
observed in a-heUcal content of protein suggested distortion whilst restoration at 
higher molar ratios. The trend was in consistence with that obtained by Hu et al. 
(2005). Apparently, the lower concentrations of drug are interactive with the 
target biomolecules. This validated the observation of lower concentrations 
intervening with the reaction. Occurrence of dimerization at higher concentrations 
may be the plausible reason for the observed pattern. 
Spectral analysis demonstrated the formation of a complex between the 
drug and sensitizer. It is expected that this complex formation inhibits 
photoexcitation at lower concentrations. Interactive forces within the drug 
molecules play a pivotal role at higher molar ratios and the consequent 
incapability to hamper the photoreaction. Our study is supported by Wang 
(1976) suggesting photodimerizatioh of 5-fluorouracil at higher concentrations. 
There is certainly potential to further improve radiochemotherapy combinations 
as well as to rationally develop new radiosensitizing drugs if a better mechanistic 
understanding of the interaction of these modalities can be gained. Cancer 
survivors are increasingly turning to complementary and alternative medicine to 
manage short and long term treatment sequelae. Dietary supplements in this 
regard could belong to the category of multivitamin, minerals, herb or botaiucals 
and natural products (Miller et al., 2008). B-vitamins have been described as 
useful drugs to treat some pathological conditions, not necessarily associated 
with their deficiency (Bertollo et aL, 2006). Although health professionals have 
increasingly come to acknowledge supplement drug interaction or precisely that 
supplement use may adversely/positively interact with prescription medications 
used for treating cancer, little is known about the possible interaction with 
medications in term of safety and benefits (Norman et al., 2003). In the present 
line of investigation the focus was on the imderstanding of interaction between a 
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major constituent of supplement therapy with the most commonly used cancer 
therapy regimen, in the provisos of radiation therapy. Further studies at the in 
vivo level would explain the possibilities of such reactions in living system under 
a particular treatment therapy. 
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Ribollavin (RF) upon irradiation with lluorcscent light generates reactive oxygen species like superoxide anion, singlet 
and triplet oxygen, flavin radicals and substantial amounts of hydrogen peroxide (H^Oi). HiOi can freely penetrate cell 
membrane and react with a transition metal ion like Cu(H), generating hydroxyl radical via the modified metal-catalyzed 
Haber-Weiss reaction. Earlier, it was reported that trypsin-chymotrypsin mixture served as an indirect antioxidant and 
decreased free radical generation. Thus, in the present study, we used photoilluminated RF as a source of ROS to investigate 
the effect of free radicals on the activity of trypsin. We also compared the damaging effect of photoilluminated RF and RF-
Cu(ll) .system using trypsin as a target molecule. RF caused fragmentation of trypsin and the effect was further enhanced, 
when Cu(ll) was added to the reaction. Results obtained with various ROS scavengers suggested that superoxide radical, 
singlet and triplet oxygen were predominantly responsible for trypsin damage caused by photoilluminated RF. On the other 
hand, when Cu(Il) was added to the reaction, hydroxyl radical was mainly responsible for trypsin damage. A mechanism of 
generation of various ROS in the reaction is also proposed. Trypsin did not show any antioxidant effect with RF alone or 
with RF-Cu(II) combination. 
Keywords: Riboflavin. Trypsin, Copper, Reactive oxygen .species 
Riboflavin (RF), vviien exposed to light, absofbs 
energy and gets excited to its singlet and triplet state. 
With molecular oxygen present in the reaction, RF 
generates various ROS. These ROS are known to 
damage red blood cell membrane and induce 
haemolysis', damage lens", and increase protein cross-
linking'. The photodegradation of RF involves both 
photolysis and photoaddition reactions 
simultaneously, leading to lumichrome and 
cyclodehydroribotlavin, as major products'*. The 
effect of a combined dosing regimen of RF and 
metalloporphyri ns with the aim of increasing the 
efficiency of phototherapeutic treatment of 
hyperbilirubinemia is also studied^ Occular 
neovascular disease, an important cau.se of blindness 
today, was used as a model to evaluate the vaso-
occlusive potential of photodynamic therapy with 
RF'. 
RF supplementation might also be a useful adjunct 
to therapy in migraine prevention^. Dermal injection 
*Corresponding author 
E-mail: imrananaseein@yalioo.coin 
Tel: (91 9719069125) 
Ablyrevialions: CAT, catalase; MNL, mannitol; RBC, red blood 
cell; RF, riboflavin; ROS, reactive oxygen species; SOD, 
superoxide dismutase; TU. thiourea; UV-A, ultra -violet-A 
of RF and exposure to near UV/visible radiation 
decrease the dermal pigment of blue nevi, which are 
recalcitrant to laser therapy^. Oxidative modification 
of cellular constituents including lipids, proteins and 
nucleic acids was also implicated in the etiology of 
various pathological conditions and in ageing'^'"'. The 
presence of RF and UV light selectively enhance 
damage to guanine bases in DNA //; vZ/ro". RF 
induces DNA damage, mainly 7,8 dehydro-8-oxo-2-
deoxy guanosine formation'". In addition, proteins are 
the other important cellular constituents damaged by 
RF. The binding studies suggested that RF interacts 
non-covalently with B S A ' ' . The spectroscopy and 
photophysics of RF is of considerable interest, due to 
its biological relevance''*. 
Transition metal ions, especially copper and iron 
frequently have unpaired electrons, and are excellent 
catalysts, playing a key role in the generation of 
strong reactive species from the less reactive ones by 
catalyzing the formation of hydroxyl radical from 
hydrogen peroxide (H2O2) via modified metal-
catalyzed Haber-Weiss reaction'^. Iron also behaves 
in a similar manner to copper by generating hydroxyl 
radical, which damages the protein when generated in 
its vicinity, resulting in the loss of activity'^ . But the 
damage by Fe(III) is less pronounced. This may be 
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due to the fact that Cu salts react to form hydroxyl 
radical, with a much greater rate constant than Fe salts 
while other divalent metal ions do not show any 
significant activity"'. 
The photoexcitation of RF may occur both in vitro 
and ;•/; vivo in the organs and tissues that are 
permeable to light such as the eyes and skin and may 
damage other cell matrix components causing 
inflammation and aging'^. RF in the presence of 
Cu(II) causes breakage of calf-thymus DNA'^ and 
induces haemolysis of human RBC'. The adult human 
body contains about 80 mg of copper'', which is 
absorbed in the intestine and transported by albumin 
to the liver. After hepatic uptake, it may be 
incorporated into copper-containing enzymes or 
ceruloplasmin, which can be transported into the 
blood''\ Cells take up and degrade ceruloplasmin, to 
obtain copper from it"". Thus, copper available in the 
system enhances the generation of ROS. 
Trypsin-chymotrypsin mixture has been shown to 
be effective anti-inflammatory agent and the 
preparation was found to reduce oxidative damage in 
burn patients by reducing the formation of free 
radicals"'. It was further proved that this mixture 
reduces stress to the liver by decreasing the levels of 
marker enzymes in the serum and consequently 
preventing tissue destruction. Conclusively, the 
combination behaves as an indirect antioxidant. Thus, 
it was of interest to examine the activity of trypsin 
alone in conditions of oxidative stress. In the present 
study, the effect of phtoilluminated RF alone and that 
of RF-Cu(II) was investigated using trypsin as the 
target molecule and the enzyme was found to be 
susceptible to oxidative damage. 
Materials and Methods 
Materials 
Trypsin, (EC 3.4.21.4) and CuCb were from SRL, 
India, while riboflavin (RF) and neocuproine were 
from Sigma Chemical Co. USA. All other chemicals 
used were of the highest purity grade available. 
Methods 
Trypsin axsay 
Trypsin was assayed by the method of Kunitz" 
using casein as the substrate. Reaction mixture in a 
final volume of 3 ml contained 10 mg casein, 10 mM 
sodium phosphate buffer (pH 7.4) and 30 ^g trypsin. 
The reaction mixtures were incubated at 37''C for 30 
min, and then terminated by the addition of 1 ml of 
10% TCA. The samples were then centrifuged for 10 
min at 2500 rpm to remove the undigested protein and 
the supernatant was used for determining the acid 
soluble peptides by the method of Lowry" . 
Inactivation of trypsin by photoilluniinated RF alone and 
RF-Cn(II) system 
Trypsin (30 |ig) was incubated with increasing 
concentrations of RF (25-150 jiM) in total volume of 
3 ml in 10 mM sodium phosphate buffer (/;H 7.4). 
The reaction mixtures were irradiated with 800 lux of 
cool fluorescent light for 30 min at room temperature. 
Trypsin was then assayed as described. 
In subsequent experiments, metals like Cu(II), 
Fe(III), Co(II), Zn(II), Mn(II), Ni(II) and Hg(ll) were 
included in the reaction. Free radical scavengers such 
as sodium azide (NaN^), potassium iodide (KI), 
thiourea (Tu), mannitol, superoxide dismutase (SOD) 
and catalase (CAT) were also included in subsequent 
experiments to determine the natlire of ROS 
generated. 
SDS-polyacrylamide gel electrophoresis 
SDS-PAGE was performed essentially by the 
method of Laemmlli^'' using mini slab gel apparatus. 
Reaction mixtures containing 25 |-ig of trypsin were 
exposed with RF alone, RF with Cu(II), RF with 
neocuproine [specific chelator of Cu(I)] and RF with 
Cu(II) in the presence of neocuproine in fluorescent 
light for 2.5 h. Various scavengers were also used in 
.some experiments. Treated samples containing 25 i^g 
of protein were electrophoresed on 15% (w/v) 
SDS-PAGE. 
Silver staining 
Protein bands were detected by silver staining of 
the gel using method of Merill"^. The gels were 
soaked in 30 ml of 50% acetone for 10 min and 
treated with solutions containing 30 ml of distilled 
water and 50 )al of 10% sodium thiosulphate. Next, 
they were washed with distilled water and then 
soaked in a solution containing 0.4 ml of 20% silver 
nitrate, 0.3 ml of 37% formaldehyde and 30 ml of 
distilled water for 8-10 min. After washing with 
distilled water again, gels were transferred to a 
solution 0.6 g of sodium carbonate, 12.5 |.il of 10%> 
sodium thiosulphate and 12.5 \.i\ of 37% 
formaldehyde to make them alkaline. After 10-20 s, 
gels were suspended in 1% glacial acetic acid for 1 
min to stop the reaction and were finally washed with 
distilled water. 
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Absorption spectroscopy 
Absorption spectra of reaction mixture containing 
75 /xM RF alone in a total volume of 3 ml was 
recorded before and after 2 h of incubation in 
fluorescent light in the range of 300 to 500 nm using 
Cintra 10 Spectrophotometer. Spectra of samples 
containing 75 /xM RF and 150 \xM CuCh were also 
recorded before and after incubation. Neocuproine 
300 /xM, was also employed to read spectral changes 
in the spectra of RF alone and RF-Cu(II). The 
incubation time for all absorption spectroscopy 
experiments was 2 h unless otherwise stated. 
Scavengers were also used in spectral experiments. 
The scavengers included were NaNj (scavenger of 
singlet oxygen), thiourea (TU) and mannitol (MNL) 
(scavenger of hydroxyl radical), KI (scavenger of 
triplet oxygen), SOD (scavenger of superoxide anion) 
and CAT (scavenger of H2O2). 
Statistical analysis 
Data were analyzed by the Student's t-test. Each 
experiment was repeated thrice and the values 
expressed as average of three independent replicates. 
Results 
Trypsin was incubated with RF and irradiated with 
visible light for 30 min. A progressive decrease in 
trypsin activity was observed with increasing 
concentrations of RF from 20 |iM to 150 |iM, with a 
complete loss of activity observed at 150 \xM RF 
(Table 1). With 75 liM RF and increasing 
concentrations of Cu(I[), inactivation of trypsin was 
achieved at the ratio of 1:2, more speciflcally at 75 
l-iM RF and 150 |iM Cu(II) (Table 1). Irradiation of 
trypsin with Cu(]I) alone had no effect (data not 
Tabic 1—Inactivation of trypsin by RF and RF + Cu(II) as a 
function of increasing concentration [Trypsin (10 (.tg/ml) was 
incubated with increasing concentration of RF (A) and 75 jiM 
RF + increasing concentration of Cu(/f) (B) in fluorescent (iglit 
for 30 min. Enzyme assay was carried out as detailed in 'Materials 
and Methods". Data are average of triplicate samples from 3 
different experiments] 
shown). In subsequent experiments, the above 
mentioned ratio of 75 |iM RF and 150 |iM Cu(II) was 
used. All the reactions were incubated in fluorescent 
light, unless otherwise mentioned. 
The decrease in the activity of trypsin caused by RF 
alone and in the presence of Cu(II) was monitored as 
a function of time of illumination in fluorescent light 
(Table 2). Irradiation for 5 min in the presence of RF 
alone resulted in only 5% loss of trypsin activity, bul 
when Cu(II) was also included 58% loss of activity 
was observed. The enzyme was almost completely 
inactivated, in the presence of RF and Cu(ll) after 25 
min of incubation while with RF alone, it still retained 
40% activity. 
The effect of other metals like Co(II), Zn(n), 
Mn(II), Ni(II), Hg(II), and Fe(III) on the activity of 
trypsin in the presence of 75 |.iM RF was also 
investigated. Only Fe(III) was able to catalyze Haber-
Weiss reaction, and resulted in 88% inhibition of 
trypsin activity at the concentration tested (150 f,i/W). 
Other metals exhibited no significant inhibitory effect 
on the catalytic activity of trypsin, when compared to 
irradiation with RF alone which exhibited 50% loss of 
activity (data not shown). The efficiency of Cu(II) 
over other transition metal ions is due to the fact that 
it catalyzes the modified Haber-Wciss reaction, 
resulting in more deleterious ROS, whereas other 
metals, except Fe(III) are not good substitutes for this 
reaction'^'. 
Inactivation of trypsin was also studied in the 
presence of different free radical scavengers to 
determine the major ROS involved in the reaction 
with RF alone and RF in the presence of Cu(II). In the 
reaction containing RF alone, SOD was most 
effective and resulted in maximum prevention of 
trypsin inactivation (83%), followed by NaN^ (70%), 
Table 2—inactivation of trypsin by RF and RF + Cu(Il) as a 
function of time [Trypsin (JO j.ig/ml) was incubated witli (.A): 
75 [iM RF alone; and (B): 75 nM RF+150 ^iM Cu(ll) and 
irradiated in fluorescent light for different time intervals. Enzyme 
assay was carried out us detailed in "Materials and Methods". Data 
are average of triplicate samples from 3 different experiments] 
(A) (B) 
RF 
(HM) 
20 
50 
75 
100 
125 
150 
% Remaining 
activity 
80 
60 
45 
40 
20 
5 
Cu (II) 
(tiM) 
20 
50 
75 
100 
125 
150 
% Remaining 
activity 
80 
45 
20 
10 
5 
0 
Incubation tune 
(min) 
5 
10 
15 
20 
25 
30 
% Remaining 
(A) 
95 
84 
80 
70 
60 
40 
trypsin activitv 
(B) 
42 
30 
28 
25 
5 
2 
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KI (63%) and CAT (60%). Whereas when Cu(II) was 
added to the above reaction, TU was most effective 
and resulted in maximum prevention of inactivation 
(88%), followed by MNL (42%), NaNj (38%), KI 
(29%), CAT (25%) and SOD (20%) (Table 3). 
SDS-PAGE of trypsin after photoillumination in 
presence of RF alone or RF-Cu(lI) was performed. 
Degradation of trypsin by RF is shown in (Fig. lA). 
Protein degradation was visible at 25 \xM RF (lane b) 
and became very significant at 200 juM RF, with the 
main band almost disappearing (lane 0- I" ^ parallel 
experiment, trypsin was photoilluminated with 75 \iM 
RF and increasing Cu(ll) concentrations (50-150 \iM) 
Table 3—Inactivation of trypsin by RF and RF + Cu(II) in tiie 
presence of free radical scavengers [Trypsin (10 |a.g/ml) was 
incubated with (A): 75 \\.M RF + 50 mM radical scavengers; and 
(B): 75 tiM RF + 150 \iM Cu(II) + 50 mM radical scavengers 
respectively and irradiated in lluorescent light for 30 min. Enzyme 
assay was carried out as detailed in "Materials and Methods'. Data 
are average of triplicate samples from 3 different experiments] 
Scavengers 
KI 
NaN, 
TU 
MNL 
SOD 
CAT 
% Activity of trypsin 
(A) 
63 
70 
35 
40 
83 
60 
(B) 
29 
38 
88 
42 
20 
25 
1 ^ 
a b c d e f 
Fig. 1—(A): Moditlcation of trypsin as a function of increasing 
concentration of RF on 15% SDS-PAGE (Trypsin (25 |.tg/ml) was 
incubated with increasing concentration of RF and irradiated for 
2.5 h in fluorescent light and then analyzed by SDS-PAGE. Lane 
a, trypsin alone: and lanes b-f. trypsin + 50, 75, 100, 150 and 
2(X) \lM RF, respectively]; and (B): Modification of trypsin as a 
function of increasing Cu(II) concentration on 157o SDS-PAGE 
[Trypsin (25 \i.g,lm\) was incubated with 75 pM RF and increasing 
Cu(ll) concentration for 2.5 h in fluorescent light and then 
analyzed by SDS-PAGE. Lane a, trypsin alone; lane b, trypsin -l-
RF; and lanes c-f, trypsin + RF and 50, 75, 100 and 150 \iM 
Cu(ll). respectively] 
for 2.5 h (Fig. IB). Protein degradation was evident at 
75 liM Cu(II) (lane d) and the protein band altogether 
disappeared at a Cu(II) concentration of 150 /xM 
(lane 0- hi the experiment performed in the presence 
of various free radical scavengers, almost complete 
inhibition of trypsin degradation by RF was observed 
when SOD, KI, NaN.i and CAT were included in the 
reaction (Fig. 2A). Whereas in the case of RF-Cu(II). 
TU was most effective in inhibiting the degradation of 
trypsin, followed by KI and NaN? (Fig. 2B). 
Cu(I) sequestering agent neocuproine was 
employed to investigate whether Cu(II) is converted 
to Cu(I) in the photodegradation process initiated by 
RF. The degradation pattern of trypsin (Fig. 3) by RF 
alone (lane b) was found to be similar to that observed 
when neocuproine was also used with RF (lane c). 
However, degradation patterns of samples treated 
with RF and Cu(Il) alone (lane d) and in combination 
with neocuproine were remarkedly different (lane e). 
The presence of neocuproine led to almost complete 
inhibition of degradation, suggesting the involvement 
of Cu(I) in RF-Cu(II)-mediated damage of trypsin. 
The spectral changes in RF induced by light under 
different conditions were recorded (Fig. 4, 5). RF 
exhibited a visible spectrum with a major peak of 
absorbance at 440 nm and a minor peak at 370 nm. 
Incubation of RF under fluorescent light for 2 h 
caused almost coinplete disappearance of absorption 
peak at 440 nm. The presence of Cu(II) restored the 
A[ 
a b 
B 
^ 
c 
». » 
d 
^ i i 
e 
^ 
f 
- 1 
g 
g 
Fig. 2—SDS-PAGE analysis of trypsin photoilluminated with 
(A): RF; and (B); RF+Cu(II) in the presence of free radical 
scavengers [Trypsin (25 ng/ml) was incubated with (A): 75 \xM 
RF; and (B): 75 fiM RF-150 /iM Cu(II) and various free radicals 
scavengers for 2.5 h in fluorescent light, respectively. The 
samples were then analyzed-by SDS-PAGE. (A): Lane a. trypsin 
alone; lane b, trypsin-l-RF; and lanes c-g, trypsin -H RF -i-
KI/NaNj/CAT/SOD/TU; and (B); Lane a, trypsin alone; lane b, 
trypsin-i-RF; lane c. trypsin+RF-i-Cu(II); and lanes d-g, trypsin + 
RF + Cu(II) -I- NaN,/KI/TU/SOD. The concentration of free 
radical scavengers was 50 mM whereas, 20 ^ig/ml SOD or CAT 
was used] 
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peak partially. In tiic presence of neocuproine, RF 
degradation was inhibited significantly (Fig. 6), 
confirming the role of Cu(I) as an essential 
intermediate in th&reaction. 
Discussion 
RF is widely distributed in human tissue and fluids 
in free and conjugated form. It has also found 
Fig. 3—SDS-PAGE of liypsiii plioloilluiiiinalcd wiili RF. 
RF+Cu(II) in presence of Cu(l) sequestering agent neocuproine 
[Trypsin (25 iig/m\) vvas incubated witli 75 fiM RF alone and 
together with 150 nM Cu(II) in the presence of 300 nM 
neocuproine for 2.5 h in Huorescent h'glit. The samples were then 
analyzed by SDS-PAGE. Lane a, trypsin alone: lane b, trypsin + 
RF; lane c, trypsin+RF+neocuproine; lane d, trypsin + RF + 
Cu(ll): and lane e. trypsin + RF + Cu(II) + neocuproine] 
widespread application in the food industry both as a 
nutrient and coloring agent. Our previous report 
shows that RF upon photoexcitation generates 
singlet and triplet excited states, which via energy 
transfer generates singlet and triplet oxygen and 
RF gets partly demoted to its original state \ 
Superoxide anion is also generated when molecular 
oxygen and water are present in the medium. It 
seems that the superoxide anion is not directly 
derived from RF, as SOD was found ineffective in 
preventing photodegradation of RF. In the presence of 
Cu(II), however when H2O and molecular O: 
are also available in the medium hydroxyl radical and 
hydroxyl ions are generated via Fenton-like 
reaction, which presumably gives rise to H^O: and 
Cu(II) gets reduced to Cu(I) in the process''\ This 
property is also exhibited by a number of other 
endogenous metabolites such as uric acid"' and 
L-DOPA-^ 
360 380 400 420 
Wivslangth In nm 
B 
400 420 440 
W«v»)«nath In nm 
Fig. 4—Absorption spectra oi' RF under different conditions [RF alone; and RF with radical scavengers (Kl, NaN,, TU, SOD, CAT and 
MNL) at (A): zero lime; and (B): 2 h of incubation under Huorescent light. (A); (1) RF+CAT; (2) RF+TU; (3) RF+MNL; (4) RF+NaN^; 
(5) RF+SOD; (6) RF+Kl; and (7) RF alone; and (B): (1) RF+NaN.,; (2) RF+KI; (3) RF+TU; (4) RF+CAT; (5) RF+MNL; (6) RF+SOD; 
and (7) RF alone. The concentration of RF and radical scavengers were 75 /xA-/. 50 mM. 20 J.lg/nil SOD or CAT was used[ 
380 380 400 420 
Wav«l«ngth In nm 
38« 400 420 440 
Wavelangth In nm 
••RF+Cii (II)+CAT 
•ttK*Cu(tlv*KI 
>RF>Cu(il) 
•4<K+Cu(ll>+MM. 
' F+Cu (M)+NAN, 
•«F+Cu(n)+TU 
•ftF+Cu(ll)+SOIJ 
Fig. 5—Ab.sorption spectra of RF+Cu(II) under different conditions [RF + Cu(II); and RF + Cu(ll) in the presence of radical scavengers 
(KI. NaNj. TU, SOD, CAT, MNL) at (A): zero time; and (B): 2 h of incubation under lluorescent light. (A): (1) RF+Cu(II)+CAT;"(2) 
RF+Cu(II)+MNL; (3) RF+Cu(n); (4) RF+Cu(II)+KI; (5) RF+Cu(n)+SOD; (6) RF+Cu(lI)+TU; and (7) RF+Cu(lI)+NaN.,. (B): (1) 
RF+Cu(II)+CAT; (2) RF+Cu(II)+Kl; (3) RF+Cu(H); (4) RF+Cu(II)+MNL; (5) RF+Cu(l[)+NaN,; (6) RF+Cu(il)+TU; and (7) 
RF+Cu(ll)+SOD. The concentration of RF, Cu(II) and radical .scavengers were 75 iiM. 150 nM. 50 mM respectively. 20 |ag/ml SOD or 
CAT was used] 
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•KF+CudlHNc" 
•Cu(l l ) 
uo 420 ua 
Wavelength In nm 
m m 420 
Wavelength In nm 
•• RF+N.o 
pj„ 6—Absorption .spccu;i ol' I^ F nionc; and RF+Cu(II) in presence of neocuproine under dilTeienl conditions [RF alone; RF + Cii(II); 
RF+ iieocupioinc; and RF + Cu(U) + ncocupioinc at (A): zero lime; and (B): 2 h of inctibation under Ouorescent light. (A): (I) RF + 
Cu(II)+neocupioine: (2) RF + neocuproine; (3) RF+Cu(II); and (4) RF alone. (B): (I) RF + Cu(ll) + neocuproine; (2) RF + Cu(II); (3) RF 
+ neocuproine; and (4) RF alone. The coiicciilralion of RF. Cu(II) and neocuproine were 75 flM. 150 i^M. 300 nM respectivelyj 
Singlet and triplet oxygen generated in the 
reaction are pos.sibly directly derived from RF, 
hence (he presence of KI and NaN^ resulted in the 
complete restoration ol" peak at 440 nm. As these 
species are not involved in any other reaction, they 
may be predominantly involved in protein damaging 
reaction. However, in the presence of Cu(I[), 
hydroxyl radical seems to be predominant in 
damaging protein, but it may not be directly derived 
from RF. as TU was effective in inhibiting 
photodegradation, when Cu(I!) was present. But, it is 
certain that Cu(Ii) is reduced to Cu(I) in the process, 
as neocuproine completely inhibited the 
photodegradation of RF in the presence of Cu(n) as 
well as degradation of trypsin, while with RF alone, il 
had no effect on either spectra of RF or on the 
degradation of trypsin. 
In conclusion, the present study suggests that 
singlet and triplet oxygen are the major protein 
damaging species that are directly derived from 
photoilluminated RF via direct energy transfer. 
However, hydoxyl radical appears to be the 
predominant damaging species that is generated via 
H2O2. when RF is illuminated in the presence of 
Cu(II). 
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